0001104659-13-028992.txt : 20130412 0001104659-13-028992.hdr.sgml : 20130412 20130412150235 ACCESSION NUMBER: 0001104659-13-028992 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 8 FILED AS OF DATE: 20130412 DATE AS OF CHANGE: 20130412 GROUP MEMBERS: DOUGLAS GRANAT GROUP MEMBERS: LAWRENCE A. OBERMAN GROUP MEMBERS: STEVEN G. SIMON GROUP MEMBERS: TRIGRAN INVESTMENTS, L.P. GROUP MEMBERS: TRIGRAN INVESTMENTS, L.P. II SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SCIENTIFIC LEARNING CORP CENTRAL INDEX KEY: 0001042173 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-EDUCATIONAL SERVICES [8200] IRS NUMBER: 943234458 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-58137 FILM NUMBER: 13758562 BUSINESS ADDRESS: STREET 1: 300 FRANK H. OGAWA PLAZA STREET 2: STE 600 CITY: OAKLAND STATE: CA ZIP: 94612-2040 BUSINESS PHONE: 5104443500 MAIL ADDRESS: STREET 1: 300 FRANK H. OGAWA PLAZA STREET 2: SUITE 600 CITY: OAKLAND STATE: CA ZIP: 94612-2040 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Trigran Investments, Inc. CENTRAL INDEX KEY: 0001336800 IRS NUMBER: 363825728 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 630 DUNDEE ROAD STREET 2: SUITE 230 CITY: NORTHBROOK STATE: IL ZIP: 60062 BUSINESS PHONE: 8476561640 MAIL ADDRESS: STREET 1: 630 DUNDEE ROAD STREET 2: SUITE 230 CITY: NORTHBROOK STATE: IL ZIP: 60062 SC 13D/A 1 a13-10011_1sc13da.htm SC 13D/A

 

 

UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 

 

 

 

SCHEDULE 13D/A

 

 

Under the Securities Exchange Act of 1934
(Amendment No. 7)*

 

Scientific Learning Corporation

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

808760102

(CUSIP Number)

 

Lawrence A. Oberman

Trigran Investments, Inc.

630 Dundee Road

Suite 230

Northbrook, IL 60062

847-656-1640

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

April 5, 2013

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. x

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 



 

CUSIP No. 808760102

 

 

1.

Names of Reporting Persons
Trigran Investments, Inc.

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 x

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
AF

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
Illinois company

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
6,690,242*

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
6,690,242*

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
6,690,242*

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
Approximately 27.4% as of April 5, 2013 (based on 23,578,753 shares of Common Stock outstanding per Form 10-K dated April 1, 2013, plus 416,184 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of Amendment 6 to this Schedule 13D, plus 401,508 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of this Amendment 7 acquired by the reporting person in connection with the transaction reported herein).

 

 

14.

Type of Reporting Person (See Instructions)
CO

 


* Includes 416,184 shares underlying presently exercisable Warrants described in Item 4 of Amendment 6 to this Schedule 13D and 401,508 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of this Amendment 7.  Also includes 46,355 shares held in certain accounts advised by Trigran Investments, Inc.  The reporting person may be deemed a beneficial owner of these 46,355 shares for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and Rule 13d-3(a) thereunder; however, the reporting person has no pecuniary interest in such shares.    

 

2



 

CUSIP No. 808760102

 

 

1.

Names of Reporting Persons
Trigran Investments, L.P.

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 x

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
WC

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
Illinois limited partnership

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
4,272,596*

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
4,272,596*

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
4,272,596*

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
Approximately 17.7% as of April 5, 2013 (based on 23,578,753 shares of Common Stock outstanding per Form 10-K dated April 1, 2013, plus 261,780 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of Amendment 6 to this Schedule 13D, plus 253,753 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of this Amendment 7 acquired by the reporting person in connection with the transaction reported herein).

 

 

14.

Type of Reporting Person (See Instructions)
PN

 


* Includes 261,780 shares underlying presently exercisable Warrants described in Item 4 of Amendment 6 to this Schedule 13D and 253,753 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of this Amendment 7.

 

3



 

CUSIP No. 808760102

 

 

1.

Names of Reporting Persons
Trigran Investments, L.P. II

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 x

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
WC

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
Illinois limited partnership

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
2,371,291*

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
2,371,291*

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
2,371,291*

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
Approximately 9.9% as of April 5, 2013 (based on 23,578,753 shares of Common Stock outstanding per Form 10-K dated April 1, 2013, plus 154,404 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of Amendment 6 to this Schedule 13D, plus 147,755 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of this Amendment 7 acquired by the reporting person in connection with the transaction reported herein).

 

 

14.

Type of Reporting Person (See Instructions)
PN

 


* Includes 154,404 shares underlying presently exercisable Warrants described in Item 4 of Amendment 6 to this Schedule 13D and 147,755 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of this Amendment 7.

 

4



 

CUSIP No. 808760102

 

 

1.

Names of Reporting Persons
Douglas Granat

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 x

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
AF

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
U.S. Citizen

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
6,690,242*

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
6,690,242*

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
6,690,242*

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
Approximately 27.4% as of April 5, 2013 (based on 23,578,753 shares of Common Stock outstanding per Form 10-K dated April 1, 2013, plus 416,184 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of Amendment 6 to this Schedule 13D, plus 401,508 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of this Amendment 7 acquired by the reporting person in connection with the transaction reported herein).

 

 

14.

Type of Reporting Person (See Instructions)
IN

 


* Includes 416,184 shares underlying presently exercisable Warrants described in Item 4 of Amendment 6 to this Schedule 13D and 401,508 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of this Amendment 7.  Also includes 46,355 shares held in certain accounts advised by Trigran Investments, Inc.  The reporting person may be deemed a beneficial owner of these 46,355 shares for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and Rule 13d-3(a) thereunder; however, the reporting person has no pecuniary interest in such shares.

 

5



 

CUSIP No. 808760102

 

 

1.

Names of Reporting Persons
Lawrence A. Oberman

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 x

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
AF

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
U.S. Citizen

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
6,690,242*

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
6,690,242*

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
6,690,242*

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
Approximately 27.4% as of April 5, 2013 (based on 23,578,753 shares of Common Stock outstanding per Form 10-K dated April 1, 2013, plus 416,184 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of Amendment 6 to this Schedule 13D, plus 401,508 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of this Amendment 7 acquired by the reporting person in connection with the transaction reported herein).

 

 

14.

Type of Reporting Person (See Instructions)
IN

 


* Includes 416,184 shares underlying presently exercisable Warrants described in Item 4 of Amendment 6 to this Schedule 13D and 401,508 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of this Amendment 7.  Also includes 46,355 shares held in certain accounts advised by Trigran Investments, Inc.  The reporting person may be deemed a beneficial owner of these 46,355 shares for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and Rule 13d-3(a) thereunder; however, the reporting person has no pecuniary interest in such shares.

 

6



 

CUSIP No. 808760102

 

 

1.

Names of Reporting Persons
Steven G. Simon

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 x

 

 

3.

SEC Use Only

 

 

4.

Source of Funds (See Instructions)
AF

 

 

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6.

Citizenship or Place of Organization
U.S. Citizen

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7.

Sole Voting Power
0

 

8.

Shared Voting Power
6,690,242*

 

9.

Sole Dispositive Power
0

 

10.

Shared Dispositive Power
6,690,242*

 

 

11.

Aggregate Amount Beneficially Owned by Each Reporting Person
6,690,242*

 

 

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)   o

 

 

13.

Percent of Class Represented by Amount in Row (11)
Approximately 27.4% as of April 5, 2013 (based on 23,578,753 shares of Common Stock outstanding per Form 10-K dated April 1, 2013, plus 416,184 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of Amendment 6 to this Schedule 13D, plus 401,508 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of this Amendment 7 acquired by the reporting person in connection with the transaction reported herein).

 

 

14.

Type of Reporting Person (See Instructions)
IN

 


* Includes 416,184 shares underlying presently exercisable Warrants described in Item 4 of Amendment 6 to this Schedule 13D and 401,508 shares of Common Stock underlying presently exercisable Warrants described in Item 4 of this Amendment 7.  Also includes 46,355 shares held in certain accounts advised by Trigran Investments, Inc.  The reporting person may be deemed a beneficial owner of these 46,355 shares for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and Rule 13d-3(a) thereunder; however, the reporting person has no pecuniary interest in such shares.

 

7



 

CUSIP No. 808760102

 

This Amended Statement of Beneficial Ownership on Schedule 13D (“Amendment 7”) amends the Amended Statement of Beneficial Ownership on Schedule 13D filed on March 30, 2012 (“Amendment 6”), and all previous Statements of Beneficial Ownership on Schedule 13D filed in connection with the parties and matters referenced herein, with respect to the common stock (the “Common Stock”) of Scientific Learning Corporation, Inc. (the “Issuer”).  Any capitalized terms used and not defined in this Amendment 7 shall have the meanings set forth in Amendment 6, previous amendments and/or the original Schedule 13D to which this Amendment 7 relates.  Only those items that are hereby reported are amended; all other items, including previously filed exhibits, remain unchanged and are incorporated by reference herein.

 

Item 3.   Source and Amount of Funds or Other Consideration

 

A total of $1,000,000 was paid to acquire the Notes and Warrants (as defined and described in Item 4, below) reported herein.  Specifically, Trigran Investments, L.P. purchased $632,000 face amount of Notes and in connection therewith also acquired Warrants to purchase 253,753 shares of the Issuer’s Common Stock at an initial Exercise Price of $1.03.  Trigran Investments, L.P. II purchased $368,000 face amount of Notes and in connection therewith also acquired Warrants to purchase 147,755 shares of the Issuer’s Common Stock at an initial Exercise Price of $1.03.  There was no additional cost for the acquisition of the Warrants beyond the face amounts paid for the Notes.

 

The Notes and Warrants were acquired in the ordinary course of each Fund’s business and are held by each Fund in separate accounts maintained for each Fund.  While the Funds’ agreements with their prime broker permits the prime broker to extend margin credit to the Funds as and when required to open or carry positions in the accounts, subject to applicable federal margin regulations, stock exchange rules, and the prime broker’s credit policies, the Funds did not purchase any of the Notes or Warrants on margin.

 

Item 4. Purpose of Transaction

 

On April 5, 2013, Trigran Investments, L.P. purchased $632,000 face amount of Subordinated Promissory Notes (the “Notes”) and in connection therewith also acquired warrants (the “Warrants”) to purchase 253,753 shares of the Issuer’s Common Stock at an initial Exercise Price of $1.03.  Trigran Investments, L.P. II purchased $368,000 face amount of Notes and in connection therewith also acquired Warrants to purchase 147,755 shares of the Issuer’s Common Stock at an initial Exercise Price of $1.03.  There was no additional cost for the acquisition of the Warrants beyond the face amounts paid for the Notes.  The Notes mature on April 5, 2015, and have a simple interest rate of 12 percent per annum.  From the date of issuance through the first anniversary date, the Issuer will pay accrued and unpaid interest quarterly in arrears by increasing the principal amount of each Note.  Thereafter, it will pay accrued and unpaid interest in cash in arrears on July 31, 2014, November 30, 2014, and the final payment date.  The proceeds are to be used for repayment of outstanding indebtedness, working capital and general corporate purposes.  The Warrants are presently exercisable and expire on April 5, 2016.  The number of shares of Common Stock into which the Warrants are exercisable, and the exercise price, will be adjusted to reflect stock splits, stock dividends, recapitalizations, reclassifications and other adjustments in the number of outstanding shares, and the exercise price may be adjusted to reflect certain dividends or distributions including distributions of stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or similar transaction.  The holder may elect to pay the exercise price in cash or in a “cashless” exercise.

 

The transaction was effected pursuant to a Subordinated Note and Warrant Purchase Agreement (the “Purchase Agreement”) between the Issuer and certain purchasers (each a “Purchaser” and, collectively, the “Purchasers”), including but not limited to the reporting persons, pursuant to which the Issuer sold to the Purchasers Notes in the total face amount of $4,600,000 and Warrants to purchase a total of 1,846,940 shares of Common Stock.  As with the reporting persons’ earlier acquisitions of the Issuer’s Common Stock, the Notes and Warrants referred to in this Schedule 13D were acquired for investment in the ordinary course of the reporting persons’ investment activities and have not been acquired with any purpose of, or with the effect of, changing or influencing the control of the Issuer, or in connection with or as a participant in any transaction having that purpose or effect.

 

In connection with the purchase of the Notes and Warrants, the Issuer and the Purchasers also entered into a “Registration Rights Agreement” pursuant to which the Issuer, upon appropriate notice from Purchasers and/or transferees or assignees of Purchasers who agree to become bound by the provisions of the Registration Rights Agreement (Purchasers and such transferees and assignees collectively defined as “Buyers”), collectively holding a majority of (a) any shares of Common Stock issued or issuable upon exercise of or otherwise pursuant to the Warrants (without giving effect to any limitations on exercise set forth in the Warrants), (b) any shares of capital stock issued or issuable as a dividend on or in exchange for or otherwise with respect to any of the foregoing, (c) any additional shares of Common Stock issuable in connection with any anti-dilution provisions in the Warrants, and (d) any shares of capital stock issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing (“Registrable Securities”) then outstanding, the Issuer will use its commercially reasonable efforts to prepare, and, on or prior to the applicable Filing Deadline (as defined in the Registration Rights Agreement) file with the SEC a Registration Statement on Form S-3 (or, if Form S-3 is not then available, on such form of Registration Statement as is then available to effect a registration of the Registrable Securities) covering the resale of the Registrable Securities.  Each Registration Statement (and each amendment or supplement thereto) will be provided to and subject to the approval of, with respect to information regarding the Buyers and their plan of distribution, which shall not be unreasonably withheld or delayed, counsel to the Buyers, prior to its filing or other submission.

 

8



 

CUSIP No. 808760102

 

In connection with the purchase of the Notes and Warrants, the Issuer and the Purchasers also entered into a “Security Agreement” pursuant to which the Issuer granted to each of the Purchasers of the Notes a security interest in all property and interests in property of the Issuer, whether now owned or hereafter acquired or existing, and wherever located, including, without limitation, all (i) accounts; (ii) receivables; (iii) equipment; (iv) general intangibles; (v) inventory; (vi) intellectual property; (vii) investment property; and (viii) proceeds and products of the foregoing.

 

In connection with the purchase of the Notes and Warrants, the Issuer, the Purchasers and Comerica Bank (the “Bank”) entered into a “Subordination Agreement” pursuant to which pursuant to which the Purchasers, in order to induce the Bank to extend credit to the Issuer and, at any time or from time to time, at the Bank’s option, to make such further loans, extensions of credit, or other accommodations to or for the account of the Issuer, or to purchase or extend credit upon any instrument or writing in respect of which the Issuer may be liable in any capacity, or to grant such renewals or extension of any such loan, extension of credit, purchase, or other accommodation as the Bank may deem advisable, each Purchaser agreed to subordinate all of the Issuer’s present and future indebtedness and obligations to such Purchaser pursuant to the Purchase Agreement to all of the Issuer’s indebtedness and obligations to the Bank; and all of such Purchaser’s security interests, if any, to all of the Bank’s security interests in the Issuer’s property, notwithstanding the respective dates of attachment or perfection of the security interest of a Purchaser and the security interest of the Bank.

 

The reporting persons are filing this Schedule 13D in accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended.  The reporting persons may in the future, subject to the terms of the agreements described in Item 6 of Amendment 5 and earlier amendments, determine to purchase more Common Stock and/or dispose of Common Stock in the ordinary course of their investment activities, as market and other conditions dictate.  However, in connection with the agreements described in Item 6 of Amendment 5 and earlier amendments, the filing persons may from time to time be provided with information by the Issuer and may convey to the Issuer their views or opinions with regard to the matters set forth therein.

 

The foregoing descriptions of the terms of the Subordinated Note and Warrant Purchase Agreement, the Registration Rights Agreement, the Security Agreement, the Subordination Agreement and the Warrants are summaries only and are qualified in their entirety by the terms of each such agreement, copies of which are attached as exhibits hereto (see Item 7, below).

 

Item 5.   Interest in Securities of the Issuer

 

(a)-(b)  Incorporated by reference to Items (7) - (11) and (13) of the cover page relating to each reporting person and the disclosure set forth in Item 4 of this Amendment 7.

 

(c)        Other than the matters referred to herein, there have been no other transactions in the Common Stock by the reporting persons in the sixty days preceding the date of this filing.

 

(d)        Owners of certain accounts managed by Trigran Investments, Inc. have or may have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, securities of the Issuer held in their accounts. No such account has such power with respect to more than five percent of the class of securities to which this Schedule 13D relates.

 

(e)        Not applicable.

 

Item 6.   Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

 

The matters set forth in Items 3, 4 and 5 and the exhibits to this Amendment 7 to Schedule 13D, and those in Amendment 6 and all previous Statements of Beneficial Ownership on Schedule 13D filed in connection with the parties and matters referenced herein (including exhibits), are incorporated in this Item 6 by reference as if fully set forth herein.  Except for the matters discussed in this Amendment 7, in previous amendments and/or the original Schedule 13D to which this Amendment 7 relates, and any exhibits thereto, there are no contracts, arrangements, understandings or relationships with respect to securities of the Issuer.

 

Item 7.   Material to be Filed as Exhibits

 

Exhibit 99.1 — Joint Filing Agreement

Exhibit 99.2 — Subordinated Note and Warrant Purchase Agreement dated April 5, 2013 (including form of Note).

Exhibit 99.3 — Registration Rights Agreement dated April 5, 2013.

Exhibit 99.4 — Security Agreement dated April 5, 2013.

Exhibit 99.5 — Subordination Agreement dated April 5, 2013.

Exhibit 99.6 — Form of Warrant to Purchase Common Stock (Trigran Investments, L.P.) dated April 5, 2013.

Exhibit 99.7 — Form of Warrant to Purchase Common Stock (Trigran Investments, L.P. II) dated April 5, 2013.

 

9



 

CUSIP No. 808760102

 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated this 12th day of April, 2013

 

 

 

TRIGRAN INVESTMENTS, INC.

 

 

 

/s/ Lawrence A. Oberman

 

Lawrence A. Oberman

 

Executive Vice President and Director

 

 

 

TRIGRAN INVESTMENTS, L.P.

 

 

 

/s/ Lawrence A. Oberman

 

Lawrence A. Oberman

 

Executive Vice President and Director of Trigran Investments, Inc., the General Partner of Trigran Investments, L.P

 

 

TRIGRAN INVESTMENTS, L.P. II

 

 

 

/s/ Lawrence A. Oberman

 

Lawrence A. Oberman

 

Executive Vice President and Director of Trigran Investments, Inc., the General Partner of Trigran Investments, L.P II

 

 

/s/ Lawrence A. Oberman

 

Lawrence A. Oberman

 

 

 

/s/ Douglas Granat

 

Douglas Granat

 

 

 

/s/ Steven G. Simon

 

Steven G. Simon

 

 

10


EX-99.1 2 a13-10011_1ex99d1.htm EX-99.1

EXHIBIT 99.1

 

JOINT FILING AGREEMENT

 

April 12, 2013

 

In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, TRIGRAN INVESTMENTS, INC., TRIGRAN INVESTMENTS, L.P., TRIGRAN INVESTMENTS, L.P. II, DOUGLAS GRANAT, LAWRENCE A. OBERMAN and STEVEN G. SIMON each hereby agree to the joint filing of this statement on Schedule 13D (including any and all amendments hereto).  In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13D. A copy of this Agreement shall be attached as an exhibit to the Statement on Schedule 13D filed on behalf of each of the parties hereto, to which this Agreement relates.

 

This Agreement may be executed in multiple counterparts, each of which shall constitute an original, one and the same instrument.

 

TRIGRAN INVESTMENTS, INC.

 

 

 

 

 

 

 

By:

/s/ Lawrence A. Oberman

 

 

Name: Lawrence A. Oberman

 

 

Title: Executive Vice President and Director

 

 

 

 

 

 

 

TRIGRAN INVESTMENTS, L.P.

 

 

 

 

 

 

 

By:

/s/ Lawrence A. Oberman

 

 

Name: Lawrence A. Oberman

 

 

Title: Executive Vice President and Director of Trigran Investments, Inc., the General Partner of Trigran Investments, L.P.

 

 

 

 

 

 

TRIGRAN INVESTMENTS, L.P. II

 

 

 

 

 

 

 

By:

/s/ Lawrence A. Oberman

 

 

Name: Lawrence A. Oberman

 

 

Title: Executive Vice President and Director of Trigran Investments, Inc., the General Partner of Trigran Investments, L.P. II

 

 

 

 

 

 

DOUGLAS GRANAT

 

 

 

 

 

 

 

/s/ Douglas Grant

 

 

 

 

LAWRENCE A. OBERMAN

 

 

 

 

 

 

 

/s/ Lawrence A. Oberman

 

 

 

 

STEVEN G. SIMON

 

 

 

 

 

 

 

/s/ Steven G. Simon

 

 


EX-99.2 3 a13-10011_1ex99d2.htm EX-99.2

EXHIBIT 99.2

 

EXECUTION VERSION

 

SUBORDINATED NOTE AND WARRANT PURCHASE AGREEMENT

 

SUBORDINATED NOTE AND WARRANT PURCHASE AGREEMENT (as amended, restated, modified or otherwise supplemented from time to time, this “Agreement”), dated as of April 5, 2013, between Scientific Learning Corporation, a Delaware corporation (the “Company”), and the purchasers set forth on the signature page of this Agreement (the “Purchasers” and, together with the Company, the “Parties”).

 

W I T N E S S E T H:

 

WHEREAS, the Company wishes to issue to the Purchasers Subordinated Promissory Notes in the form of Exhibit A (each a “Note” and together the “Notes”) in the aggregate principal amount of four million six hundred thousand Dollars ($4,600,000) for the purpose described in Section 2.1; and

 

WHEREAS, the Purchasers desire to purchase such notes from the Company for such purpose,

 

NOW, THEREFORE, in consideration of the mutual agreements set forth herein, the Parties agree as follows:

 

ARTICLE 1

 

DEFINITIONS

 

Section 1.1                                   General Definitions.  Wherever used in this Agreement, the Exhibits or the Schedules attached hereto, unless the context otherwise requires, the following terms have the following meanings:

 

Affiliate” means, with respect to any Person, any other Person:

 

(a)                                 that owns, directly or indirectly, in the aggregate more than 10% of the beneficial ownership interest of such Person;

 

(b)                                 that directly or indirectly through one or more intermediaries controls, or is controlled by, or is under common control with, such Person; or

 

(c)                                  that directly or indirectly is a general partner, controlling shareholder, or managing member of such Person.

 

Agreement Date” means the date of this Agreement.

 

Applicable Laws” means all statutes, rules and regulations of any Governmental Authority in the United States or elsewhere.

 

Authorizations” has the meaning set forth in Section 3.1(p).

 



 

Business Day” means a day on which banks are open for business in The City of New York and San Francisco, California.

 

Change of Control” means an event that shall be deemed to have occurred any time after the Agreement Date when any of the following events occurs:

 

(1)                                 any “person” or “group,” other than the Company, its Subsidiaries and the employee benefits plans of the Company and of its Subsidiaries, has become the direct or indirect “beneficial owner,” of the shares of the Company’s capital stock representing more than 50% of the total voting power of the Company;

 

(2)                                 consummation of any consolidation or merger of the Company pursuant to which the Common Stock is or will be converted into cash, securities or other property or any sale, lease or other transfer in one transaction or a series of transactions of all or substantially all of the consolidated assets of the Company and its Subsidiaries, taken as a whole, to any person other than one or more of the Company’s Subsidiaries; provided, however, that if in any such transaction the holders of more than 50% of the shares of the Company’s common equity, representing more than 50% of the voting power of the Company immediately prior to such transaction, own, directly or indirectly, more than 50% of all classes of common equity, representing more than 50% of the total voting power of the continuing or surviving Person or transferee or the parent thereof immediately after such transaction, such transaction shall not constitute a Change of Control under this clause (2); or

 

(3)                                 the holders of the Common Stock approve any plan or proposal for the Company’s liquidation or dissolution.

 

For purposes of this definition:

 

(i)                                     whether a person is a “beneficial owner” will be determined in accordance with Rule 13d-3 under the Exchange Act;

 

(ii)                                  “person” includes any syndicate or group that would be deemed to be a “person” under Section 13(d)(3) of the Exchange Act; and

 

(iii)                               any transaction or event that constitutes a Change of Control under both clause (1) and clause (2) above will be deemed to be a Change of Control solely under clause (2) above.

 

Code” means the Internal Revenue Code of 1986, as amended, and any Treasury Regulations promulgated thereunder.

 

Comerica Loan Agreement” means that certain Amended and Restated Loan and Security Agreement dated as of February 9, 2012 (as amended by that certain First Amendment to Amended and Restated Loan and Security Agreement dated as of June 11, 2012, that certain Second Amendment to Amended and Restated Loan and Security Agreement dated as of August 14, 2012 and that certain Third Amendment to Amended and Restated Loan and Security Agreement dated as of April 5, 2013), by and between Comerica Bank and the Company, as in effect on the date hereof.

 

2



 

Common Stock” means the common stock, par value $0.001 per share, of the Company or any security into which such common stock is reclassified or which is issued in replacement of the common stock.

 

Default” means any event which, at the giving of notice, lapse of time or fulfillment of any other applicable condition (or any combination of the foregoing), would constitute an Event of Default.

 

Disclosure Schedule” means the disclosure schedule attached to this Agreement.

 

Dollars” and the “$” sign mean the lawful currency of the United States of America.

 

Domestic Subsidiary” means a Subsidiary organized under the laws of a jurisdiction located in the United States of America, other than any such Subsidiary substantially all of the assets of which consist of stock in Foreign Subsidiaries that are “controlled foreign corporations” within the meaning of Section 957(a) of the Code.

 

Event of Default” has the meaning given to it in Section 5.4.

 

Exchange Act” means the Securities Exchange Act of 1934, as amended, including the rules and regulations promulgated thereunder.

 

Excluded Taxes” means with respect to any Purchaser, (a) income or franchise Taxes imposed on (or measured by) such Purchaser’s net income by the United States of America, or by the jurisdiction (or any political subdivision thereof) under the laws of which such Purchaser is organized or incorporated or in which the principal office or applicable lending office of such Purchaser is located or with which it has a present or former connection (other than any connection arising solely from having executed, delivered, performed its obligations or received payment under, or enforced this Agreement), (b) any branch profits Taxes imposed by the United States of America, or (c) any withholding Tax that is imposed on amounts payable to the Purchaser under laws in effect at the time the Purchaser becomes a party to this Agreement (or designates a new lending office) or is directly attributable to such Purchaser’s failure or inability to comply with Section 2.5(d), except to the extent that the Purchaser (or its assignor, if any) was entitled, at the time of designation of a new lending office (or assignment), to receive additional amounts from the Company with respect to such withholding Tax pursuant to Section 2.5(a) or is legally unable to comply with Section 2.5(d) as a result of any change in law occurring subsequent to the date such Purchaser becomes a party to this Agreement (or designates a new lending office).

 

Final Payment” means such amount as may be necessary to repay the outstanding principal and interest amount of the Notes and any other amounts owing by the Company to the Purchasers pursuant to the Transaction Documents.

 

Final Payment Date” means, subject to Section 2.3(a), the earlier of (i) the date on which the Company repays the Notes (together with any other amounts accrued and unpaid under the Transaction Documents) and (ii) the second anniversary of the Agreement Date.

 

3



 

GAAP” means generally accepted accounting principles consistently applied as set forth in the opinions and pronouncements of the Accounting Principles Board and the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board (or agencies with similar functions of comparable stature and authority within the accounting profession).

 

Government Authority” means any government, governmental department, ministry, cabinet, commission, board, bureau, agency, tribunal, regulatory authority, instrumentality, judicial, legislative, fiscal, or administrative body or entity, whether domestic or foreign, federal, state or local, having jurisdiction over the matter or matters and Person or Persons in question.

 

Indebtedness” means the following:

 

(i)                                     all indebtedness for borrowed money;

 

(ii)                                  the deferred purchase price of assets or services (other than payables) which in accordance with GAAP would be shown to be a liability on the balance sheet;

 

(iii)                               all guarantees of Indebtedness;

 

(iv)                              the maximum amount of all letters of credit issued or acceptance facilities established for the account of the Company and any of its Subsidiaries, including without duplication, all drafts drawn thereunder;

 

(v)                                 all capitalized lease obligations (determined in accordance with GAAP on the Agreement Date); and

 

(vi)                              all Indebtedness of another Person secured by any Lien on any property of the Company or its Subsidiaries, whether or not such Indebtedness has been assumed or is recourse (with the amount thereof, in the case of any such indebtedness that has not been assumed by the Company or its Subsidiaries, being measured as the lower of (x) fair market value of such property and (y) the amount of the indebtedness secured).

 

In no event shall the term “Indebtedness” include (a) any indebtedness under any overdraft or cash management facilities or under credit cards or purchase card arrangements so long as any such indebtedness is repaid in full no later than five Business Days following the date on which it was incurred or in the case of such indebtedness in respect of credit or purchase cards, within 60 days of its incurrence, (b) any obligations in respect of a lease properly classified as an operating lease in accordance with GAAP (as in effect on the Agreement Date), (c) any liability for federal, state, local or other taxes not yet delinquent or being contested in good faith and for which adequate reserves have been established to the extent required by GAAP, (d) accrued liabilities in the ordinary course of business or (e) any customer deposits or advance payments received in the ordinary course of business.

 

Indemnified Person” has the meaning given to it in Section 6.11.

 

4



 

Indemnified Taxes” means all Taxes including Other Taxes, other than Excluded Taxes.

 

Indemnity” has the meaning given to it in Section 6.11.

 

Interest Rate” means 12% simple interest per annum.

 

IP” and “Intellectual Property” have the respective meanings given to them in Section 3.1(l).

 

Lien” means any lien, pledge, preferential arrangement, mortgage, security interest, deed of trust, charge, assignment, hypothecation, title retention, or other encumbrance on or with respect to property or interest in property.

 

Loan” means the aggregate principal amount outstanding under the Notes.

 

Loss” has the meaning given to it in Section 6.11.

 

Majority in Interest” means the Purchasers holding Notes representing at least 51% of the aggregate principal amount of the outstanding Notes.

 

Material Adverse Effect” means a material adverse effect on (a) the business, operations, condition (financial or otherwise) or assets of the Company and its Subsidiaries, taken as a whole, (b) the validity or enforceability of any material provision of any Transaction Document, (c) the ability of the Company to timely perform the Obligations or (d) the rights and remedies of the Purchasers, taken as a whole, under any Transaction Document.

 

Obligations” means all obligations (monetary or otherwise) of the Company arising under or in connection with the Transaction Documents other than the Registration Rights Agreement and the Warrants.

 

Organizational Documents” means the Certificate of Incorporation and Bylaws, each as amended to date, of the Company or its Subsidiaries, as the context may require.

 

Other Taxes” means any and all present or future stamp or documentary taxes or any other excise or property taxes, duties, other charges or similar levies, and all liabilities with respect thereto, together with any interest, fees, additions to tax or penalties applicable thereto (including by reason of any delay in payment) arising from any payment made hereunder or from the execution, delivery, registration or enforcement of, or otherwise with respect to, any Transaction Document.

 

Permitted Indebtedness” means Indebtedness existing as of the Agreement Date and set forth in the Disclosure Schedule and:

 

(i)                                     the Obligations;

 

(ii)                                  Indebtedness in an outstanding aggregate principal amount not to exceed $4,250,000, consisting of Indebtedness presently or hereafter outstanding in favor of Comerica Bank (the “Comerica Loan”), whether in the form of the

 

5



 

Comerica Loan Agreement or revolving credit loans, term loans, receivables financing or letters of credit, in each case, as amended, restated, modified, renewed, refunded, replaced or refinanced (with refunding, replacement or refinancing by Comerica Bank and not, for avoidance of doubt, any other lender) in whole or in part from time to time; provided that no such debt facility (or amendment, restatement, modification, renewal, refunding, replacement or refinancing thereof) shall result in such Indebtedness having a maturity date for all principal and interest later than the Final Payment Date;

 

(iii)                               Indebtedness described in Item (v) under the definition of Indebtedness;

 

(iv)                              Indebtedness secured by purchase money Liens; provided that such Indebtedness when incurred by the Company or any of its Subsidiaries shall not exceed the purchase price of the asset(s) financed;

 

(v)                                 Performance bonds, surety bonds, bank guaranties and similar instruments incurred in the ordinary course of business;

 

(vi)                              Guarantees with respect to any obligation that would otherwise constitute Permitted Indebtedness if incurred directly by the Company;

 

(vii)                           Indebtedness (i) of the Company to any Subsidiary or (ii) of any Subsidiary to Company or any other Subsidiary;

 

(viii)                        Indebtedness consisting of (A) the financing of insurance premiums or (B) take-or-pay obligations contained in supply agreements; and

 

(ix)                              Any refinancings, renewals, extensions, increases or replacements of Indebtedness listed in clauses (iii) or (iv) so long as no such Indebtedness shall be refinanced for a principal amount in excess of the principal balance outstanding thereon at the time of such refinancing.

 

Person” means and includes any natural person, individual, partnership, joint venture, corporation, trust, limited liability company, limited company, joint stock company, unincorporated organization, government entity or any political subdivision or agency thereof, or any other entity.

 

Register” has the meaning set forth in Section 1.4(b).

 

Registration Rights Agreement” means the Registration Rights Agreement, dated as of the Agreement Date, by and among the Company and the Purchasers, as amended, restated, modified or supplemented from time to time.

 

SEC” means the United States Securities and Exchange Commission.

 

SEC Reports” means the annual, quarterly and periodic reports filed by the Company with the SEC.

 

6



 

Securities Act” means the Securities Act of 1933, as amended, including the rules and regulations promulgated thereunder.

 

Security Agreement” mean the agreement executed on the Agreement Date pursuant to which the Company grants to the Purchasers a lien the collateral described therein to secure its obligations under the Transaction Documents (excluding the Warrants and the Registration Rights Agreement).

 

Subordination Agreement” mean the agreement executed on the Agreement Date among the Company, the Purchasers and Comerica Bank.

 

Subsidiary” or “Subsidiaries” means, as to the Company, any entity of which securities or other ownership interests having ordinary voting power to elect a majority of the board of directors or other persons performing similar functions are at the time directly or indirectly owned by the Company.

 

Taxes” means all present or future taxes, levies, imposts, stamp or other duties, fees, assessments, deductions, withholdings, all other governmental charges, and all liabilities with respect thereto, together with any interest, fees, additions to tax or penalties applicable thereto (including by reason of any delay in payment).

 

Transaction Documents” means this Agreement, the Notes, the Security Agreement, the Subordination Agreement, the Warrants, the Registration Rights Agreement and any other document or instrument delivered in connection with any of the foregoing and dated the Agreement Date or subsequent thereto, whether or not specifically mentioned herein or therein.

 

Warrants” has the meaning given to it in Section 2.9.

 

Warrant Shares” has the meaning set forth in Section 3.1(w).

 

Section 1.2                                   Interpretation.  In this Agreement, unless the context otherwise requires, all words and personal pronouns relating thereto shall be read and construed as the number and gender of the party or parties requires and the verb shall be read and construed as agreeing with the required word and pronoun; the division of this Agreement into Articles and Sections and the use of headings and captions is for convenience of reference only and shall not modify or affect the interpretation or construction of this Agreement or any of its provisions; the words “herein,” “hereof,” “hereunder,” “hereinafter” and “hereto” and words of similar import refer to this Agreement as a whole and not to any particular Article or Section hereof; the words “include,” “including,” and derivations thereof shall be deemed to have the phrase “without limitation” attached thereto unless otherwise expressly stated; references to a specified Article, Exhibit, Section or Schedule shall be construed as a reference to that specified Article, Exhibit, Section or Schedule of this Agreement; and any reference to any of the Transaction Documents means such document as the same shall be amended, restated, supplemented or modified and from time to time in effect.

 

Section 1.3                                   Business Day Adjustment.  If the day by which a payment is due to be made is not a Business Day, that payment shall be made by the next succeeding Business Day.

 

7



 

Section 1.4                                   Registration of Notes.

 

(a)                                 The Company or its agent shall record on its books and records the amount of each Note, the interest rate applicable, all payments of principal and interest thereon and the principal balance thereof from time to time outstanding.

 

(b)                                 The Company or its agent shall establish and maintain at the Company’s address referred to in Section 6.1, (i) a record of ownership (the “Register”) in which the Company agrees to register by book entry the Notes, and any assignment of any such Note, and (ii) accounts in the Register in accordance with its usual practice in which it shall record (1) the names and addresses of the Purchasers (and any change thereto pursuant to this Agreement), (2) the amount of the Note held by each Purchaser, (3) the amount of any principal or interest due and payable or paid, and (4) any other payment received by the Purchasers from the Company and its application to the Notes.

 

(c)                                  Notwithstanding anything to the contrary contained in this Agreement, the Notes evidencing the Loan are registered obligations; the right, title and interest of the Purchasers and their assignees in and to the Notes shall be transferable only upon notation of such transfer in the Register; and no assignment thereof shall be effective until recorded therein. This Section 1.4 shall be construed so that the Loan is at all times maintained in “registered form” within the meaning of Sections 163(f), 871(h)(2) and 881(c)(2) of the Code.

 

(d)                                 The Company and the Purchasers shall treat each Person whose name is recorded in the Register as a Purchaser for all purposes of this Agreement. Information contained in the Register with respect to any Purchaser shall be available for access by the Company or such Purchaser at any reasonable time and from time to time upon reasonable prior notice.

 

ARTICLE 2

 

ISSUANCE AND SALE OF THE NOTES AND WARRANTS

 

Section 2.1                                   Use of Proceeds.  The proceeds of the Loan will be used for the repayment of outstanding Indebtedness, working capital and general corporate purposes.

 

Section 2.2                                   Purchase of Notes.  Subject to the conditions set forth in Article 4, the Purchasers shall purchase the Notes on the Agreement Date in accordance with their respective allocations set forth on Schedule 1.  The obligation of each Purchaser to purchase its Note is several and not joint.

 

Section 2.3                                   Payment.  Payments on account of the principal amounts of the Notes shall be made only as follows:  (a) The Company shall pay to the Purchasers the outstanding principal amount of the Notes (together with any remaining accrued but unpaid interest in respect thereof) on the earliest to occur of (i) the Final Payment Date, (ii) the date the principal amount of the Notes are declared to be or automatically becomes due and payable following an Event of Default, and (iii) pursuant to the provisions of Section 5.3.

 

8



 

(b)                                 Each payment (including any prepayment) shall be applied first, to accrued and unpaid interest and second, to principal and shall be allocated among the Purchasers in accordance with the respective amounts due each of them under their respective Notes.

 

(c)                                  Subject to the provisions of Section 5.3, the Notes may be prepaid, in whole or in part, at any time and from time to time upon 2 Business Days’ notice to the Purchasers.  Any principal amount prepaid under the Notes shall be accompanied by a prepayment premium equal to the net present value of the future interest amounts that would have been due on such principal had interest continued to accrue through the Final Payment Date.  The discount rate shall be determined by reference to the then-current rate on U.S. treasury bills having a maturity period nearest to the period between the date of prepayment and the Final Payment Date.

 

Section 2.4                                   Payments.  Payments of any amounts due to the Purchasers under this Agreement shall be made in Dollars in immediately available funds prior to 4:00 p.m. New York City time on such date that any such payment is due, at such bank or places as the Purchasers shall from time to time designate in writing at least 5 Business Days prior to the date such payment is due.  The Company shall pay all and any costs (administrative or otherwise) imposed by banks, clearing houses, or any other financial institution, in connection with making any payments under any of the Transaction Documents, except for any costs imposed by the Purchasers’ banking institutions.

 

Section 2.5                                   Taxes, Duties and Fees.

 

(a)                                 Any and all payments hereunder or under any other Transaction Document shall be made, in accordance with this Section 2.5, free and clear of and without deduction for any and all present or future Taxes except as required by applicable law. If Company shall be required by law to deduct any Indemnified Taxes from or in respect of any sum payable hereunder or under any other Transaction Document, (i) the sum payable shall be increased by as much as shall be necessary so that after making all required deductions for Indemnified Taxes (including deductions for Indemnified Taxes applicable to additional sums payable under this Section 2.5) the Purchasers shall receive an amount equal to the sum they would have received had no such deductions been made (any and all such additional amounts payable to Purchasers shall hereafter be referred to as the “Additional Amounts”), (ii) Company shall make such deductions, and (iii) Company shall pay the full amount deducted to the relevant taxing or other authority in accordance with applicable law. Within thirty (30) days after the date of any payment of such Taxes, Company shall furnish to the applicable Purchaser the original or a certified copy of a receipt evidencing payment thereof or other evidence of such payment reasonably satisfactory to such Purchaser.

 

(b)                                 In addition, Company agrees to pay, and authorizes Purchasers to pay in its name, all Other Taxes. Within 30 days after the date of any payment of Other Taxes, Company shall furnish to Purchasers the original or a certified copy of a receipt evidencing payment thereof or other evidence of such payment reasonably satisfactory to the Purchasers holding a Majority in Interest.

 

9



 

(c)                                  Company shall reimburse and indemnify, within 10 days after receipt of demand therefor, each Purchaser for all Indemnified Taxes (including all Indemnified Taxes imposed by any jurisdiction on amounts payable under this Section 2.5(c)) paid by such Purchaser, whether or not such Indemnified Taxes were correctly or legally asserted. A certificate of the applicable Purchaser(s) setting forth the amounts to be paid thereunder and delivered to Company shall be conclusive, binding and final for all purposes, absent manifest error.

 

(d)                                 Each Purchaser (other than a Foreign Person (as hereinafter defined)) on or before the Agreement Date shall provide to Company a properly completed and executed IRS Form W-9 certifying that such Purchaser is organized under the laws of the United States. Each Purchaser organized under the laws of a jurisdiction outside the United States (a “Foreign Person”) that is entitled to an exemption from or reduction in U.S. withholding tax shall provide Company with a properly completed and executed IRS Form W-8ECI, W-8BEN, W-8IMY (including all required attachments) or other applicable form, or any other applicable certificate or document reasonably requested by the Company, and, if such Foreign Person is relying on the portfolio interest exception of Section 871(h) or Section 881(c) of the Code (or any successor provision thereto), shall also provide the Company with a certificate (the “Portfolio Interest Certificate”) representing that such Foreign Person is not a “bank” for purposes of Section 881(c) of the Code (or any successor provision thereto), is not a 10% holder of the Company described in Section 871(h)(3)(B) of the Code (or any successor provision thereto), and is not a controlled foreign corporation receiving interest from a related person (within the meaning of Sections 881(c)(3)(C) and 864(d)(4) of the Code, or any successor provisions thereto). Each Purchaser shall provide new forms (or successor forms) upon the expiration or obsolescence of any previously delivered forms and shall promptly notify the Company of any change in circumstances which would modify or render invalid any claimed exemption or reduction.

 

(e)                                  If a Purchaser determines in good faith that it has received a refund from a Government Authority relating to Taxes in respect of which the Company paid Additional Amounts or made a payment pursuant to Section 2.5(c), such Purchaser shall promptly pay such refund to the Company, net of all out-of-pocket expense (including any Taxes imposed thereon) of such Purchaser incurred in obtaining such refund, provided that the Company, upon the request of such Purchaser, agrees to repay the amount paid over to the Company (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to such Purchaser if such Purchaser is required to repay such refund to such Governmental Authority. Nothing in this Section shall require any Purchaser to disclose any information it deems confidential (including, without limitation, its tax returns) to any Person, including Company.

 

(f)                                   For the avoidance of doubt, the provisions of this Section 2.5 shall not apply to payments on or under the Warrants or Warrant Shares.

 

Section 2.6                                   Costs, Expenses and Losses.  If, as a result of any failure by the Company to pay any sums due under this Agreement on the due date therefor (after the expiration of any applicable grace periods), the Purchasers shall incur costs, expenses and/or losses, by reason of the liquidation or redeployment of deposits from third parties, the Company shall pay to the Purchasers upon request by the Purchasers, the amount of such costs, expenses and/or losses within fifteen (15) days after receipt by it of a certificate from the Purchasers

 

10



 

setting forth in reasonable detail such costs, expenses and/or losses, along with supporting documentation.  For the purposes of the preceding sentence, “costs, expenses and/or losses” shall include, without limitation, any interest paid or payable to carry any unpaid amount and any loss, premium, penalty or expense which may be incurred in obtaining, liquidating or employing deposits of or borrowings from third parties in order to make, maintain or fund the Loan or any portion thereof.

 

Section 2.7                                   Interest.  The outstanding principal amount of the Notes shall bear interest at the Interest Rate (calculated on the basis of the actual number of days elapsed in each period).  From the date hereof through the first anniversary of the Agreement Date, the Company shall pay accrued and unpaid interest quarterly in arrears by increasing the principal amount of each Note (“PIK Interest”) on each such quarterly date and thereafter interest shall accrue on such increased principal amount.  After the first anniversary of the Agreement Date, the Company shall pay interest in cash in arrears on the outstanding principal amount of each Note, as increased by the amount of PIK Interest on such Note, on July 31, 2014, November 30, 2014 and the Final Payment Date.

 

Section 2.8                                   Interest on Late Payments.  Without limiting the remedies available to the Purchasers under the Transaction Documents or otherwise, to the maximum extent permitted by applicable law, if the Company fails to make a required payment of principal or interest with respect to the Loan when due, or otherwise while a Default or Event of Default is continuing, the Company shall pay, in respect of such principal and interest at the rate per annum equal to the Interest Rate plus six percent (6%) for so long as such payment remains outstanding.  Such interest shall be payable on demand by Purchasers representing a Majority in Interest; provided that from and after the Final Payment Date, if any amounts remain unpaid in respect of the Loan, all accrued and unpaid interest shall thereafter be paid (1) quarterly in arrears on the first day of each calendar quarter commencing July 1, 2013 or (2) if sooner, on demand by Purchasers representing a Majority in Interest.

 

Section 2.9                                   Delivery of Warrants.

 

(a)                                 On the Agreement Date, the Company shall issue to the Purchasers warrants to purchase an aggregate of 1,846,940 shares of Common Stock, each in substantially the form set forth as Exhibit B hereto (the “Warrants”), at an initial Exercise Price of $1.03.

 

(b)                                 All Warrants issued pursuant to this Section 2.9 shall be allocated among the Purchasers as set forth on Schedule 1.

 

11



 

ARTICLE 3

 

REPRESENTATIONS AND WARRANTIES

 

Section 3.1                                   Representations and Warranties of the Company.  The Company represents and warrants as of the Agreement Date that except as set forth in the Disclosure Schedule or the SEC Reports:

 

(a)                                 The Company is conducting its business in compliance with its Organizational Documents, which are in full force and effect with no defaults outstanding thereunder.

 

(b)                                 No Default or Event of Default (or any other default or event of default, however described) has occurred under any of the Transaction Documents.

 

(c)                                  The Company (i) is capable of paying its debts as they fall due, is not unable and has not admitted its inability to pay its debts as they fall due, (ii) is not bankrupt or insolvent and (iii) has not taken action, and no such action has been taken by a third party, for the Company’s winding up, dissolution, or liquidation or similar executory or judicial proceeding or for the appointment of a liquidator, custodian, receiver, trustee, administrator or other similar officer for the Company or any or all of its assets or revenues.

 

(d)                                 No Lien exists on the Company’s assets.

 

(e)                                  The Company’s obligation to make any payment under this Agreement and the Notes (together with all charges in connection therewith) is absolute and unconditional, and there exists no right of setoff or recoupment, counterclaim, cross-claim or defense of any nature whatsoever to any such payment.

 

(f)                                   No Indebtedness of the Company exists other than Permitted Indebtedness.

 

(g)                                  The Company is validly existing as a corporation in good standing under the laws of Delaware.  The Company has full power and authority to own its properties and conduct its business as currently conducted, and is duly qualified to do business as a foreign entity and is in good standing in each jurisdiction in which the conduct of its business makes such qualification necessary and in which the failure to so qualify or be in good standing would have a Material Adverse Effect.

 

(h)                                 There is not pending or, to the knowledge of the Company, threatened in writing, any action, suit or other proceeding before any Governmental Authority (a) to which the Company is a party or (b) which has as the subject thereof any assets owned by the Company.  There are no current or pending, legal, governmental or regulatory enforcement actions, suits or other proceedings to which the Company or any of its assets is subject.

 

(i)                                     Each of the Transaction Documents has been duly authorized, executed and delivered by the Company, and constitutes a valid, legal and binding obligation of the Company enforceable in accordance with its terms, except as such enforceability may be limited

 

12



 

by (i) applicable insolvency, bankruptcy, reorganization, moratorium or other similar laws affecting creditors’ rights generally, (ii) by equitable principles (regardless of whether enforcement is sought in equity or at law), (iii) rules of law governing specific performance, injunctive relief or other equitable remedies and by general principles of equity, and (iv) by applicable laws and principles of public policy in the case of indemnification provisions.  The execution, delivery and performance of the Transaction Documents by the Company and the consummation of the transactions therein contemplated will not (A) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or, result in the creation or imposition of any Lien (other than the Lien in favor of the Purchasers) upon any assets of the Company pursuant to, any agreement to which the Company is a party or by which the Company is bound or to which any of the assets of the Company is subject, (B) result in any violation of or conflict with the provisions of the Organizational Documents of the Company or (C) result in the violation of any law or any judgment, order, rule, regulation or decree of any Governmental Authority applicable to the Company, except, in the case of clause (C) above, for any such conflict, breach or violation that would not have a Material Adverse Effect.  No consent, approval, authorization or order of, or registration or filing with any Governmental Authority is required for the execution, delivery and performance of any of the Transaction Documents or for the consummation by the Company of the transactions contemplated hereby except for such registrations and filings in connection with the issuance of the Warrants and Warrant Shares pursuant the Transaction Documents that are necessary to comply with federal and state securities laws, rules and regulations, such registrations and filings contemplated by the Registration Rights Agreement and filings contemplated by the Security Agreement.  The Company has the corporate power and authority to enter into the Transaction Documents and to consummate the transactions contemplated under the Transaction Documents.

 

(j)                                    The Company holds, and is operating in compliance in all material respects with, all material franchises, grants, authorizations, licenses, permits, easements, consents, certificates and orders of any Governmental Authority (collectively, “Necessary Documents”) required for the conduct of its business and all Necessary Documents are valid and in full force and effect.  The Company has not received written notice of any revocation or modification of any of the Necessary Documents, which revocation, modification or non-renewal, individually or in the aggregate, would result in a Material Adverse Effect, and the Company has no reason to believe that any of the Necessary Documents will not be renewed in the ordinary course.  The Company is in compliance in all material respects with all applicable federal, state, local and foreign laws, regulations, orders and decrees applicable to the conduct of its business.

 

(k)                                 The Company has good and marketable title to all of its assets.  The property held under lease by the Company is held under valid, subsisting and enforceable leases with only such exceptions with respect to any particular lease as do not interfere in any material respect with the conduct of the business of the Company.

 

(l)                                     The Company owns, possesses, licenses or has the right to use pursuant to a valid and enforceable written license, implied license or other legally enforceable right, or could obtain on commercially reasonable terms, all of the Intellectual Property (as defined below) that is necessary for the conduct of its business as currently conducted (the “IP”) except as would not have a Material Adverse Effect.  To the knowledge of the Company, the material IP

 

13



 

owned by the Company that is registered with or issued by a Governmental Authority is valid and enforceable.  There is no pending or, to the knowledge of the Company, threatened in writing, action, suit, other proceeding or claim by any third person challenging or contesting the validity, scope, use, ownership, enforceability, or other rights of the Company in or to any IP and the Company has not received any written notice regarding any such action, suit, or other proceeding.  To the knowledge of the Company, the Company has not infringed or misappropriated any material intellectual property rights of others.  There is no pending or threatened in writing action, suit, other proceeding or claim by others that the Company infringes upon, violates or uses the Intellectual Property rights of others without authorization; and the Company has not received any written notice regarding, any such action, suit, other proceeding or claim.  The Company is not a party to or bound by any options, licenses, or agreements with respect to IP other than licenses entered into in the ordinary course of business.  The term “Intellectual Property” as used herein means (i) all patents, patent applications, patent disclosures and inventions (whether patentable or unpatentable and whether or not reduced to practice), (ii) all trademarks, service marks, trade dress, trade names, slogans, logos, and corporate names and Internet domain names, together with all of the goodwill associated with each of the foregoing, (iii) copyrights, copyrightable works, and licenses, (iv) registrations and applications for registration for any of the foregoing, (v) computer software (including but not limited to source code and object code), data, databases, and documentation thereof, (vi) trade secrets and other confidential information, (vii) other intellectual property, and (viii) copies and tangible embodiments of the foregoing (in whatever form and medium).

 

(m)                             The Company is not in violation in any material respect of the Organizational Documents of the Company, or in breach of or otherwise in default under, and no event has occurred which, with notice or lapse of time or both, would constitute such breach or other default in the performance of any agreement or condition contained in any agreement under which it may be bound, or to which any of its assets is subject, except for such breaches or defaults as could not reasonably be expected to have a Material Adverse Effect.

 

(n)                                 All federal, state, local and foreign income and franchise and other material Tax returns, reports and statements (collectively, the “Tax Returns”) required to be filed by the Company have been filed with the appropriate Governmental Authorities, all such Tax Returns are true and correct in all material respects, and all Taxes, assessments and other governmental charges and impositions reflected therein and all other material Taxes, assessments and other governmental charges otherwise due and payable have been paid prior to the date on which any liability may be added thereto for non-payment thereof except for those contested in good faith by appropriate proceedings diligently conducted and for which adequate reserves are maintained on the books of the Company in accordance with GAAP.  As of the Agreement Date, no Tax Return is under audit or examination by any Governmental Authority, and no notice of any audit or examination or any assertion of any claim for Taxes has been given or made in writing by any Governmental Authority.  The Company has properly withheld all material amounts required to be withheld by the Company from its respective employees for all periods in full and complete compliance with the Tax, social security and unemployment withholding provisions of applicable law and such withholdings have been timely paid to the respective Governmental Authorities.  The Company has not participated in a “reportable transaction” within the meaning of Treasury Regulation Section 1.6011-4(b) or has been a member of an affiliated, combined or unitary group.

 

14



 

(o)                                 The Company has not granted rights to develop, manufacture, produce, assemble, distribute, license, market or sell its products to any other Person except in the ordinary course of business and is not bound by any agreement that affects the exclusive right of the Company to develop, manufacture, produce, assemble, distribute, license, market or sell its products except in the ordinary course of business.

 

(p)                                 The Company:  (A)  is in compliance in all material respects with all Applicable Laws; (B) does not have any correspondence or notice from any Governmental Authority alleging or asserting material noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto required by any Applicable Laws (together, the “Authorizations”); (C) possesses and complies in all material respects with the Authorizations, which are valid and in full force and effect except where the failure to possess or comply with any Authorization thereto would not result in a Material Adverse Effect; (D) has not received written notice that any Governmental Authority has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorization and has not received any written notice that any Governmental Authority is considering such action, in each case except as would not have a Material Adverse Effect; and (E) has filed, obtained, maintained or submitted all reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations, except as would not have a Material Adverse Effect.

 

(q)                                 The financial statements of the Company included in its Annual Report on Form 10-K for the fiscal year ended December 31, 2012 and in its Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, June 30 and September 30, 2012, together with the related notes fairly present in all material respects the financial condition of the Company as of the dates indicated and the results of operations and changes in cash flows for the periods therein specified in conformity with GAAP consistently applied throughout the periods involved, subject, in the case of unaudited financial statements, to immaterial year-end audit adjustments; and, except as disclosed in such financial statements, there are no material off-balance sheet arrangements or any other relationships with unconsolidated entities or other persons, that may have a material current or, to the Company’s knowledge, material future effect on the Company’s financial condition, results of operations, liquidity, capital expenditures, capital resources or significant components of revenue or expenses.

 

(r)                                    The Company maintains a system of internal accounting controls sufficient to provide reasonable assurances that (i) transactions are executed in accordance with management’s general or specific authorization; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences.

 

(s)                                   (i)No “prohibited transaction” as defined under Section 406 of ERISA or Section 4975 of the Code, or any individual or class exemption issued and not exempt under ERISA Section 408 and the regulations and published interpretations thereunder has occurred with respect to any Employee Benefit Plan, except as for such transaction that would not have a

 

15



 

Material Adverse Effect, (ii) at no time within the last seven (7) years has the Company or any ERISA Affiliate maintained, sponsored, participated in, contributed to or has or had any liability or obligation in respect of any Employee Benefit Plan subject to Section 302 of ERISA, Title IV of ERISA, or Section 412 of the Code or any “multiemployer plan” as defined in Section 3(37) of ERISA or any multiple employer plan for which the Company or any ERISA Affiliate has incurred or could reasonably be expected to incur liability under Section 4063 or 4064 of ERISA, (iii) no Employee Benefit Plan represents any current or future liability for retiree health, retiree life insurance, or other retiree welfare benefits except as may be required by the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, or similar state or local law, (iv) each Employee Benefit Plan is and has been operated in compliance with its terms and all applicable laws, including but not limited to ERISA and the Code, except for such failures to comply that would not have a Material Adverse Effect, (v) no event has occurred (including a “reportable event” as such term is defined in Section 4043 of ERISA) and no condition exists that would subject the Company or any ERISA Affiliate to any tax, fine, lien, penalty or liability imposed by ERISA, the Code or other applicable law, except for any such tax, fine, lien, penalty or liability that would not, individually or in the aggregate, have a Material Adverse Effect, (vi) the Company does not maintain any Foreign Benefit Plan that could reasonably be expected to give rise to a material liability or material obligation for the Company, and (vii) the Company does not have any obligations under any collective bargaining agreement.  As used in this clause (t), “Employee Benefit Plan” means any material “employee benefit plan” within the meaning of Section 3(3) of ERISA, including, without limitation, all stock purchase, stock option, stock-based severance, employment, change-in-control, medical, disability, fringe benefit, bonus, incentive, deferred compensation, employee loan and all other employee benefit plans, agreements, programs, policies or other arrangements, whether or not subject to ERISA, under which (A) any current or former employee, director or independent contractor of the Company or any of its Subsidiaries has any present or future right to benefits and which are contributed to, sponsored by or maintained by the Company or any of its respective Subsidiaries or (B) the Company or any of its Subsidiaries has had or has any present or future obligation or liability; “ERISA” means the Employee Retirement Income Security Act of 1974, as amended; “ERISA Affiliate” means any member of the Company’s controlled group as defined in Code Section 414 (b), (c), (m) or (o); and “Foreign Benefit Plan” means any Employee Benefit Plan established, maintained or contributed to outside of the United States of America or which covers any employee working or residing outside of the United States.

 

(t)                                    The Company has no Subsidiaries other than as set forth on the Disclosure Schedule.

 

(u)                                 Subsequent to December 31, 2012, the Company has not declared or paid any dividends or made any distribution of any kind with respect to its capital stock; and there has not been any change in the capital stock (other than a change in the number of outstanding shares of Common Stock due to the issuance of shares upon the exercise of outstanding options or warrants), or any issuance of options, warrants, convertible securities or other rights to purchase the capital stock, of the Company, except as such transactions may have occurred under the Company’s equity compensation plans and/or employee stock purchase plan.

 

(v)                                 All of the issued and outstanding shares of capital stock of the Company are duly authorized and validly issued, fully paid and nonassessable, have been issued in

 

16



 

compliance with all federal and state and foreign securities laws, were not issued in violation of or subject to any preemptive rights or other rights to subscribe for or purchase securities that have not been waived in writing.  The Warrants and the shares of Common Stock issuable upon exercise of the Warrants (the “Warrant Shares”), have been duly authorized and the Warrant Shares have been reserved for issuance on exercise of the Warrants. The Warrant Shares when issued, delivered and paid for in accordance with the terms of the Warrants, will have been validly issued and will be fully paid and nonassessable.  There are no preemptive rights or other rights to subscribe for or to purchase, or any restriction upon the voting or transfer of any shares of Common Stock, pursuant to the Company’s Organizational Documents or any agreement to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound.  All of the issued and outstanding shares of capital stock of each of the Company’s Subsidiaries have been duly and validly authorized and issued and are fully paid and nonassessable, and the Company or its Subsidiaries owns of record and beneficially, free and clear of any claims, Liens, proxies, or equities, all of the issued and outstanding shares of such stock.  There are no options, warrants, agreements, contracts or other rights in existence to purchase or acquire from the Company or any Subsidiary of the Company any shares of the capital stock of the Company or any Subsidiary of the Company, except for such options or rights issued pursuant to the Company’s equity compensation plans and/or employee stock purchase plan and the Warrants.

 

(w)                               No Subsidiary of the Company conducts any material part of the business conducted by the Company and each of its Subsidiaries taken as a whole.

 

(x)                                 None of the SEC Reports since January 1, 2012, as of the time of filing, contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements therein not misleading as of the date of filing.  The Company has filed all documents required to be filed with the SEC on a timely basis.  Subsequent to the date of filing of the Company’s most recent quarterly SEC Report, no event has occurred that could reasonably be expected to result in a Material Adverse Effect.

 

(y)                                 No representation or warranty of the Company contained in this Agreement, as qualified by the Disclosure Schedule, and no certificate furnished or to be furnished to Purchasers at the Closing contains any untrue statement of a material fact or omits to state a material fact necessary in order to make the statements contained herein or therein not misleading in light of the circumstances under which they were made.

 

Section 3.2                                   Company Acknowledgment.  The Company acknowledges that it has made the representations and warranties referred to in Section 3.1 in connection with the Purchasers entering into the Transaction Documents and that the Purchasers have entered into the Transaction Documents on the basis of, and in full reliance on, each of such representations and warranties.

 

17



 

Section 3.3                                   Representations and Warranties of the Purchasers.  Each Purchaser represents and warrants to the Company as of the Agreement Date that:

 

(a)                                 It is acquiring the Notes, Warrants and the Warrant Shares solely for its account for investment, not as an agent or nominee, and not with a view to or for resale in connection with any distribution of the Notes, Warrants or Warrant Shares or any part thereof.

 

(b)                                 The Notes, Warrants and the Warrants Shares have not been registered under the Securities Act on the basis that no distribution or public offering of the stock of the Company is to be effected.  It realizes that the basis for the exemptions may not be present if, notwithstanding its representations, such Purchaser has a present intention of acquiring the securities for a fixed or determinable period in the future, selling (in connection with a distribution or otherwise), granting any participation in, or otherwise distributing the securities.  None of the Purchasers has such present intention.

 

(c)                                  The Notes, Warrants and the Warrant Shares must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption for such registration is available.

 

(d)                                 Neither the Notes, Warrants nor the Warrant Shares may be sold pursuant to Rule 144 adopted under the Securities Act unless certain conditions are met.

 

(e)                                  Purchaser will not make any disposition of all or any part of the Notes, Warrants or Warrant Shares:

 

(i)                                     Until there is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition is made in accordance with said registration statement; or

 

(ii)                                  Unless disposed of pursuant to an exemption from registration under the Securities Act, including pursuant to Rules 144 or 144A, and Purchaser provides a legal opinion to Company in form and substance reasonably satisfactory to Company; or

 

(iii)                               Unless pursuant to a private sale effected under applicable formal or informal SEC interpretation or guidance, such as a so-called “4(1) and a half” sale pursuant to a legal opinion provided by Purchaser to the Company in form and substance reasonably acceptable to Company.

 

The Company will not require such a legal opinion (x) in any transaction in compliance with Rule 144 or (y) in any transaction in which the Purchaser distributes the securities in question to an Affiliate of such Purchaser; provided that each transferee agrees in writing to be subject to the terms of this Agreement including this paragraph (e).

 

(f)                                   It understands and agrees that all certificates evidencing the shares to be issued to the Purchasers upon exercise of the Warrants may bear a legend as set forth in the Warrants.

 

18



 

(g)                                  Such Purchaser is an “accredited investor” as defined in Regulation D promulgated under the Securities Act.

 

(h)                                 Such Purchaser, if not an individual, is duly organized and validly existing under the laws of the jurisdiction of its formation.

 

(i)                                     Each Transaction Document to which it is a party has been duly authorized, executed and delivered by such Purchaser and constitutes the valid and legally binding obligation of such Purchaser, enforceable in accordance with its terms, except as such enforceability may be limited by (i) applicable insolvency, bankruptcy, reorganization, moratorium or other similar laws affecting creditors’ rights generally, (ii) by equitable principles (regardless of whether enforcement is sought in equity or at law), (iii) rules of law governing specific performance, injunctive relief or other equitable remedies and by general principles of equity, and (iv) by applicable laws and principles of public policy in the case of indemnification provisions.

 

(j)                                    Such Purchaser has full power and authority to purchase the Notes and to enter into and perform its other obligations under each of the Transaction Documents and carry out the other transactions contemplated thereby.

 

(k)                                 Such Purchaser (A) has had reasonable opportunity to ask questions of and receive answers from Company concerning the Transaction Documents, (B) has been permitted access, to such Purchaser’s satisfaction, to the SEC Reports, and (C) understands that the entry into the Transaction Documents and the investment in the securities issued thereunder is subject to risks as stated in the risk factors disclosed in the SEC Reports or as otherwise may be applicable to similar investments and acknowledges that it has had an opportunity to review, and upon review, fully understands such risk factors.

 

ARTICLE 4

 

CONDITIONS OF CLOSING

 

Section 4.1                                   Conditions to Purchase of Notes.  The obligation of the Purchasers to purchase the Notes shall be subject to the fulfillment of the following conditions:

 

(a)                                 The Purchasers shall have received executed counterparts of the Transaction Documents from the Company, and a certificate as to Organizational Documents, resolutions and incumbency reasonably acceptable to the Purchasers;

 

(b)                                 All actions required to be taken by the Company pursuant to Section 2.9 shall have been taken;

 

(c)                                  The Company shall have executed and delivered to the Purchasers the Registration Rights Agreement; and

 

(d)                                 No Default or Event of Default has occurred or would result from the purchase of Notes.

 

19



 

Section 4.2                                   Conditions to Issuance of Notes.  The obligation of the Company to issue the Notes shall be subject to the fulfillment of the following condition:

 

(a)                                 The Company shall have received executed counterparts of the Subordination Agreement from the Purchasers and Comerica Bank.

 

ARTICLE 5

 

PARTICULAR COVENANTS AND EVENTS OF DEFAULT

 

Section 5.1                                   Affirmative Covenants.  Unless the Purchasers holding a Majority in Interest of the Notes shall otherwise agree:

 

(i)                                     The Company shall and shall cause its Subsidiaries to maintain its existence and qualify and remain qualified to do its business as currently conducted, except in each case (a) where the failure to so maintain such qualification would not reasonably be expected to have a Material Adverse Effect or (b) the Company or any Subsidiary may merge, liquidate or dissolve into another Subsidiary or the Company to the extent not prohibited by Section 5.2(i); provided that if any such event constitutes a Change of Control and the Purchasers holding a Majority in Interest waive the put right provided for in Section 5.3, then the provisions of this Section 5.1(i) shall not have any force or effect with respect to such event.

 

(ii)                                  The Company shall and shall cause its Subsidiaries to comply in all material respects with all Applicable Laws, except where the necessity of compliance therewith is contested in good faith by appropriate proceedings or where the failure to comply would not have a Material Adverse Effect.

 

(iii)                               The Company shall obtain and shall cause its Subsidiaries to make and keep in full force and effect all Necessary Documents, except where the failure to do so would not have a Material Adverse Effect.

 

(iv)                              The Company shall promptly notify the Purchasers of the occurrence of (i) any Default or Event of Default, (ii) any claim, litigation, arbitration, mediation or administrative or regulatory proceeding that are instituted against the Company or any of its Subsidiaries, (iii) any notice or any other action taken by any Person in respect of a claimed default (whether or not constituting a Default) by the Company under any other note, evidence of indebtedness, indenture or other material financial obligation to which or with respect to which the Company is a party or obligor, whether as principal, guarantor, surety or otherwise, in each case, in an aggregate principal amount in excess of $200,000 or (iv) any judgment not covered by insurance, final or otherwise, against the Company; provided that such notice shall be given concurrently with public disclosure of any such event to the extent necessary to comply with applicable securities laws.

 

(v)                                 If the Company is not required to file reports pursuant to Sections 13 or 15(d) of the Exchange Act, the Company will provide to the Purchasers quarterly financial statements for itself and its Subsidiaries within 45 days after the end of each quarter, and audited annual financial statements within 120 days after the end of each year prepared in accordance with GAAP with a report thereon by the Company’s independent certified public accountants.  If the

 

20



 

Company is required to file such reports, the Company will timely file with the SEC (subject to appropriate extensions made under Rule 12b-25 of the Exchange Act) any annual reports, quarterly reports and other periodic reports required to be filed pursuant to Section 13 or 15(d) of the Exchange Act.

 

(vi)                              The Company shall maintain its principal place of business at 300 Frank H. Ogawa Plaza, Suite 600, Oakland, CA 94612.

 

(vii)                           The Company shall cause all of its properties used or useful in the conduct of its business to be maintained and kept in good condition, repair and working order, ordinary wear and tear excepted.

 

(viii)                        The Company shall maintain, with financially sound and reputable insurers, insurance with respect to its properties and business against such casualties and contingencies as shall be in accordance with the general practices of businesses engaged in similar activities in similar geographic areas and in amounts, containing such terms, in such forms and for such periods as may be reasonable and prudent and customary for similar businesses.

 

(ix)                              The Company shall take all necessary and advisable steps to obtain or maintain ownership in and/or protection of all material IP, and will not do any act, or omit to do any act, whereby any material IP of the Company may become abandoned, invalidated, dedicated to the public domain, or diminished in value.

 

(x)                                 The Company shall duly pay and discharge, before the same shall become overdue, all taxes, assessments and other governmental charges imposed upon it and its properties; provided, that any such tax, assessment or charge need not be paid if the validity or amount thereof shall currently be contested in good faith by appropriate proceedings and if the Company shall have set aside on its books adequate reserves with respect thereto.

 

(xi)                              The Company shall permit representatives designated by the Purchasers, upon reasonable prior notice to the Company if no Default has occurred and is continuing (and at any time without notice if a Default has occurred and is continuing), to visit and inspect the Company’s properties, to examine its corporate and financial records (and make copies thereof or extracts therefrom), to discuss its affairs, finances and accounts with the Companys officers. Each Purchaser agrees to exercise such rights in a manner so as not to disrupt unreasonably the Company’s ordinary course of business activities and to maintain, and to use its best efforts to cause its representatives to maintain the confidentiality of any information so obtained by it.

 

(xii)                           The Company shall, as promptly as practicable, notify the Purchasers upon becoming aware of any proposed (i) sale of the Company or (ii) sale or other disposition of any property of the Company, including any Change of Control, following an event of default under the Comerica Loan Agreement requested to be implemented by (or anticipated to be approved by) Comerica Bank.

 

(xiii)                        In the event of a default or event of default under the Comerica Loan Agreement (which term for purposes of this clause (xiii) only shall include any future indebtedness owing to Comerica Bank), the Purchasers shall have the right, but not the obligation, at their sole option, to advance to the Company a cash amount sufficient to repay in full all obligations of the Company to Comerica Bank.  Should the Purchasers (or any group thereof) advance such amount to the Company, then the Company and such participating Purchasers shall immediately execute and

 

21



 

deliver documents identical to those then in place with respect to the Comerica Loan Agreement with the following changes (and such other changes as may be mutually acceptable to the parties): (1) references to Comerica Bank shall refer to such Purchasers, (2) the principal amount due shall be equal to the amount so advanced, (3) any matter requiring Comerica Bank’s consent or waiver shall instead require the consent or waiver of a majority in interest (determined by amounts advanced) of such Purchasers and (4) the interest rate on all obligations due thereunder shall be 12% per annum.  The Purchasers agree among themselves that the right to advance any such funds as aforesaid shall be allocated among them ratably in accordance with the principal amounts of their respective Notes, with participating Purchasers having a right of over-subscription (allocated in the same manner among participating Purchasers) in respect of any unsubscribed amounts.

 

Section 5.2                                   Negative Covenants.  Unless the Purchasers holding a Majority in Interest of the Notes shall otherwise agree:

 

(i)                                     The Company shall not and shall not permit any Subsidiary to (a) liquidate, provided that a Subsidiary may liquidate or merge into the Company or any other Subsidiary, or dissolve (unless, in any such case, such Subsidiary ceases to own any operating assets or conduct business), or (b) consummate any merger or consolidation, unless (x) the Company or a Subsidiary is the surviving corporation; provided that if any such event constitutes a Change of Control and the Purchasers holding a Majority in Interest waive the put right provided for in Section 5.3, then the provisions of this Section 5.2(i) shall not have any force or effect with respect to such event.

 

(ii)                                  The Company shall not and shall not permit any Subsidiary to create, incur, assume, guarantee or remain liable with respect to any Indebtedness, other than Permitted Indebtedness.

 

(iii)                               Except as permitted by the Comerica Loan Agreement, the Company shall not (i) create or incur or suffer to be created or incurred or to exist any Lien (other than Liens in respect of the Permitted Indebtedness), or (ii) enter into or permit to exist any arrangement or agreement (other than the Comerica Loan) which prohibits the Company or any of its Subsidiaries from creating, assuming or incurring any Liens.

 

(iv)                              Except as permitted by the Comerica Loan Agreement, the Company shall not declare, pay or make any dividend or distribution on shares of its capital stock or apply any of its funds, property or assets to the purchase, redemption or other retirement or acquisition of any shares of its capital stock (or pay into or set aside for a sinking fund for such purpose), or of any options to purchase or acquire any capital stock of the Company.

 

(v)                                 Except as permitted by the Comerica Loan Agreement, the Company shall not sell, lease or otherwise dispose of any of its properties, including accounts receivable and including any disposition of property as part of a sale and leaseback transaction, to or in favor of any person, except for sales of inventory in the ordinary course of business and (for so long as no Default exists) dispositions of its equipment which, in the aggregate during any consecutive twelve-month period, have a fair market value of $100,000 or less.

 

22



 

(vi)          Except as permitted by the Comerica Loan Agreement, the Company shall not engage in any transaction with any Affiliate that is not a wholly-owned Subsidiary, or with any Person in which any such Affiliate has a substantial interest or is an officer, director, partner, member or trustee, in any case on terms more favorable to such Person than would have been obtainable on an arms’-length basis in the ordinary course of business.

 

(vii)         The Company shall not make any significant change in accounting treatment or reporting practices, except as required by GAAP.

 

Section 5.3            Change of Control.  The Company shall give the Purchasers notice of a Change of Control at least 30 days prior to the consummation of such transaction but in any event not later than five Business Days following the first public announcement thereof.  Unless otherwise waived by the Purchasers holding a Majority in Interest within five days prior to the consummation of the Change of Control, the Final Payment shall be paid to the Purchasers simultaneously with the consummation of such Change of Control; provided that the Final Payment due in connection with such Change of Control shall be an amount equal to 101% of the amount of the Final Payment that would otherwise be due.

 

Section 5.4            General Acceleration Provision upon Events of Default.  If one or more of the events specified in this Section 5.4 shall have happened and be continuing beyond the applicable cure period (each, an “Event of Default”), the Purchasers holding a Majority in Interest of the Notes, by written notice to the Company, may declare the principal of, and accrued and unpaid interest on, the Notes or any part of any of them (together with any other amounts accrued or payable under the Transaction Documents) to be, and the same shall thereupon become, immediately due and payable, without any further notice and without any presentment, demand, or protest of any kind, all of which are hereby expressly waived by the Company, and take any further action available at law or in equity, including, without limitation, the sale of the collateral securing the Loan and all other rights acquired in connection with the Loan:

 

(a)           The Company shall have failed to make payment of (i) principal under the Notes when due or (ii) any interest under the Notes when due and such failure shall have continued for three (3) Business Days.

 

(b)           The Company shall have failed to comply with the due observance or performance of any covenant contained in this Agreement, the Security Agreement or the Notes (other than the covenants described in (a) above), and such failure shall not have been cured by the Company within 10 days after receiving written notice of such failure from a Majority in Interest of the Purchasers.

 

(c)           Any representation or warranty made by the Company in any Transaction Document shall have been incorrect, false or misleading in any material respect as of the date it was made.

 

(d)           (i)  The Company shall generally be unable to pay its debts as such debts become due, or shall admit in writing its inability to pay its debts as they come due or shall make a general assignment for the benefit of creditors; (ii) the Company shall declare a moratorium on

 

23



 

the payment of its debts; (iii) the commencement by the Company of proceedings to be adjudicated bankrupt or insolvent, or the consent by it to the commencement of bankruptcy or insolvency proceedings against it, or the filing by it of a petition or answer or consent seeking reorganization, intervention or other similar relief under any applicable law, or the consent by it to the filing of any such petition or to the appointment of an intervenor, receiver, liquidator, assignee, trustee, sequestrator (or other similar official) of all or substantially all of its assets; (iv) the commencement against the Company of a proceeding in any court of competent jurisdiction under any bankruptcy or other applicable law (as now or hereafter in effect) seeking its liquidation, winding up, dissolution, reorganization, arrangement, adjustment, or the appointment of an intervenor, receiver, liquidator, assignee, trustee, sequestrator (or other similar official), and any such proceeding shall continue undismissed, or any order, judgment or decree approving or ordering any of the foregoing shall continue unstayed or otherwise in effect, for a period of ninety (90) days; or (v) any other event shall have occurred which under any applicable law would have an effect analogous to any of those events listed above in this subsection.

 

(e)           One or more judgments against the Company or any Subsidiary or attachments against any of their respective property not covered by insurance in an amount individually or in the aggregate in excess of $500,000, remain(s) unpaid, unstayed on appeal, undischarged, unbonded or undismissed for a period of 60 days from the date of entry of such judgment.

 

(f)            Any authorization necessary for the execution, delivery or performance by the Company of any Transaction Document or for the validity or enforceability of any of the Obligations under any Transaction Document is not given or is withdrawn or ceases to remain in full force or effect.

 

(g)           The validity of any Transaction Document shall be contested by the Company, or any treaty, law, regulation, communiqué, decree, ordinance or policy of any jurisdiction shall purport to render any material provision of any Transaction Document invalid or unenforceable or shall purport to prevent or materially delay the performance or observance by the Company of the Obligations.

 

(h)           There is a failure to perform any agreement to which the Company of any Subsidiary is a party resulting in a right by a third party to accelerate the maturity of any Indebtedness for borrowed money in an amount in excess of $500,000.

 

(i)            So long as the Purchasers hold the Warrants, the occurrence of an Event of Default (as such term is defined in the Warrants).

 

Section 5.5            Automatic Acceleration on Dissolution or Bankruptcy.  Notwithstanding any other provisions of this Agreement, if an Event of Default under clauses (iii) or (iv) of Section 5.4(d) shall occur, the principal of the Notes (together with any other amounts accrued or payable under the Transaction Documents) shall thereupon become immediately due and payable without any presentment, demand, protest or notice of any kind, all of which are hereby expressly waived by the Company.

 

24



 

Section 5.6            Recovery of Amounts Due.  If any amount payable hereunder is not paid as and when due, the Company hereby authorizes the Purchasers to proceed, to the fullest extent permitted by applicable law, without prior notice, by right of set-off, banker’s lien or counterclaim, against any moneys or other assets of the Company to the full extent of all amounts payable to the Purchasers.

 

ARTICLE 6

 

MISCELLANEOUS

 

Section 6.1            Notices.  Any notices required or permitted to be given under the terms hereof shall be sent by certified or registered mail (return receipt requested) or delivered personally or by courier (including a recognized overnight delivery service) or by facsimile or by electronic mail (if such party designates an e-mail address herein for such purpose) and shall be effective five (5) days after being placed in the mail, if mailed by regular United States mail, or upon receipt, if delivered personally or by courier (including a recognized overnight delivery service) or by facsimile, or when read by electronic mail (sender shall have received a “read by recipient” confirmation) in each case addressed to a party.  The addresses for such communications shall be:

 

If to the Company:

 

300 Frank H. Ogawa Plaza, Suite 600

Oakland, CA 94612

Attn: General Counsel
Email: legal@scilearn.com

 

With copy to:

 

Wilson Sonsini Goodrich & Rosati, Professional Corporation

650 Page Mill Road

Palo Alto, CA 94304

Fax: 650-493-6811

Email:  sbernard@wsgr.com

Attn:  Steven Bernard

 

If to the Purchasers, to each at its address on the signature pages hereto, with a copy to:

 

Fulbright & Jaworski L.L.P.

666 Fifth Avenue

New York, New York 10103

Fax: 212-318-3400

Attn: Michael R. Flynn

 

Section 6.2            Waiver of Notice.  Whenever any notice is required to be given to the Purchasers or the Company under the any of the Transaction Documents, a waiver thereof in

 

25



 

writing signed by the person or persons entitled to such notice, whether before or after the time stated therein, shall be deemed equivalent to the giving of such notice.

 

Section 6.3            Reimbursement of Legal and Other Expenses.  If any amount owing to the Purchasers under any Transaction Document shall be collected through enforcement of this Agreement, any Transaction Document or restructuring of the Loan in the nature of a work-out, settlement, negotiation, or any process of law, or shall be placed in the hands of third Persons for collection, the Company shall pay (in addition to all monies then due in respect of the Loan or otherwise payable under any Transaction Document) reasonable attorneys’ and other reasonable fees and out-of-pocket expenses incurred by the Purchasers in respect of such collection.  Promptly following the closing of the Loan contemplated by this Agreement, the Company shall reimburse the Purchasers for the reasonable fees and out of pocket expenses incurred by Fulbright & Jaworski L.L.P., counsel to the Purchasers, in an amount not to exceed $50,000.

 

Section 6.4            Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York applicable to contracts made and to be performed in such State.  Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, employees or agents) may be commenced non-exclusively in the state and federal courts sitting in the City of New York.  Each party hereby irrevocably submits to the non-exclusive jurisdiction of the state and federal courts sitting in the City of New York, borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court.  Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.  The parties hereby waive all rights to a trial by jury.

 

Section 6.5            Successors and Assigns.  This Agreement shall bind and inure to the respective successors and assigns of the Parties, except that Company may not assign or otherwise transfer all or any part of its rights under the Transaction Documents without the prior written consent of a Majority in Interest of the Purchasers; provided that the Company may assign or transfer all or any part of its rights under the Transaction Documents without the prior written consent of the Purchasers in connection with a Change of Control if the Purchasers holding a Majority in Interest waive the put right provided for in Section 5.3.

 

Section 6.6            Entire Agreement; Amendments.  The Transaction Documents contain the entire understanding of the Parties with respect to the matters covered thereby and supersede any and all other written and oral communications, negotiations, commitments and writings with respect thereto.  The provisions of this Agreement and the Transaction Documents may be waived, modified, supplemented or amended by an instrument in writing signed by the

 

26



 

authorized officer of each the Company and Purchasers holding a Majority in Interest.  Notwithstanding the foregoing:

 

(a)           In the event that any such amendment or waiver would, by its terms, treat in a discriminatory manner a single Purchaser (or group of Purchasers), such amendment or waiver shall also require the written consent of the Purchaser so adversely affected (or a majority in interest of the group of such Purchasers); and

 

(b)           any provision hereof may be waived by the waiving party on such party’s own behalf, without the consent of any other party.

 

The Company shall give prompt written notice of any amendment or waiver hereunder to any party that did not consent in writing thereto.  Any amendment, termination or waiver effected in accordance with this Section 6.6 shall be binding on each Party and all of such Party’s successors and permitted assigns, whether or not any such Party, successor or assignee entered into or approved such amendment or waiver.

 

Section 6.7            Severability.  If any provision of this Agreement shall be invalid, illegal or unenforceable in any respect under any law, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.  The Parties shall endeavor in good faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provision.

 

Section 6.8            Counterparts.  This Agreement may be executed in several counterparts, and by each Party on separate counterparts, each of which and any photocopies and facsimile copies thereof shall be deemed an original, but all of which together shall constitute one and the same agreement.

 

Section 6.9            Survival.

 

(a)           This Agreement and all agreements, representations and warranties made in the Transaction Documents, and in any document, certificate or statement delivered pursuant thereto or in connection therewith shall be considered to have been relied upon by the other Parties and shall survive the execution and delivery of this Agreement and the making of the Loan hereunder regardless of any investigation made by any such other Party or on its behalf, and shall continue in force until all amounts payable under the Transaction Documents shall have been fully paid in accordance with the provisions thereof, and the Purchasers shall not be deemed to have waived, by reason of making the Loan, any Event of Default that may arise by reason of such representation or warranty proving to have been false or misleading, notwithstanding that the Purchasers may have had notice or knowledge of any such Event of Default or may have had notice or knowledge that such representation or warranty was false or misleading at the time the Notes were purchased.

 

(b)           The obligations of the Company and the Purchasers under the Transaction Documents that, by their terms, would survive the consummation of the transactions contemplated hereby, the repayment of the Loan, or the termination of this Agreement or any provision hereof, shall so survive and remain in full force and effect.

 

27



 

Section 6.10         Waiver.  Neither the failure of, nor any delay on the part of, any Party in exercising any right, power or privilege hereunder, or under any other Transaction Document, shall operate as a waiver thereof, nor shall any single or partial exercise of any right, power or privilege hereunder, or under any other Transaction Document, preclude other or further exercise thereof or the exercise of any other right, power or privilege; nor shall any waiver of any right, power, privilege or default hereunder, or under any other Transaction Document, constitute a waiver of any other right, power, privilege or default or constitute a waiver of any default of the same or of any other term or provision.  No course of dealing and no delay in exercising, or omission to exercise, any right, power or remedy accruing to the Purchasers upon any default under this Agreement, or any other agreement shall impair any such right, power or remedy or be construed to be a waiver thereof or an acquiescence therein; nor shall the action of the Purchasers in respect of any such default, or any acquiescence by it therein, affect or impair any right, power or remedy of the Purchasers in respect of any other default.  All rights and remedies herein provided are cumulative and not exclusive of any rights or remedies otherwise provided by law.

 

Section 6.11         Indemnity.

 

(a)           The Company shall, at all times, indemnify and hold the Purchasers (the “Indemnity”) and each of the Purchasers’ respective directors, partners, officers, employees, agents, counsel and advisors (each, an “Indemnified Person”) harmless in connection with any losses, damages, liabilities, penalties, or other expenses resulting from claims from third parties arising out of, or relating to, this Agreement or the Security Agreement or the use or intended use of the Loan other than in accordance with this Agreement, which an Indemnified Person may incur or to which an Indemnified Person may become subject (each, a “Loss”).  The Indemnity shall not apply to the extent that a court or arbitral tribunal with jurisdiction over the subject matter of the Loss, and over the Purchasers or the Company, as applicable, and such other Indemnified Person that had an adequate opportunity to defend its interests, determines that such Loss resulted from the gross negligence or willful misconduct of the Indemnified Person, which determination results in a final, non-appealable judgment or decision of a court or tribunal of competent jurisdiction.  The Indemnity is independent of and in addition to any other agreement of any Party under any Transaction Document to pay any amount to the Purchasers or the Company, as applicable, and any exclusion of any obligation to pay any amount under this subsection shall not affect the requirement to pay such amount under any other section hereof or under any other agreement.

 

(b)           Promptly after receipt by an Indemnified Person under this Section 6.11 of notice of the commencement of any action (including any governmental action), such Indemnified Person shall, if a Loss in respect thereof is to be made against any Party (the “Indemnifying Person”) under this Section 6.11, deliver to the Purchaser a written notice of the commencement thereof, and the Purchaser shall have the right to participate in, and, to the extent the Purchaser so desires, to assume control of the defense thereof with counsel mutually satisfactory to the Purchaser and the Indemnified Person, as the case may be.

 

(c)           An Indemnified Person shall have the right to retain its own counsel with the reasonable fees and expenses to be paid by the Purchaser if, in the reasonable opinion of counsel for the Purchaser, the representation by such counsel of the Indemnified Person and the Purchaser would be inappropriate due to actual or potential differing interests between such

 

28



 

Indemnified Person and any other party represented by such counsel in such proceeding. Notwithstanding the foregoing, the Purchaser shall pay for only one separate legal counsel for the Indemnified Persons, and such legal counsel shall be selected by the Purchaser. The failure to deliver written notice to the Purchaser within a reasonable time of the commencement of any such action shall not relieve the Purchaser of any liability to the Indemnified Person under this Section 6.11, except to the extent that the Purchaser is actually prejudiced in its ability to defend such action. The indemnification required by this Section 6.11 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as such expense, loss, damage or liability is incurred and is due and payable.

 

(d)           Without prejudice to the survival of any other agreement of any of the Parties hereunder, the agreements and the obligations of the Parties contained in this Section 6.11 shall survive the termination of each other provision hereof and the payment of all amounts payable to the Purchasers hereunder.

 

Section 6.12         No Usury.  The Transaction Documents are hereby expressly limited so that in no contingency or event whatsoever, whether by reason of acceleration or otherwise, shall the amount paid or agreed to be paid to the Purchasers for the Loan exceed the maximum amount permissible under applicable law.  If from any circumstance whatsoever fulfillment of any provision hereof, at the time performance of such provision shall be due, shall involve transcending the limit of validity prescribed by law, then, ipso facto, the obligation to be fulfilled shall be reduced to the limit of such validity, and if from any such circumstance the Purchasers shall ever receive anything which might be deemed interest under applicable law, that would exceed the highest lawful rate, such amount that would be deemed excessive interest shall be applied to the reduction of the principal amount owing on account of the Loan, or if such deemed excessive interest exceeds the unpaid balance of principal of the Loan, such deemed excess shall be refunded to the Company.  All sums paid or agreed to be paid to the Purchasers for the Loan shall, to the extent permitted by applicable law, be deemed to be amortized, prorated, allocated and spread throughout the full term of the Loan until payment in full so that the deemed rate of interest on account of the Loan is uniform throughout the term thereof.  The terms and provisions of this Section shall control and supersede every other provision of this Agreement and the Notes.

 

Section 6.13         Further Assurances.  From time to time, the Company shall perform any and all acts and execute and deliver to the Purchasers such additional documents as may be necessary or as reasonably requested by the Purchasers to carry out the purposes of any Transaction Document or to preserve and protect the Purchasers’ rights as contemplated therein.

 

Section 6.14         Independent Transaction Documents.  Each Transaction Document constitutes an independent agreement between the parties thereto (the “Transaction Parties”) and no Transaction Document shall be construed so as to affect the rights of the Transaction Parties to their rights and remedies under another Transaction Document.

 

Section 6.15         Time of the Essence.  Time is of the essence in respect of the transactions contemplated by the Transaction Documents.

 

[SIGNATURE PAGE FOLLOWS]

 

29



 

IN WITNESS WHEREOF, the Purchasers and the Company have caused this Agreement to be duly executed as of the 5th day of April, 2013.

 

COMPANY:

 

 

 

 

 

SCIENTIFIC LEARNING CORPORATION

 

 

 

 

 

 

 

 

By:

/s/ Jane A. Freeman

 

 

Name:

Jane A. Freeman

 

 

Title:

CFO

 

 

 

[Signature Page to Subordinated Note and Warrant Purchase Agreement]

 



 

PURCHASERS:

 

 

 

BLACKWELL PARTNERS LLC

 

 

 

 

By: Nantahala Capital Management, LLC

 

Its Investment Manager

 

 

 

 

 

 

 

By:

/s/ Wilmot Harkey

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

 

 

 

 

 

 

NANTAHALA CAPITAL PARTNERS II, LIMITED PARTNERSHIP

 

 

 

By: Nantahala Capital Management, LLC

 

Its General Partner

 

 

 

 

 

 

 

By:

/s/ Wilmot Harkey

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

 

 

 

 

 

 

NANTAHALA CAPITAL PARTNERS, LIMITED PARTNERSHIP

 

 

 

By: Nantahala Capital Management, LLC

 

Its General Partner

 

 

 

 

 

 

 

By:

/s/ Wilmot Harkey

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

 

[Signature Page to Subordinated Note and Warrant Purchase Agreement]

 



 

TRIGRAN INVESTMENTS, LP

 

 

 

 

By: Trigran Investments, Inc.

 

Its General Partner

 

 

 

 

 

 

By:

/s/ Lawrence Oberman

 

 

Name: Lawrence Oberman

 

 

Title: Executive Vice President

 

 

 

 

 

 

 

TRIGRAN INVESTMENTS, LP II

 

 

 

 

By: Trigran Investments, Inc.

 

Its General Partner

 

 

 

 

 

 

 

By:

/s/ Lawrence Oberman

 

 

Name: Lawrence Oberman

 

 

Title: Executive Vice President

 

 

[Signature Page to Subordinated Note and Warrant Purchase Agreement]

 



 

RJ PARTNERS LLC

 

 

 

 

 

 

 

By:

/s/ Robert J. Schmiedeler

 

 

Name: Robert J. Schmiedeler

 

 

Title: Manager

 

 

[Signature Page to Subordinated Note and Warrant Purchase Agreement]

 



 

PAULA A. TALLAL, REVOCABLE TRUST

 

 

 

 

 

 

 

By:

/s/ Paula A. Tallal

 

 

Name: Paula A. Tallal

 

 

Title: Trustee

 

 

[Signature Page to Subordinated Note and Warrant Purchase Agreement]

 



 

JANE A. FREEMAN LIVING TRUST (5/30/12)

 

 

 

 

 

 

 

/s/ Jane A. Freeman

 

Name: Jane A. Freeman

 

Title: Trustee

 

 

[Signature Page to Subordinated Note and Warrant Purchase Agreement]

 



 

RODMAN W. MOORHEAD III REVOCABLE TRUST

 

 

 

 

 

 

 

By:

/s/ Rodman W. Moorhead, III

 

 

Name: Rodman W. Moorhead, III

 

 

Title: Trustee

 

 

[Signature Page to Subordinated Note and Warrant Purchase Agreement]

 



 

ROBERT BOWEN

 

 

 

/s/ Robert Bowen

 

 

[Signature Page to Subordinated Note and Warrant Purchase Agreement]

 



 

NOEL MOORE

 

 

 

 

 

/s/ Noel S. Moore

 

 

[Signature Page to Subordinated Note and Warrant Purchase Agreement]

 



 

SCHEDULE 1

 

PURCHASER

 

FACE AMOUNT OF
NOTE

 

NUMBER OF WARRANT
SHARES

 

Nantahala Capital Partners, Limited Partnership

 

$

404,000

 

162,210

 

Nantahala Capital Partners II, Limited Partnership

 

$

1,299,000

 

521,560

 

Blackwell Partners, LLC

 

$

497,000

 

199,550

 

Trigran Investments, L.P.

 

$

632,000

 

253,753

 

Trigran Investments, L.P. II

 

$

368,000

 

147,755

 

RJ Partners LLC

 

$

200,000

 

80,302

 

Paula A. Tallal, Revocable Trust

 

$

250,000

 

100,377

 

Noel Moore

 

$

400,000

 

160,603

 

The Rodman W. Moorhead III Revocable Trust

 

$

250,000

 

100,377

 

Robert Bowen

 

$

200,000

 

80,302

 

Jane A. Freeman Living Trust (5/30/12)

 

$

100,000

 

40,151

 

 



 

DISCLOSURE SCHEDULE

 



 

Exhibit A

 

FOR PURPOSES OF SECTION 1272, 1273 AND 1275 OF THE CODE, THIS NOTE IS BEING ISSUED WITH ORIGINAL ISSUE DISCOUNT.  COMPANY WILL PROVIDE PROMPTLY TO ANY PURCHASER, UPON WRITTEN REQUEST, THE ISSUE DATE, ISSUE PRICE, AMOUNT OF ORIGINAL ISSUE DISCOUNT, AND YIELD TO MATURITY WITH RESPECT TO SUCH PURCHASER’S NOTE.  ANY SUCH WRITTEN REQUEST SHOULD BE MADE TO SCIENTIFIC LEARNING CORPORATION, 300 FRANK H. OGAWA PLAZA, SUITE 600 OAKLAND, CA 94612, ATTENTION: GENERAL COUNSEL.

 

THIS NOTE IS SUBJECT TO THE TERMS OF THAT CERTAIN SUBORDINATION AGREEMENT, DATED AS OF APRIL 5, 2013, BY AND AMONG THE COMPANY, THE PURCHASER AND COMERICA BANK.

 

PROMISSORY NOTE

 

Registered — Number [      ]

 

April 5, 2013

 

FOR VALUE RECEIVED, Scientific Learning Corporation, a Delaware corporation (the “Maker”), by means of this Promissory Note (this “Note”), hereby unconditionally promises to [                   ] (the “Payee”), a principal amount equal to [            ], in lawful money of the United States of America and in immediately available funds, on the dates provided in the Agreement.

 

This Note is a “Note” referred to in the Subordinated Note and Warrant Purchase Agreement dated as of April 5, 2013 between the Maker, the Payee and the other parties thereto (as amended, restated, modified and supplemented and in effect from time to time, the “Agreement”), with respect to the Loan made by the Payee thereunder.  Capitalized terms used herein and not expressly defined in this Note shall have the respective meanings assigned to them in the Agreement.

 

This Note shall bear interest on the principal amount hereof pursuant to the provisions of the Agreement.

 

The Maker shall make all payments to the Payee of interest and principal under this Note in the manner provided in and otherwise in accordance with the Agreement.  The outstanding principal amount of this Note, together with any accrued but unpaid interest in respect hereof, shall be due and payable in full on the Final Payment Date.

 

If default (beyond any applicable grace period) is made in the punctual payment of principal or any other amount under this Note in accordance with the Agreement, or if any other Event of Default has occurred and is continuing, this Note shall, at the option of the Purchasers holding a Majority in Interest of the Notes exercised at any time upon or after the occurrence and during the continuance of any such payment default or other Event of Default and in accordance

 

A-1



 

with the applicable provisions of the Agreement (including without limitation Section 5.4 thereof), become immediately due and payable.

 

All payments of any kind due to the Payee from the Maker pursuant to this Note shall be made in the full face amount thereof.  Subject to the terms of the Agreement, all such payments will be free and clear of, and without deduction or withholding for, any present or future taxes.  The Maker shall pay all and any costs (administrative or otherwise) imposed by the Maker’s banks, clearing houses, or any other financial institution, in connection with making any payments hereunder.

 

The Maker shall pay all costs of collection, including, without limitation, all reasonable, documented legal expenses and attorneys’ fees, paid or incurred by the Payee in collecting and enforcing this Note.

 

Other than those notices required to be provided by Payee to Maker under the terms of the Agreement, the Maker and every endorser of this Note, or the obligations represented hereby, expressly waives presentment, protest, demand, notice of dishonor or default, and notice of any kind with respect to this Note and the Agreement or the performance of the obligations under this Note and/or the Agreement.  No renewal or extension of this Note or the Agreement, no release of any Person primarily or secondarily liable on this Note or the Agreement, including the Maker and any endorser, no delay in the enforcement of payment of this Note or the Agreement, and no delay or omission in exercising any right or power under this Note or the Agreement shall affect the liability of the Maker or any endorser of this Note.

 

No delay or omission by the Payee in exercising any power or right hereunder shall impair such right or power or be construed to be a waiver of any default, nor shall any single or partial exercise of any power or right hereunder preclude the full exercise thereof or the exercise of any other power or right.  The provisions of this Note may be waived or amended only in accordance with Section 6.6 of the Agreement.  This Note may be prepaid in whole or in part in accordance with the provisions of the Agreement.

 

This Note, and any rights of the Payee arising out of or relating to this Note, may, at the option of the Payee, be enforced by the Payee in the courts of the United States of America located in the Southern District of the State of New York or in any other courts having jurisdiction.  For the benefit of the Payee, the Maker hereby irrevocably agrees that any legal action, suit or other proceeding arising out of or relating to this Note may be brought in the courts of the State of New York or of the United States of America for the Southern District of New York, and hereby consents that personal service of summons or other legal process may be made as set forth in Section 6.1 of the Agreement, which service the Maker agrees shall be sufficient and valid.  The Maker hereby waives any and all rights to demand a trial by jury in any action, suit or other proceeding arising out of or relating to this Note or the transactions contemplated by this Note.

 

This Note shall be governed by, and construed in accordance with, the laws of the State of New York applicable to contracts made and to be performed in such State.

 

A-2



 

[Signature page follows]

 

A-3



 

IN WITNESS WHEREOF, an authorized representative of the Maker has executed this Note as of the date first written above.

 

 

 

 

SCIENTIFIC LEARNING CORPORATION

 

 

 

 

 

 

By:

 

 

 

 

Name:

 

 

 

Title

 

A-4


EX-99.3 4 a13-10011_1ex99d3.htm EX-99.3

EXHIBIT 99.3

 

EXECUTION VERSION

 

REGISTRATION RIGHTS AGREEMENT

 

REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 5, 2013, by and among Scientific Learning Corporation, a Delaware corporation (the “Company”), and those lenders set forth on Schedule 1 to the Subordinated Note and Warrant Purchase Agreement (as defined below) (each individually, a “Lender” and together, the “Lenders”).

 

WHEREAS:

 

A. In connection with the Subordinated Note and Warrant Purchase Agreement by and among the parties hereto of even date herewith (the “Purchase Agreement”), the Company has agreed, upon the terms and subject to the conditions contained therein, to issue and sell to the Lenders Warrants (as defined below) in the amount described in the Purchase Agreement, where each of the Warrants is exercisable into shares of the Company’s common stock, $0.001 value per share (the “Common Stock”), each upon the terms and conditions and subject to the limitations and conditions set forth in the Warrants, all subject to the terms and conditions of the Purchase Agreement; and

 

B. To induce the Lenders to execute and deliver the Purchase Agreement, the Company has agreed to provide certain registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the “Securities Act”), and applicable state securities laws,

 

NOW, THEREFORE, In consideration of the premises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Lenders hereby agree as follows:

 

1. DEFINITIONS.

 

a. As used in this Agreement, the following terms shall have the following meanings:

 

(i) “Additional Filing Deadline” means, with respect to any Registration Statements that may be required pursuant to Section 2(ii), (a) the first date or time that such Registrable Securities may then be included in a Registration Statement if such Registration Statement is required because the SEC shall have notified the Company in writing that certain Registrable Securities were not eligible for inclusion on a previously filed Registration Statement, or (b) if such additional Registration Statement is required for a reason other than as described in (a) above, the twentieth (20th) day following the date on which the Company first knows that such additional Registration Statement is required; provided, however, if the Additional Filing Deadline would otherwise fall more than forty-five (45) days, but less than ninety-one (91) days, after the end of the Company’s most recent fiscal year and the Company is unable to comply with the Additional Filing Deadline solely as a result of the unavailability of audited financial statements for such fiscal year, the Additional Filing Deadline shall be extended until the first business day following the earlier to occur of (a) the deadline (without regard to any extensions that may be permitted by Rule 12b-25 under the Exchange Act) for filing by the Company of an annual report on Form 10-K containing such financial statements with the SEC and (b) the date on which the Company files an annual report on Form 10-K containing such financial statements with the SEC.

 

(ii) “Additional Registration Deadline” means, with respect to any additional Registration Statement(s) that may be required to be filed pursuant to Section 2(ii), the thirtieth (30th) day following (a) the first date or time that such Registrable Securities may then be included in a Registration Statement if such Registration Statement is required because the SEC shall have notified the Company in writing that certain Registrable Securities were not eligible for inclusion on a previously filed Registration Statement, or (b) if such additional Registration Statement is required for a reason other than as described in (a) above, the fortieth (40th) day following the date on which the Company first knows that such additional Registration Statement(s) is required; provided, however, if the applicable Additional Filing Deadline is extended due to the proviso contained in Section 1(a)(i) above, then such Additional Registration Deadline shall be extended until the thirtieth (30th) or fortieth (40th) day, as the case may be, following the Additional Filing Deadline, as so extended, and provided, further, that if, following the filing date but before the date that the Additional Registration Statement is declared effective by the SEC, the Company is unable to file a pre-

 



 

effective amendment to the Additional Registration Statement that is required in order to cause such Additional Registration Statement to become effective because such amendment would otherwise be filed more than forty-five (45) days, but less than ninety-one (91) days, after the end of the Company’s last fiscal year and the audited financial statements for such year are unavailable, the Additional Registration Deadline shall be the date that is the later of (a) thirty (30) days after the earlier of (1) the deadline (without regard to any extensions that may be permitted by Rule 12b-25 under the Exchange Act) for filing by the Company of an annual report on Form 10-K containing such financial statements with the SEC and (2) the date on which the Company files an annual report on Form 10-K containing such financial statements with the SEC, and (b) sixty (60) days after the Registration Statement is filed.

 

(iii) “Buyer” means any Lender and any transferee or assignee who agrees to become bound by the provisions of this Agreement in accordance with Section 9 hereof.

 

(iv) “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, and any successor statute.

 

(v) “Filing Deadline” means, (1) for the Registration Statement required to be filed pursuant to Section 2(i), the date that is forty-five (45) calendar days following the Request Date and, (2) in the case of Section 2(ii), means the Additional Filing Deadline; provided however, if the Filing Deadline (other than the deadline referred to in clause (1) of this definition) would otherwise fall more than forty-five (45) days, but less than ninety-one (91) days, after the end of the Company’s most recent fiscal year and the Company is unable to comply with the Filing Deadline solely as a result of the unavailability of audited financial statements for such fiscal year, the Filing Deadline shall be extended until the first business day following the earlier to occur of (a) the deadline (without regard to any extensions that may be permitted by Rule 12b-25 under the Exchange Act) for filing by the Company of an annual report on Form 10-K containing such financial statements with the SEC and (b) the date on which the Company files an annual report on Form 10-K containing such financial statements with the SEC.

 

(vi) “Issuance Date” means April 5, 2013.

 

(vii) “Person” means and includes any natural person, partnership, joint venture, corporation, trust, limited liability company, limited company, joint stock company, unincorporated organization, government entity or any political subdivision or agency thereof, or any other entity.

 

(viii) “Registration Deadline” shall mean, other than for purposes of the Registration Statements required under Section 2(ii), the earlier of (i) the date that is ninety (90) days after the date that the applicable Registration Statement is actually filed or (ii) the date that is ninety (90) days after the applicable Filing Deadline and, with respect to any Registration Statements required to be filed under Section 2(ii), the Additional Registration Deadline.

 

(ix) “Register,” “Registered,” and “Registration” refer to a registration effected by preparing and filing a Registration Statement or Statements in compliance with the Securities Act and pursuant to Rule 415 under the Securities Act or any successor rule providing for offering securities on a continuous basis, and the declaration or ordering of effectiveness of such Registration Statement by the United States Securities and Exchange Commission (the “SEC”).

 

(x) “Registrable Securities,” for a given Registration, means (a) any shares of Common Stock (the “Warrant Shares”) issued or issuable upon exercise of or otherwise pursuant to the Warrants (without giving effect to any limitations on exercise set forth in the Warrants), (b) any shares of capital stock issued or issuable as a dividend on or in exchange for or otherwise with respect to any of the foregoing, (c) any additional shares of Common Stock issuable in connection with any anti-dilution provisions in the Warrants, and (d) any shares of capital stock issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing.  Securities will cease to be Registrable Securities when (A) they have been effectively registered under the Securities Act and disposed of in accordance with the registration statement covering them; (B) they have been distributed to the public pursuant to Rule 144 under the Securities Act; or (C) they have been otherwise transferred and new certificates for them not bearing a restrictive legend have been issued by the Company.

 

(xi) “Registration Statement(s)” means a registration statement(s) of the Company under the Securities Act required

 

2



 

to be filed hereunder.

 

(xii) “Warrant(s)” means the warrants issued by the Company pursuant to the Purchase Agreement.

 

2. REGISTRATION.  (i) Following the date on which the Company receives notice from Buyers holding a majority of Registrable Securities then outstanding (the “Request Date”), the Company shall use its commercially reasonable efforts to prepare, and, on or prior to the applicable Filing Deadline (as defined above) file with the SEC a Registration Statement (the “Demand Registration Statement”) on Form S-3 (or, if Form S-3 is not then available, on such form of Registration Statement as is then available to effect a registration of the Registrable Securities) covering the resale of the Registrable Securities.  The number of shares of Common Stock initially included in such Registration Statement shall be no less than the aggregate number of Warrant Shares that are then issuable upon exercise of or otherwise pursuant to the Warrants issued on the Issuance Date, without regard to any limitation on the Buyers’ ability to exercise the Warrants, respectively.  Each Registration Statement (and each amendment or supplement thereto) shall be provided to and subject to the approval, with respect to information regarding the Buyers and their plan of distribution, which shall not be unreasonably withheld or delayed, of counsel to the Buyers prior to its filing or other submission.

 

(ii) If for any reason the SEC does not permit all of the Registrable Securities to be included in the Registration Statement filed pursuant to Section 2(i) above, or for any other reason any Registrable Securities are not then included in a Registration Statement filed under this Agreement (the “Excluded Registrable Securities”), then the Company shall use its commercially reasonable efforts to prepare, and, promptly but in no event later than the Additional Filing Deadline, file with the SEC an additional Registration Statement covering the resale of all Excluded Registrable Securities.

 

3.  OBLIGATIONS OF THE COMPANY. In connection with the registration of the Registrable Securities, the Company shall have the following obligations:

 

a. The Company shall prepare promptly, and file with the SEC, after the Request Date (but no later than the Filing Deadline), a Registration Statement with respect to the number of Registrable Securities provided in Section 2, and thereafter use its commercially reasonable efforts to cause each such Registration Statement relating to Registrable Securities to become effective no later than the Registration Deadline, and shall keep the Registration Statement current and effective pursuant to Rule 415 of the Securities Act at all times until such date as is the earlier of (i) the date on which all of the Registrable Securities for such Registration Statement have been sold and (ii) the date on which all of the Registrable Securities for such Registration Statement (in the reasonable opinion of counsel to the Buyers delivered in writing to the Company) may be immediately sold to the public without registration or restriction (including without limitation as to volume by each holder thereof) under the Securities Act (the “Registration Period”).

 

b. The Company shall use its commercially reasonable efforts to prepare and file with the SEC such amendments (including post-effective amendments) and supplements to each Registration Statement and the prospectus used in connection with each Registration Statement as may be necessary to keep each Registration Statement current and effective at all times during the Registration Period, and, during such period, comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company covered by each Registration Statement until the earlier of (i) such time as all of such Registrable Securities have been disposed of in accordance with the intended methods of disposition by the seller or sellers thereof as set forth in each Registration Statement and (ii) the termination of the Registration Period.

 

c. The Company shall furnish to each Buyer and its legal counsel (i) promptly after the same is prepared and publicly distributed, filed with the SEC, or received by the Company, one copy of each Registration Statement and any amendment thereto, each preliminary prospectus and prospectus and each amendment or supplement thereto, and, in the case of a Registration Statement referred to in Section 2, each letter written by or on behalf of the Company to the SEC or the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC, in each case relating to such Registration Statement (other than any portion of any thereof which contains information for which the Company has sought confidential treatment), and (ii) such number of copies of a prospectus, including a preliminary prospectus, and all amendments and supplements thereto and such other documents as a Buyer may reasonably request in order to facilitate the disposition of the Registrable Securities

 

3



 

owned by such Buyer, although the Company may determine in its reasonable judgment to provide any such copies in electronic form only. The Company will immediately notify the Buyers by facsimile of the effectiveness of each Registration Statement or any post-effective amendment. The Company will respond to any and all comments received from the SEC as soon as reasonably practicable, with a view towards causing each Registration Statement or any amendment thereto to be declared effective by the SEC as soon as practicable and shall file an acceleration request as soon as practicable, but no later than ten (10) business days, following the resolution or clearance of all SEC comments or, if applicable, following notification by the SEC that any such Registration Statement or any amendment thereto will not be subject to review, provided, however, that if during such period, the Company is unable to file such acceleration request because such acceleration request would otherwise be filed more than forty-five (45), but less than ninety-one (91) days, after the end of the Company’s most recent fiscal year and the audited financial statements for such fiscal year are unavailable at such time, such obligation to file an acceleration request shall be extended until the first business day following the earlier of (a) the deadline (without regard to any extensions that may be permitted by Rule 12b-25 under the Exchange Act) for filing by the Company of an annual report on Form 10-K containing such financial statements with the SEC and (b) the date on which the Company files an annual report on Form 10-K containing such financial statements with the SEC.

 

d. The Company shall use its commercially reasonable efforts to (i) register and qualify, in any jurisdiction where registration and/or qualification is required, the Registrable Securities covered by the Registration Statements under such other securities or “blue sky” laws of such jurisdictions in the United States as the Buyers shall reasonably request, (ii) prepare and file in those jurisdictions such amendments (including post-effective amendments) and supplements to such registrations and qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions as may be necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv) take all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 3(d), (y) subject itself to general taxation in any such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction.

 

e.  Promptly after becoming aware of such event, the Company shall notify each Buyer of the happening of any event, of which the Company has knowledge, as a result of which the prospectus included in any Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading, and use its commercially reasonable efforts promptly to prepare a supplement or amendment to any Registration Statement to correct such untrue statement or omission, and deliver such number of copies of such supplement or amendment to each Buyer as such Buyer may reasonably request.

 

f. The Company shall use its commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness of any Registration Statement, and, if such an order is issued, to obtain the prompt withdrawal of such order and to notify each Buyer who holds Registrable Securities being sold (or, in the event of an underwritten offering, the managing underwriters) of the issuance of such order and the resolution thereof.

 

g. The Company shall permit a single firm of counsel designated by the Buyers to review such Registration Statement and all amendments and supplements thereto (as well as all requests for acceleration or effectiveness thereof), at Buyers’ own cost, a reasonable period of time prior to their filing with the SEC (not less than three (3) business days but not more than eight (8) business days) and not file any documents in a form to which such counsel reasonably objects and will not request acceleration of such Registration Statement without prior notice to such counsel.

 

h. The Company shall use its commercially reasonable efforts to cause all the Registrable Securities covered by each Registration Statement to be listed on each securities exchange on which securities of the same class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted under the rules of such exchange, and, if listed on a national exchange, to arrange for at least two market makers to register with Financial Industry Regulatory Authority, Inc. (“FINRA”) as such with respect to such Registrable Securities.

 

i. The Company shall provide a transfer agent and registrar, which may be a single entity, for the Registrable Securities not later than the effective date of the Registration Statement.

 

4



 

j. The Company shall cooperate with each Buyer who holds Registrable Securities being offered and the managing underwriter or underwriters as reasonably requested by them with respect to an applicable Registration Statement, if any, to facilitate the timely preparation and delivery of certificates (not bearing any restrictive legends) representing Registrable Securities to be offered pursuant to such Registration Statement and enable such certificates to be in such denominations or amounts, as the case may be, as the managing underwriter or underwriters, if any, or the Buyer may reasonably request and registered in such names as the managing underwriter or underwriters, if any, or the Buyer may request.

 

k. At the reasonable request of a Buyer, the Company shall prepare and file with the SEC such amendments (including post-effective amendments) and supplements to a Registration Statement and any prospectus used in connection with the Registration Statement as may be necessary in order to change the plan of distribution set forth in such Registration Statement.

 

l. The Company during the Registration Period shall comply with all applicable laws related to a Registration Statement and offering and sale of securities and all applicable rules and regulations of governmental authorities in connection therewith (including, without limitation, the Securities Act and the Exchange Act and the rules and regulations promulgated by the SEC).

 

m.  If required by the Financial Industry Regulatory Authority, Inc. Corporate Financing Department, the Company shall promptly effect a filing with FINRA pursuant to FINRA Rule 5110 with respect to the public offering contemplated by resales of securities under the Registration Statement (an “Issuer Filing”), and pay the filing fee required by such Issuer Filing. The Company shall use commercially reasonable efforts to pursue the Issuer Filing until FINRA issues a letter confirming that it does not object to the terms of the offering contemplated by the Registration Statement.

 

n.  Notwithstanding anything to the contrary herein, at any time after the effective date of the Registration Statement, the Company may delay the disclosure of material, non-public information concerning the Company or any of its Subsidiaries the disclosure of which at the time is not, in the good faith opinion of the board of directors of the Company, in the best interest of the Company and, in the opinion of counsel to the Company, otherwise required (a “Grace Period”), provided that the Company shall promptly notify the Investors in writing of the (i) existence of material, nonpublic information giving rise to a Grace Period (provided that in each such notice the Company shall not disclose the content of such material, non-public information to any of the Investors) and the date on which such Grace Period will begin and (ii) date on which such Grace Period ends, provided further that no Grace Period shall exceed thirty (30) consecutive days and during any three hundred sixty five (365) day period all such Grace Periods shall not exceed an aggregate of ninety (90) days. For purposes of determining the length of a Grace Period above, such Grace Period shall begin on and include the date the Investors receive the notice referred to in clause (i) above and shall end on and include the later of the date the Investors receive the notice referred to in clause (ii) above and the date referred to in such notice.

 

4. OBLIGATIONS OF THE BUYER. In connection with the registration of the Registrable Securities, each Buyer shall have the following obligations:

 

a. It shall be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect to the Registrable Securities of a Buyer that such Buyer shall furnish to the Company such information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it as shall be reasonably required to effect the registration of such Registrable Securities and shall execute such documents in connection with such registration as the Company may reasonably request. At least five (5) business days prior to the first anticipated filing date of a Registration Statement, the Company shall notify each Buyer of the information the Company requires from such Buyer.  Any such information shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein not misleading.

 

b. Each Buyer, by such Buyer’s acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of a Registration Statement hereunder, unless such Buyer has notified the Company in writing of the Buyer’s election to exclude all of the

 

5



 

Buyer’s Registrable Securities from such Registration Statement.

 

c. Each Buyer agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 3(e) or 3(f), the Buyer will immediately discontinue disposition of Registrable Securities pursuant to the Registration Statement covering such Registrable Securities until the Buyer’s receipt of the copies of the supplemented or amended prospectus contemplated by Section 3(e) or 3(f) and, if so directed by the Company, the Buyer shall deliver to the Company (at the expense of the Company) or destroy (and deliver to the Company a certificate of destruction) all copies in the Buyer’s possession, of the prospectus covering such Registrable Securities current at the time of receipt of such notice.

 

5. EXPENSES OF REGISTRATION. All reasonable expenses, other than underwriting discounts and commissions, incurred in connection with registrations, filings or qualifications pursuant to Sections 2 and 3, including, without limitation, all registration, listing and qualification fees, printers and accounting fees, and the fees and disbursements of counsel for the Company (but not including fees and disbursements for counsel for any Buyer) shall be borne by the Company.

 

6. INDEMNIFICATION. In the event any Registrable Securities are included in a Registration Statement under this Agreement:

 

a. The Company will indemnify, hold harmless and defend (i) each Buyer, (ii) the directors, officers, partners, managers, members, employees, agents and each Person who controls any Buyer within the meaning of the Securities Act or the Exchange Act, if any, (iii) any underwriter (as defined in the Securities Act) for each Buyer in connection with an underwritten offering pursuant to Section 2 hereof, and (iv) the directors, officers, partners, employees and each Person who controls any such underwriter within the meaning of the Securities Act or the Exchange Act, if any (each, an “Indemnified Person”), against any joint or several losses, claims, damages, liabilities or expenses (collectively, together with actions, proceedings or inquiries by any regulatory or self-regulatory organization, whether commenced or threatened, in respect thereof, “Claims”) to which any of them may become subject insofar as such Claims arise out of or are based upon: (i) any untrue statement or alleged untrue statement of a material fact in a Registration Statement or the omission or alleged omission to state therein a material fact required to be stated or necessary to make the statements therein not misleading; or (ii) any untrue statement or alleged untrue statement of a material fact contained in any preliminary prospectus if used prior to the effective date of such Registration Statement, or contained in the final prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement thereto with the SEC) or the omission or alleged omission to state therein any material fact necessary to make the statements made therein, in light of the circumstances under which the statements therein were made, not misleading (the matters in the foregoing clauses (i) and (ii) being, collectively, “Violations”). The Company shall reimburse the Indemnified Person, promptly as such expenses are incurred and are due and payable, for any reasonable legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such Claim.  Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this Section 6(a) shall not apply (A)(i) to a Claim arising out of or based upon a Violation to the extent that such Violation occurs in reliance upon and in conformity with information furnished in writing to the Company by any Indemnified Person for use in connection with the preparation of such Registration Statement or any such amendment thereof or supplement thereto, or (ii) to the extent due to the failure of any Buyer to timely deliver any prospectus, including any corrected prospectus, timely made available by the Company pursuant to Section 3(d) hereto; or (B) to any amounts paid in settlement of any Claim effected without the prior written consent of the Company, which consent shall not be unreasonably withheld.  Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified Person and shall survive the transfer of the Registrable Securities by the Buyer pursuant to Section 9.

 

b. Promptly after receipt by an Indemnified Person under this Section 6 of notice of the commencement of any action (including any governmental action), such Indemnified Person shall, if a Claim in respect thereof is to be made against the Company under this Section 6, deliver to the Company a written notice of the commencement thereof, and the Company shall have the right to participate in, and, to the extent the Company so desires, to assume control of the defense thereof with counsel mutually satisfactory to the Company and the Indemnified Person, as the case may be; provided, however, that an Indemnified Person shall have the right to retain its own counsel with the reasonable fees and expenses to be paid by the Company, if, in the reasonable opinion of counsel for the Buyer, the representation by such counsel of the Indemnified Person and the Company would be inappropriate due to actual or

 

6



 

potential differing interests between such Indemnified Person and any other party represented by such counsel in such proceeding. The Company shall pay for only one separate legal counsel for the Indemnified Persons, and such legal counsel shall be selected by Buyers. The failure to deliver written notice to the Company within a reasonable time of the commencement of any such action shall not relieve the Company of any liability to the Indemnified Person under this Section 6, except to the extent that the Company is actually prejudiced in its ability to defend such action.

 

c.  Each Buyer will indemnify, hold harmless and defend (i) the Company, and (ii) the directors, officers, partners, managers, members, employees, or agents of the Company, if any (each, a “Company Indemnified Person”), against any Claims to which any of them may become subject insofar as such Claims arise out of or are based upon any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any other law, including, without limitation, any state securities law, or any rule or regulation thereunder relating to the offer or sale of the Registrable Securities, which occurs due to the inclusion by the Company in a Registration Statement of false or misleading information about a Buyer, where such information was furnished in writing to the Company by such Buyer for the purpose of inclusion in such Registration Statement.  Notwithstanding anything herein to the contrary, the indemnity agreement contained in this Section 6(c) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Buyers, which consent shall not be unreasonably withheld or delayed; and provided, further, however, that a Buyer shall be liable under this Section 6(c) for only that amount of a Claim as does not exceed the net amount of proceeds received by such Buyer as a result of the sale of Registrable Securities pursuant to such Registration Statement.

 

d.  Promptly after receipt by a Company Indemnified Person under this Section 6 of notice of the commencement of any action (including any governmental action), such Company Indemnified Person shall, if a Claim in respect thereof is to be made against a Buyer under this Section 6, deliver to such Buyer a written notice of the commencement thereof, and such Buyer shall have the right to participate in, and, to the extent such Buyer so desires, to assume control of the defense thereof with counsel mutually satisfactory to such Buyer and the Company Indemnified Person, as the case may be; provided, however, that a Company Indemnified Person shall have the right to retain its own counsel with the reasonable fees and expenses to be paid by the Buyer, if, in the reasonable opinion of counsel for the Company, the representation by such counsel of the Company Indemnified Person and the Buyer would be inappropriate due to actual or potential differing interests between the Company Indemnified Person and any other party represented by such counsel in such proceeding.  A Buyer shall pay for only one separate legal counsel for the Company Indemnified Persons, and such legal counsel shall be selected in the reasonable judgment of the Company.

 

e.  The indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as such expense, loss, damage or liability is incurred and is due and payable.

 

7.  CONTRIBUTION.  To the extent any indemnification by the Company or any Buyer is prohibited or limited by law, each of the Company and each Buyer agrees to make the maximum contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law, based upon a comparative fault standard.

 

8.  REPORTS UNDER THE 1934 ACT.  With a view to making available to the Buyers the benefits of Rule 144 promulgated under the Securities Act or any other similar rule or regulation of the SEC that may at any time permit the Buyers to sell securities of the Company to the public without registration the Company agrees to:

 

a.  make and keep public information available, as those terms are understood and defined in Rule 144; and

 

b.  file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act so long as the Company remains subject to such requirements and the filing of such reports and other documents is required for the applicable provisions of Rule 144.

 

9.  ASSIGNMENT OF REGISTRATION RIGHTS.  The rights under this Agreement shall be automatically assignable by each Buyer to any transferee of all or any portion of the Registrable Securities if:  (i) the Buyer agrees in writing with the transferee or assignee to assign such rights, and a copy of such agreement is furnished to the

 

7



 

Company within a reasonable time after such assignment, (ii) the Company is, within a reasonable time after such transfer or assignment, furnished with written notice of (a) the name and address of such transferee or assignee, and (b) the securities with respect to which such registration rights are being transferred or assigned, and (iii) at or before the time the Company receives the written notice contemplated by clause (ii) of this sentence, the transferee or assignee agrees in writing with the Company to be bound by all of the provisions contained herein.  In the event that the Company receives notice from a Buyer in writing that it has transferred all or any portion of its Registrable Securities pursuant to this Section, the Company shall have at least fifteen (15) days to file any amendments or supplements necessary to include the requisite selling securityholder information with respect to such transferee in the Registration Statement.

 

10.  AMENDMENT OF REGISTRATION RIGHTS.  Provisions of this Agreement may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively or prospectively), only in the manner provided in Section 6.6 of the Purchase Agreement.

 

11.  MISCELLANEOUS.

 

a.  Any notices required or permitted to be given under the terms hereof shall be sent by certified or registered mail (return receipt requested) or delivered personally or by courier (including a recognized overnight delivery service) or by facsimile and shall be effective five days after being placed in the mail, if mailed by regular United States mail, or upon receipt, if delivered personally or by courier (including a recognized overnight delivery service) or by facsimile, in each case addressed to a party.  The addresses for such communications shall be:

 

If to the Company:

 

Scientific Learning Corporation

300 Frank H. Ogawa Plaza, Suite 600

Oakland, CA 94612

Attn: General Counsel
Email: legal@scilearn.com

 

With copy to:

 

Wilson Sonsini Goodrich & Rosati, Professional Corporation

650 Page Mill Road

Palo Alto, CA 94304

Fax: 650-493-6811

Email:  sbernard@wsgr.com

Attn:  Steven Bernard

 

If to a Buyer, to each at the address set forth on Schedule 1 to the Purchase Agreement with a copy to:

 

Fulbright & Jaworski L.L.P.

666 Fifth Avenue

New York, NY 10103

Fax: 212-318-3400

 

Attn: Michael Flynn

 

Each of Company or any Buyer shall provide notice to the other party of any change in address.

 

c.  Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy, shall not operate as a waiver thereof.

 

8



 

d.  Governing Law.  All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.  Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.  Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives (to the extent permitted by applicable law), and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.  Each party hereby irrevocably waives (to the extent permitted by applicable law) personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.  The parties hereby waive (to the extent permitted by applicable law) all rights to a trial by jury.  If either party shall commence an action or proceeding to enforce any provision of this Agreement, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

 

e.  This Agreement, the Warrants and the Purchase Agreement (including all schedules and exhibits thereto) constitute the entire agreement among the parties hereto with respect to the subject matter hereof and thereof.  There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and therein.  This Agreement, the Warrants and the Purchase Agreement supersede all prior agreements and understandings among the parties hereto with respect to the subject matter hereof and thereof.

 

f.  Subject to the requirements of Section 9 hereof, this Agreement shall inure to the benefit of and be binding upon the successors and assigns of each of the parties hereto.

 

g.  The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.

 

h.  This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which shall constitute one and the same agreement.  This Agreement, once executed by a party, may be delivered to the other party hereto by facsimile transmission of a copy of this Agreement bearing the signature of the party so delivering this Agreement.

 

i.  Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

j.  The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party.

 

k.  In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law.  Any provision hereof which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision hereof.

 

l.  There shall be no oral modifications or amendments to this Agreement.  This Agreement may be modified or amended only in writing.

 

9



 

o.  This Agreement shall terminate and be of no further force or effect upon the date that is eight (8) years from the date hereof.

 

[Remainder of page left intentionally blank]

 

[Signature page follows]

 

10



 

IN WITNESS WHEREOF, the undersigned Buyers and the Company have caused this Registration Rights Agreement to be duly executed as of the date first written above.

 

 

COMPANY:

 

 

 

SCIENTIFIC LEARNING CORPORATION

 

 

 

 

 

By:

/s/ Jane A. Freeman

 

Name:

Jane A. Freeman

 

Title:

CFO

 

 

[Signature Page to Registration Rights Agreement]

 



 

BUYERS:

 

 

 

 

 

BLACKWELL PARTNERS LLC

 

 

 

By: Nantahala Capital Management, LLC

 

Its Investment Manager

 

 

 

 

 

 

 

By:

/s/ Wilmot Harkey

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

 

 

 

 

 

 

NANTAHALA CAPITAL PARTNERS II,

 

LIMITED PARTNERSHIP

 

 

 

By: Nantahala Capital Management, LLC

 

Its General Partner

 

 

 

 

 

 

 

By:

/s/ Wilmot Harkey

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

 

 

 

 

 

 

NANTAHALA CAPITAL PARTNERS,

 

LIMITED PARTNERSHIP

 

 

 

By: Nantahala Capital Management, LLC

 

Its General Partner

 

 

 

 

 

 

 

By:

/s/ Wilmot Harkey

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

 

[Signature Page to Registration Rights Agreement]

 



 

TRIGRAN INVESTMENTS, LP

 

 

 

By: Trigran Investments, Inc.

 

Its General Partner

 

 

 

 

 

 

 

By:

/s/ Lawrence A. Oberman

 

 

Name: Lawrence Oberman

 

 

Title: Executive Vice President

 

 

 

 

 

 

 

TRIGRAN INVESTMENTS, LP II

 

 

 

 

By: Trigran Investments, Inc.

 

Its General Partner

 

 

 

 

 

 

 

By:

/s/ Lawrence A. Oberman

 

 

Name: Lawrence Oberman

 

 

Title: Executive Vice President

 

 

[Signature Page to Registration Rights Agreement]

 



 

RJ PARTNERS LLC

 

 

 

 

 

 

 

By:

/s/ Robert J. Schmiedeler

 

 

Name: Robert J. Schmiedeler

 

 

Title: Manager

 

 

[Signature Page to Registration Rights Agreement]

 



 

PAULA A. TALLAL, REVOCABLE TRUST

 

 

 

 

 

 

 

By:

/s/ Paula A. Tallal

 

 

Name: Paula A. Tallal

 

 

Title: Trustee

 

 

[Signature Page to Registration Rights Agreement]

 



 

JANE A. FREEMAN LIVING TRUST (5/30/12)

 

 

 

 

 

 

 

/s/ Jane A. Freeman

 

Name:  Jane A. Freeman

 

Title: Trustee

 

 

[Signature Page to Registration Rights Agreement]

 



 

THE RODMAN W. MOORHEAD III REVOCABLE TRUST

 

 

 

 

 

 

 

By:

/s/ Rodman W. Moorhead, III

 

 

Name: Rodman W. Moorhead, III

 

 

Title: Trustee

 

 

[Signature Page to Registration Rights Agreement]

 



 

ROBERT BOWEN

 

 

 

 

 

/s/ Robert Bowen

 

 

[Signature Page to Registration Rights Agreement]

 



 

NOEL MOORE

 

 

 

 

 

/s/ Noel S. Moore

 

 

[Signature Page to Registration Rights Agreement]

 


EX-99.4 5 a13-10011_1ex99d4.htm EX-99.4

EXHIBIT 99.4

 

SECURITY AGREEMENT

 

This Security Agreement (as amended, restated, modified or otherwise supplemented from time to time, this “Agreement”), dated as of April 5, 2013, is entered into between Scientific Learning Corporation, a Delaware corporation (the “Obligor”), in favor of the entities identified as secured parties on the signature pages of this Agreement (individually, a “Secured Party,” and together, the “Secured Parties”).

 

W I T N E S S E T H:

 

WHEREAS, Obligor has entered into a Subordinated Note and Warrant Purchase Agreement, dated as of the date hereof (as amended, restated, modified or otherwise supplemented from time to time, the “Purchase Agreement”), with the Secured Parties;

 

WHEREAS, Obligor wishes to grant to the Secured Parties a security interest in certain collateral of the Obligor and the Secured Parties wish to receive such security interest on the date hereof, all as more fully set forth herein;

 

NOW, THEREFORE, in consideration of the mutual agreements set forth herein, Obligor and the Secured Parties agree as follows:

 

1.                                      Grant of Security Interest.

 

(a)                     To secure payment and performance of the Obligations, Obligor hereby grants to the Secured Parties a security interest in all property and interests in property of Obligor, whether now owned or hereafter acquired or existing, and wherever located (the “Collateral”), including, without limitation, the following (the “Security Interest”):

 

(i)                                                 all Accounts;

 

(ii)                                              all Receivables;

 

(iii)                                           all Equipment;

 

(iv)                                          all General Intangibles;

 

(v)                                             all Inventory;

 

(vi)                                          all Intellectual Property;

 

(vii)                                       all Investment Property; and

 

(viii)                                    all proceeds and products of the foregoing.

 

1



 

(b)                     Notwithstanding anything herein to the contrary, in no event shall the Security Interest granted hereunder attach to, and the Collateral shall not include, (i) any asset of the Obligor to the extent that and for so long as the grant of a security interest therein is prohibited by any applicable law, rule, regulation, statute or order of any Governmental Authority, (ii) more than 65% of the issued and outstanding voting equity interests of any Foreign Subsidiary, (iii) any contract or agreement to which the Obligor is a party or any of its rights or interests thereunder if and for so long as the grant of such Security Interest shall constitute or result in (A) the unenforceability of any right of the Obligor therein or (B) in a breach or termination pursuant to the terms of, or a default under, any such contract or agreement (other than to the extent that any such term would be rendered ineffective pursuant to Sections 9-406, 9-407, 9-408 or 9-409 of the New York UCC or any other applicable law or principles of equity); provided, however, that such Security Interest shall attach immediately at such time as the condition causing such unenforceability shall be remedied and, to the extent severable, shall attach immediately to any portion of such contract or agreement that does not result in any of the consequences specified in subclauses (A) or (B) of this clause (iii), including any proceeds of such contract or agreement, (iv) any trust accounts, payroll accounts and escrow accounts maintained by the Obligor, and (v) any asset or property that is subject to a purchase money Lien or Lien securing any capital lease obligations permitted under the Purchase Agreement to the extent that the documents relating to such purchase money Lien or capital lease obligations would not permit such asset or property to be subject to the Security Interests created hereby.

 

2.                                      Obligor’s Representations and Warranties. The Obligor represents and warrants to the Secured Parties as follows:

 

(a)                     The Obligor has, and as to Collateral acquired or arising after the date hereof, will have, good and valid rights in, and title to, the Collateral with respect to which it has purported to grant a Security Interest hereunder, except for the Security Interest and Liens in respect of the Permitted Indebtedness and minor defects in title that do not interfere with its ability to conduct its business as currently conducted or to utilize the Collateral for its intended purposes, and has full power and authority to grant to the Secured Parties the Security Interest in the Collateral pursuant hereto and to execute, deliver and perform its obligations in accordance with the terms of this Agreement, without the consent or approval of any other Person other than any consent or approval which has been obtained;

 

(b)                     There is no agreement in effect on the date hereof that prohibits the creation of the Security Interest by the Obligor; and

 

(c)                      All written information heretofore or hereafter furnished by the Obligor to each Secured Party is or will be true and correct in all material respects as of the date with respect to which such information was or will be furnished.

 

3.                                      Obligor’s Covenants.  The Obligor warrants, covenants and agrees with the Secured Parties that, from and after the date of this Agreement until any and all amounts owed by the Obligor to any Secured Party are paid in full:

 

(a)                     The Obligor shall not enter into any such agreement prohibiting or limiting the creation of the Security Interest by the Obligor other than (i) restrictions or conditions imposed

 

2



 

by any agreement relating to secured Permitted Indebtedness if such restrictions or conditions apply only to the property or assets permitted to secure such Indebtedness (or other secured obligations, as the case may be) and the products and proceeds thereof, (ii) customary restrictions and conditions contained in agreements relating to any assets pending such sale; provided that such restrictions apply only to the assets that are to be sold and such sale is permitted under the Purchase Agreement, (iii) customary provisions in leases, licenses and other agreements restricting the assignment thereof or the subletting of the premises subject thereto, (iv) the Transaction Documents, (v) restrictions on cash or other deposits or net worth imposed by customers or lessors or required by insurance, surety or bonding companies under contracts entered into in the ordinary course of business, and (vi) encumbrances or restrictions arising or existing by reason of applicable law or any applicable rule, regulation, order, permit or grant.

 

(b)                     The Obligor shall defend the title to the Collateral against any and all Persons and against any and all claims.

 

(c)                      At any time and from time to time, at the request of any Secured Party, the Obligor shall execute and deliver one or more financing statements and/or continuation statements (whether pursuant to the New York UCC or otherwise), and any amendments thereof and supplements thereto, and such other instruments as the Secured Parties shall reasonably require in order to perfect, protect, preserve and maintain the Security Interest, and shall pay the cost of filing and recording the same or filing and recording this Agreement or any such statements in all public offices wherever filing or recording is reasonably deemed by any Secured Party to be necessary or desirable.  The Obligor agrees that a carbon, photographic or other reproduction of this Agreement or a financing statement is sufficient as a financing statement.

 

(d)                     The Obligor shall diligently collect all of its accounts and accounts receivable constituting Collateral unless and until the Secured Parties exercise their right to collect the accounts and accounts receivable.  Upon any Default, the Obligor shall, at the request of the Secured Parties, notify its account debtors of the Security Interest in any account or account receivable and that payment thereof is to be made directly to the Secured Parties.

 

(e)                      The Obligor shall keep the Collateral (consisting of tangible personal property) at its present location and not to remove the same (other than motor vehicles or inventory sold as permitted under the Purchase Agreement) without the prior written consent of the Majority in Interest in each instance.

 

4.                                      Secured Parties’ Covenants. Each of the Secured Parties agrees that (i) such party will not, directly or indirectly, take any action with respect to the Collateral or the Security Interest or its rights and remedies provided for herein without the prior agreement of Secured Parties representing a Majority in Interest., (ii) such party will take such actions as are reasonably necessary to effectuate the instructions or decisions of the Secured Parties representing a Majority in Interest in respect of all rights and remedies under this Agreement, including, without limitation, appointing one or more agents selected by the Secured Parties representing a Majority in Interest to act as collateral agent with respect to the Collateral.

 

3



 

5.                                      Remedies on Default.

 

(a)                     Upon any Event of Default and upon demand by the Secured Parties representing a Majority in Interest, the Obligor agrees immediately to assemble the Collateral and make it available to the Secured Parties at the place and time designated in such demand.  The Secured Parties shall be entitled to immediate possession of the Collateral and the Secured Parties may: (i) enter any premises where any Collateral may be located for the purpose of assembling or taking possession of and removing same and (ii) sell, assign, lease or otherwise dispose of the Collateral or any part thereof, either at public or private sale acceptable to the Secured Parties.  Any Secured Party may, in its discretion and as it may deem advisable, bid or become the purchaser at any such sale described in clause (ii) above, free from any right of redemption (which is hereby expressly waived by the Obligor).  Until any such sale, the Secured Parties may store the Collateral on the premises where it is located when seized, and if said premises are the property of the Obligor, the Obligor agrees not to charge the Secured Parties for storage thereof for a period of ninety (90) days before or after sale or disposition of said Collateral.  The Secured Parties will give the Obligor reasonable notice of time and place of any public sale or the time after which any private sale or other intended disposition will be made.  The requirement of reasonable notice shall be met if such notice is mailed to the Obligor at least five (5) days before the time of the sale or disposition.

 

(b)                     The net cash proceeds resulting from the collection, liquidation, sale or other disposition of the Collateral shall be applied: first to the expenses (including all attorneys’ fees) of preparing for sale, storing, processing, selling, collecting, and/or liquidating the Collateral and the like; second to the Secured Parties, for the principal and interest due under the Notes in an amount equal to their respective pro rata portions of such proceeds.  The Obligor shall be liable to the Secured Parties and shall pay to the Secured Parties on demand any deficiency which may remain after such sale, disposition, collection or liquidation of Collateral, and the Secured Parties in turn agree to remit to the Obligor, or other such persons as their interests may appear, any surplus remaining after all such liabilities have been paid in full.

 

(c)                      Upon the request of the Secured Parties representing a Majority in Interest, after the occurrence of any Event of Default, any proceeds of accounts, accounts receivable or inventory constituting Collateral received by the Obligor, whether in the form of cash, checks, notes or other instruments, shall be held in trust by the Obligor in favor of the Secured Parties and the Obligor shall deliver said proceeds daily to the Secured Parties, without commingling, in the identical form received.

 

(d)                     In the event the Secured Parties seek to take possession of any or all Collateral by court process, the Obligor hereby irrevocably waives any bonds and any surety or security relating thereto required by any statute, court rule or otherwise as an incident to such possession, and waives any demand for possession prior to the commencement of any suit or action to recover with respect thereto and waives the right to demand a jury in any action in which any of the Secured Parties is a party.

 

6.                                      Other Rights upon Event of Default.  In addition to all rights and remedies herein, upon an Event of Default, each Secured Party shall have such other rights and remedies as are set forth

 

4



 

in the New York UCC, to the extent the same are not inconsistent with the provisions of this Agreement.

 

7.                                      Definitions.  Capitalized terms used in this Agreement and not otherwise defined herein have the meanings specified in the Purchase Agreement.  All terms defined in the New York UCC and not defined herein or in the Purchase Agreement have the meanings specified in the New York UCC.

 

New York UCC” means the Uniform Commercial Code as from time to time in effect in the State of New York.

 

8.                                      Notices.  Any notices required or permitted to be given under the terms hereof shall be sent by certified or registered mail (return receipt requested) or delivered personally or by courier (including a recognized overnight delivery service) or by facsimile or by electronic mail (if such party designates an e-mail address herein for such purpose) and shall be effective five (5) days after being placed in the mail, if mailed by regular United States mail, or upon receipt, if delivered personally or by courier (including a recognized overnight delivery service) or by facsimile, or when read by electronic mail (sender shall have received a “read by recipient” confirmation) in each case addressed to a party.  The addresses for such communications shall be:

 

For the Obligor:

300 Frank H. Ogawa Plaza, Suite 600

Oakland, CA 94612

Attn: General Counsel
Email: legal@scilearn.com

 

with a courtesy copy to:

Wilson Sonsini Goodrich & Rosati, Professional Corporation

650 Page Mill Road

Palo Alto, CA 94304

Fax: 650-493-6811

Email:  sbernard@wsgr.com

Attn:  Steven Bernard

 

For the Secured Parties, to each at its address on Schedule 1 to the Purchase Agreement, with a copy to

 

Fulbright & Jaworski L.L.P.

666 Fifth Avenue

New York, NY 10103

Fax: 212-318-3400

 

Attn: Michael Flynn

 

5



 

9.                                      General.

 

(a)                     This Agreement shall bind and inure to the respective successors and assigns of the Obligor and the Secured Parties, except that the Obligor may not assign or otherwise transfer all or any part of its rights under the this Agreement without the prior written consent of the Secured Parties.

 

(b)                     This Agreement, taken together with the other Transaction Documents, contains the entire understanding of the Parties with respect to the matters covered thereby and supersede any and all other written and oral communications, negotiations, commitments and writings with respect thereto.  The provisions of this Agreement may be waived, modified, supplemented or amended only as provided in Section 6.6 of the Purchase Agreement.

 

(c)                      All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York applicable to contracts made and to be performed in such State.

 

(d)                     This Agreement may be executed in several counterparts, and by each party on separate counterparts, each of which and any photocopies and facsimile copies thereof shall be deemed an original, but all of which together shall constitute one and the same agreement.

 

(e)                      (i) This Agreement, the Security Interest and all other security interests granted hereby shall terminate when all the Obligations (other than contingent obligations not yet accrued and payable) have been paid in full.

 

(ii)                                  Upon any sale or other transfer by Obligor of any Collateral that is not prohibited under the Purchase Agreement, or upon the effectiveness of any written consent to the release of the Security Interest granted hereby in any Collateral pursuant to the Purchase Agreement, including upon the written consent of a Majority in Interest of the Lenders under the Purchase Agreement, the Security Interest in such Collateral shall be automatically released.

 

(f)                       In connection with any termination or release pursuant to clause (i) or (ii) of Section 9(e), the Secured Parties shall execute and deliver to the Obligor, at the Obligor’s expense, all documents that the Obligor shall reasonably request to evidence such termination or release of its obligations or the Security Interests in its Collateral.  A Majority in Interest of the Lenders under the Purchase Agreement may take any such action or release any or all security hereunder.

 

(g)                      If any provision contained in this Agreement shall be invalid, illegal or unenforceable in any respect under any law, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.  The Parties shall endeavor in good faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provision.

 

(h)                     From time to time, the Obligor shall perform any and all acts and execute and deliver to the Secured Parties such additional documents as may be necessary or as reasonably

 

6



 

requested by the Secured Parties to carry out the purposes of this Agreement or to preserve and protect the Secured Parties’ rights as contemplated herein.

 

[Signature page follows]

 

7



 

IN WITNESS WHEREOF, each of the Parties hereto has caused this Agreement to be executed and delivered by its duly authorized officer on the date first set forth above.

 

 

OBLIGOR:

 

 

 

SCIENTIFIC LEARNING CORPORATION

 

 

 

 

 

By:

/s/ Jane A. Freeman

 

Name: Jane A. Freeman

 

Title:  CFO

 

 

[Signature Page to Security Agreement]

 



 

SECURED PARTIES:

 

 

 

 

 

BLACKWELL PARTNERS LLC

 

 

 

By: Nantahala Capital Management, LLC

 

Its Investment Manager

 

 

 

 

 

 

 

By:

/s/ Wilmot Harkey

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

 

 

 

 

 

 

NANTAHALA CAPITAL PARTNERS II,

 

LIMITED PARTNERSHIP

 

 

 

 

By: Nantahala Capital Management, LLC

 

Its General Partner

 

 

 

 

 

 

 

By:

/s/ Wilmot Harkey

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

 

 

 

 

 

 

NANTAHALA CAPITAL PARTNERS,

 

LIMITED PARTNERSHIP

 

 

 

 

By: Nantahala Capital Management, LLC

 

Its General Partner

 

 

 

 

 

 

 

By:

/s/ Wilmot Harkey

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

 

[Signature Page to Security Agreement]

 



 

TRIGRAN INVESTMENTS, LP

 

 

 

By: Trigran Investments, Inc.

 

Its General Partner

 

 

 

 

 

By:

/s/ Lawrence A. Oberman

 

 

Name: Lawrence Oberman

 

 

Title: Executive Vice President

 

 

 

 

 

 

 

TRIGRAN INVESTMENTS, LP II

 

 

 

 

By: Trigran Investments, Inc.

 

Its General Partner

 

 

 

 

 

 

 

By:

/s/ Lawrence A. Oberman

 

 

Name: Lawrence Oberman

 

 

Title: Executive Vice President

 

 

[Signature Page to Security Agreement]

 



 

RJ PARTNERS LLC

 

 

 

 

 

 

 

By:

/s/ Robert J. Schmiedeler

 

 

Name: Robert J. Schmiedeler

 

 

Title: Manager

 

 

[Signature Page to Security Agreement]

 



 

PAULA A. TALLAL, REVOCABLE TRUST

 

 

 

 

 

 

 

By:

/s/ Paula A. Tallal

 

 

Name: Paula A. Tallal

 

 

Title: Trustee

 

 

[Signature Page to Security Agreement]

 



 

JANE A. FREEMAN LIVING TRUST (5/30/12)

 

 

 

 

 

 

 

/s/ Jane A. Freeman

 

Name: Jane A. Freeman

 

Title: Trustee

 

 

[Signature Page to Security Agreement]

 



 

RODMAN W. MOORHEAD III REVOCABLE TRUST

 

 

 

 

 

 

 

By:

/s/ Rodman W. Moorhead, III

 

 

Name: Rodman W. Moorhead, III

 

 

Title: Trustee

 

 

[Signature Page to Security Agreement]

 



 

ROBERT BOWEN

 

 

 

 

 

 

 

/s/ Robert Bowen

 

 

[Signature Page to Security Agreement]

 



 

NOEL MOORE

 

 

 

 

 

 

 

/s/ Noel S. Moore

 

 

[Signature Page to Security Agreement]

 


EX-99.5 6 a13-10011_1ex99d5.htm EX-99.5

EXHIBIT 99.5

 

SUBORDINATION AGREEMENT

 

This Subordination Agreement is made as of April 5, 2013 by and among each of the undersigned creditors (individually, a “Creditor” and, collectively, the “Creditors”), and Comerica Bank (“Bank”).

 

Recitals

 

A.            Scientific Learning Corporation, a Delaware corporation (“Borrower”), has requested and/or obtained certain loans or other credit accommodations from Bank which are or may be from time to time secured by assets and property of Borrower.

 

B.            Each Creditor has extended loans or other credit accommodations to Borrower, and/or may extend loans or other credit accommodations to Borrower from time to time.

 

C.            In order to induce Bank to extend credit to Borrower and, at any time or from time to time, at Bank’s option, to make such further loans, extensions of credit, or other accommodations to or for the account of Borrower, or to purchase or extend credit upon any instrument or writing in respect of which Borrower may be liable in any capacity, or to grant such renewals or extension of any such loan, extension of credit, purchase, or other accommodation as Bank may deem advisable, each Creditor is willing to subordinate: (i) all of Borrower’s indebtedness and obligations to such Creditor, whether presently existing or arising in the future, pursuant to that certain Subordinated Note and Warrant Purchase Agreement, dated as of April 5, 2013 (the “Purchase Agreement”), by and among Borrower and the Creditors (the “Subordinated Debt”) to all of Borrower’s indebtedness and obligations to Bank; and (ii) all of such Creditor’s security interests, if any, to all of Bank’s security interests in the Borrower’s property.

 

NOW, THEREFORE, THE PARTIES AGREE AS FOLLOWS:

 

1.             Each Creditor subordinates to Bank any security interest or lien that such Creditor may have in any property of Borrower. Notwithstanding the respective dates of attachment or perfection of the security interest of a Creditor and the security interest of Bank, the security interest of Bank in the Collateral, as defined in that certain Amended and Restated Loan and Security Agreement between Borrower and Bank, dated as of February 9, 2012, as amended from time to time, including but without limitation by that certain First Amendment to Amended and Restated Loan and Security Agreement dated as of June 11, 2012, that certain Second Amendment to Amended and Restated Loan and Security Agreement dated as of August 14, 2012 and that certain Third Amendment to Amended and Restated Loan and Security Agreement dated as of April 5, 2013 (the “Loan Agreement”), shall at all times be prior to the security interest of such Creditor. Capitalized terms not otherwise defined herein shall have the same meaning as in the Loan Agreement.

 

2.             All Subordinated Debt is subordinated in right of payment to all obligations of Borrower to Bank now existing or hereafter arising, together with all costs of collecting such obligations (including attorneys’ fees), including, without limitation, all interest accruing after the commencement by or against Borrower of any bankruptcy, reorganization or similar proceeding, and all obligations under the Loan Agreement (the “Senior Debt”); provided, however, that at no time shall the principal amount of the Senior Debt exceed Four Million Two Hundred Fifty Thousand Dollars ($4,250,000).

 

3.             No Creditor will demand or receive from Borrower (and Borrower will not pay to any Creditor) all or any part of the Subordinated Debt, by way of payment, prepayment, setoff, lawsuit or otherwise, nor will any Creditor exercise any remedy with respect to the Collateral, nor will any Creditor commence, or cause to commence, prosecute or participate in any administrative, legal or equitable action against Borrower, for so long as any portion of the Senior Debt remains outstanding, provided, however, that each Creditor may receive regularly scheduled payments of interest that constitute Subordinated Debt, so long as an event of default under the Loan Agreement has not occurred, is not continuing and would not exist immediately after the payment to such Creditor was made. Nothing in this Agreement shall prohibit a Creditor from converting all or any part of the Subordinated Debt into equity securities of Borrower.

 



 

4.             Each Creditor shall promptly deliver to Bank in the form received (except for endorsement or assignment by such Creditor where required by Bank) for application to the Senior Debt any payment, distribution, security or proceeds received by such Creditor with respect to the Subordinated Debt other than in accordance with this Agreement.

 

5.             In the event of Borrower’s insolvency, reorganization or any case or proceeding under any bankruptcy or insolvency law or laws relating to the relief of debtors, these provisions shall remain in full force and effect, and Bank’s claims against Borrower and the estate of Borrower shall be paid in full before any payment is made to any Creditor.

 

6.             For so long as any of the Senior Debt remains unpaid, each Creditor irrevocably appoints Bank as such Creditor’s attorney in fact, and grants to Bank a power of attorney with full power of substitution, in the name of such Creditor or in the name of Bank, for the use and benefit of Bank, without notice to such Creditor, to perform at Bank’s option the following acts in any bankruptcy, insolvency or similar proceeding involving Borrower:

 

(i)            To file the appropriate claim or claims in respect of the Subordinated Debt on behalf of Creditor if Creditor does not do so prior to 30 days before the expiration of the time to file claims in such proceeding and if Bank elects, in its sole discretion, to file such claim or claims; and

 

(ii)           To accept or reject any plan of reorganization or arrangement on behalf of Creditor and to otherwise vote Creditor’s claims in respect of any Subordinated Debt in any manner that Bank deems appropriate for the enforcement of its rights hereunder.

 

7.             For so long as any of the Senior Debt remains unpaid, each Creditor agrees that it will not object to or oppose (i) the sale of the Borrower, or (ii) the sale or other disposition of any property of the Borrower, if Bank has consented to such sale of the Borrower or sale or disposition of any property of the Borrower. If requested by Bank, each Creditor shall affirmatively consent to such sale or disposition and shall take all necessary actions and execute such documents and instruments as Bank may reasonably request in connection with and to facilitate such sale or disposition.

 

8.             Each Creditor shall immediately affix a legend to the instruments evidencing the Subordinated Debt stating that the instruments are subject to the terms of this Agreement. No amendment of the documents evidencing or relating to the Subordinated Debt shall directly or indirectly modify the provisions of this Agreement in any manner which might terminate or impair the subordination of the Subordinated Debt or the subordination of the security interest or lien that such Creditor may have in any property of Borrower. By way of example, such instruments shall not be amended to (i) increase the rate of interest with respect to the Subordinated Debt, or (ii) accelerate the payment of the principal or interest or any other portion of the Subordinated Debt.

 

9. This Agreement shall remain effective for so long as Borrower owes any amounts to Bank under the Loan Documents. If, at any time after payment in full of the Senior Debt any payments of the Senior Debt must be disgorged by Bank for any reason (including, without limitation, the bankruptcy of Borrower), this Agreement and the relative rights and priorities set forth herein shall be reinstated as to all such disgorged payments as though such payments had not been made and each Creditor shall immediately pay over to Bank all payments received with respect to the Subordinated Debt to the extent that such payments would have been prohibited hereunder. At any time and from time to time, without notice to Creditors, Bank may take such actions with respect to the Senior Debt as Bank, in its sole discretion, may deem appropriate, including, without limitation, terminating advances to Borrower, increasing the principal amount (subject to Section 2 above), extending the time of payment, increasing applicable interest rates, renewing, compromising or otherwise amending the terms of any documents affecting the Senior Debt and any collateral securing the Senior Debt, and enforcing or failing to enforce any rights against Borrower or any other person. No such action or inaction shall impair or otherwise affect Bank’s rights hereunder. Each waives the benefits, if any, of Civil Code sections 2799, 2808, 2809, 2810, 2815, 2819, 2820, 2821, 2822, 2838, 2839, 2845, 2847, 2848, 2849, 2850, 2899 and 3433.

 

10.          This Agreement shall bind any successors or assignees of a Creditor and shall benefit any successors or assigns of Bank. This Agreement is solely for the benefit of each Creditor and Bank and not for the benefit of Borrower or any other party. Each Creditor further agrees that if Borrower is in the process of refinancing

 

2



 

a portion of the Senior Debt with a new lender, and if Bank makes a request of such Creditor, Creditor shall agree to enter into a new subordination agreement with the new lender on substantially the terms and conditions of this Agreement.

 

11.          This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument.

 

12.          This Agreement shall be governed by and construed in accordance with the laws of the State of California, without giving effect to conflicts of laws principles. Each Creditor and Bank hereby submits to the exclusive jurisdiction of the state and Federal courts located in California. THE UNDERSIGNED ACKNOWLEDGE THAT THE RIGHT TO TRIAL BY JURY IS A CONSTITUTIONAL ONE, BUT THAT IT MAY BE WAIVED UNDER CERTAIN CIRCUMSTANCES. TO THE EXTENT PERMITTED BY LAW, EACH\ PARTY, AFTER CONSULTING (OR HAVING HAD THE OPPORTUNITY TO CONSULT) WITH COUNSEL OF ITS, HIS OR HER CHOICE, KNOWINGLY AND VOLUNTARILY, AND FOR THE MUTUAL BENEFIT OF ALL PARTIES, WAIVES ANY RIGHT TO TRIAL BY JURY IN THE EVENT OF LITIGATION ARISING OUT OF OR RELATED TO THIS AGREEMENT OR ANY OTHER DOCUMENT, INSTRUMENT OR AGREEMENT BETWEEN THE UNDERSIGNED PARTIES.

 

13.          JUDICIAL REFERENCE PROVISION.

 

(a)           In the event the Jury Trial Waiver set forth above is not enforceable, the parties elect to proceed under this Judicial Reference Provision.

 

(b)           With the exception of the items specified in clause (c), below, any controversy, dispute or claim (each, a “Claim”) between the parties arising out of or relating to this Agreement or any other document, instrument or agreement between the undersigned parties (collectively in this Section, the “Loan  Documents”), will be resolved by a reference proceeding in California in accordance with the provisions of Sections 638 et seq. of the California Code of Civil Procedure (“CCP”), or their successor sections, which shall constitute the exclusive remedy for the resolution of any Claim, including whether the Claim is subject to the reference proceeding. Except as otherwise provided in the Loan Documents, venue for the reference proceeding will be in the Superior Court in the County where the real property involved in the action, if any, is located or in a County where venue is otherwise appropriate under applicable law (the “Court”).

 

(c)           The matters that shall not be subject to a reference are the following: (i) nonjudicial foreclosure of any security interests in real or personal property, (ii) exercise of selfhelp remedies (including, without limitation, set-off), (iii) appointment of a receiver and (iv) temporary, provisional or ancillary remedies (including, without limitation, writs of attachment, writs of possession, temporary restraining orders or preliminary injunctions). This Agreement does not limit the right of any party to exercise or oppose any of the rights and remedies described in clauses (i) and (ii) or to seek or oppose from a court of competent jurisdiction any of the items described in clauses (iii) and (iv). The exercise of, or opposition to, any of those items does not waive the right of any party to a reference pursuant to this Agreement.

 

(d)           The referee shall be a retired Judge or Justice selected by mutual written agreement of the parties. If the parties do not agree within ten (10) days of a written request to do so by any party, then, upon request of any party, the referee shall be selected by the Presiding Judge of the Court (or his or her representative). A request for appointment of a referee may be heard on an ex parte or expedited basis, and the parties agree that irreparable harm would result if ex parte relief is not granted.

 

(e)           The parties agree that time is of the essence in conducting the reference proceedings. Accordingly, the referee shall be requested, subject to change in the time periods specified herein for good cause shown, to (i) set the matter for a status and trial-setting conference within fifteen (15) days after the date of selection of the referee, (ii) if practicable, try all issues of law or fact within one hundred twenty (120) days after the date of the conference and (iii) report a statement of decision within twenty (20) days after the matter has been submitted for decision.

 

3



 

(f)            The referee will have power to expand or limit the amount and duration of discovery.  The referee may set or extend discovery deadlines or cutoffs for good cause, including a party’s failure to provide requested discovery for any reason whatsoever. Unless otherwise ordered based upon good cause shown, no party shall be entitled to “priority” in conducting discovery, depositions may be taken by either party upon seven (7) days written notice, and all other discovery shall be responded to within fifteen (15) days after service.  All disputes relating to discovery which cannot be resolved by the parties shall be submitted to the referee whose decision shall be final and binding.

 

(g)           Except as expressly set forth in this Agreement, the referee shall determine the manner in which the reference proceeding is conducted including the time and place of hearings, the order of presentation of evidence, and all other questions that arise with respect to the course of the reference proceeding. All proceedings and hearings conducted before the referee, except for trial, shall be conducted without a court reporter, except that when any party so requests, a court reporter will be used at any hearing conducted before the referee, and the referee will be provided a courtesy copy of the transcript. The party making such a request shall have the obligation to arrange for and pay the court reporter. Subject to the referee’s power to award costs to the prevailing party, the parties will equally share the cost of the referee and the court reporter at trial.

 

(h)           The referee shall be required to determine all issues in accordance with existing case law and the statutory laws of the State of California. The rules of evidence applicable to proceedings at law in the State of California will be applicable to the reference proceeding. The referee shall be empowered to enter equitable as well as legal relief, enter equitable orders that will be binding on the parties and rule on any motion which would be authorized in a court proceeding, including without limitation motions for summary judgment or summary adjudication. The referee shall issue a decision at the close of the reference proceeding which disposes of all claims of the parties that are the subject of the reference. Pursuant to CCP § 644, such decision shall be entered by the Court as a judgment or an order in the same manner as if the action had been tried by the Court and any such decision will be final, binding and conclusive. The parties reserve the right to appeal from the final judgment or order or from any appealable decision or order entered by the referee. The parties reserve the right to findings of fact, conclusions of laws, a written statement of decision, and the right to move for a new trial or a different judgment, which new trial, if granted, is also to be a reference proceeding under this provision.

 

(i)            If the enabling legislation which provides for appointment of a referee is repealed (and no successor statute is enacted), any dispute between the parties that would otherwise be determined by reference procedure will be resolved and determined by arbitration.  The arbitration will be conducted by a retired judge or Justice, in accordance with the California Arbitration Act §1280 through §1294.2 of the CCP as amended from time to time. The limitations with respect to discovery set forth above shall apply to any such arbitration proceeding.

 

(j)            THE PARTIES RECOGNIZE AND AGREE THAT ALL CONTROVERSIES, DISPUTES AND CLAIMS RESOLVED UNDER THIS REFERENCE PROVISION WILL BE DECIDED BY A REFEREE AND NOT BY A JURY. AFTER CONSULTING (OR HAVING HAD THE OPPORTUNITY TO CONSULT) WITH COUNSEL OF ITS, HIS OR HER OWN CHOICE, EACH PARTY KNOWINGLY AND VOLUNTARILY, AND FOR THE MUTUAL BENEFIT OF ALL PARTIES, AGREES THAT THIS REFERENCE PROVISION WILL APPLY TO ANY CONTROVERSY, DISPUTE OR CLAIM BETWEEN OR AMONG THEM ARISING OUT OF OR IN ANY WAY RELATED TO, THIS AGREEMENT OR THE OTHER LOAN DOCUMENTS.

 

This Agreement represents the entire agreement with respect to the subject matter hereof, and supersedes all prior negotiations, agreements and commitments. No Creditor is relying on any representations by Bank or Borrower in entering into this Agreement, and each Creditor has kept and will continue to keep itself fully apprised of the financial and other condition of Borrower. This Agreement represents the entire agreement with respect to the subject matter hereof, and supersedes all prior negotiations, agreements and commitments. No Creditor is relying on any representations by Bank or Borrower in entering into this Agreement, and each Creditor has kept and will continue to keep itself fully apprised of the financial and other condition of Borrower. This Agreement may be amended only by written instrument signed by Creditors (in the manner provided in Section 6.6 of the Purchase Agreement) and Bank.

 

4



 

14.          In the event of any legal action to enforce the rights of a party under this Agreement, the party prevailing in such action shall be entitled, in addition to such other relief as may be granted, all reasonable costs and expenses, including reasonable attorneys’ fees, incurred in such action.

 

[Balance of Page Intentionally Left Blank]

 



 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written.

 

 

“Bank”

 

 

 

COMERICA BANK

 

 

 

 

By:

 

 

 

 

 

Title:

 

 

 

 

 

 

 

 

“Creditors”

 

 

 

 

BLACKWELL PARTNERS LLC

 

 

 

 

 

 

By: Nantahala Capital Management, LLC

 

Its Investment Manager

 

 

 

 

 

 

 

By:

 

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

 

 

 

 

 

 

NANTAHALA CAPITAL PARTNERS II, LIMITED PARTNERSHIP

 

 

 

 

 

 

 

By: Nantahala Capital Management, LLC

 

Its General Partner

 

 

 

 

 

 

 

By:

 

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

 

 

 

 

 

 

NANTAHALA CAPITAL PARTNERS, LIMITED PARTNERSHIP

 

 

 

 

 

 

 

By: Nantahala Capital Management, LLC

 

Its General Partner

 

 

 

 

 

 

 

By:

 

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

[Signature Page to Subordination Agreement]

 



 

 

CREDITORS

 

 

 

BLACKWELL PARTNERS LLC

 

 

 

 

 

By: Nantahala Capital Management, LLC

 

Its Investment Manager

 

 

 

 

 

 

 

By:

/s/ Wilmot Harkey

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

 

 

 

 

 

 

NANTAHALA CAPITAL PARTNERS II, LIMITED PARTNERSHIP

 

 

 

 

 

 

 

By: Nantahala Capital Management, LLC

 

Its General Partner

 

 

 

 

 

 

 

By:

/s/ Wilmot Harkey

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

 

 

 

NANTAHALA CAPITAL PARTNERS, LIMITED PARTNERSHIP

 

 

 

 

 

 

 

By: Nantahala Capital Management, LLC

 

Its General Partner

 

 

 

 

 

 

 

By:

/s/ Wilmot Harkey

 

 

Name: Wilmot Harkey

 

 

Title: Manager

 

[Signature Page to Subordination Agreement]

 



 

 

TRIGRAN INVESTMENTS, LP

 

 

 

 

 

 

 

By: Trigran Investments, Inc.

 

Its General Partner

 

 

 

 

 

 

 

By:

/s/Lawrence Oberman

 

 

Name: Lawrence Oberman

 

 

Title: Executive Vice President

 

 

 

 

 

 

 

TRIGRAN INVESTMENTS, LP II

 

 

 

 

 

 

 

By: Trigran Investments, Inc.

 

Its General Partner

 

 

 

 

 

 

 

By:

/s/ Lawrence Oberman

 

 

Name: Lawrence Oberman

 

 

Title: Executive Vice President

 

[Signature Page to Subordination Agreement]

 



 

 

RJ PARTNERS LLC

 

 

 

 

 

 

 

By:

/s/ Robert J. Schmiedeler

 

 

Name: Robert J. Schmiedeler

 

 

Title: Manager

 

[Signature Page to Subordination Agreement]

 



 

 

PAULA A. TALLAL, REVOCABLE TRUST

 

 

 

 

 

 

 

By:

/s/ Paula A. Tallal

 

 

Name: Paula A. Tallal

 

 

Title: Trustee

 

[Signature Page to Subordination Agreement]

 



 

 

JANE A. FREEMAN LIVING TRUST (5/30/12)

 

 

 

 

 

/s/ Jane A. Freeman

 

By: Jane A. Freeman

 

Title: Trustee

 

[Signature Page to Subordination Agreement]

 



 

 

THE RODMAN W. MOORHEAD III REVOCABLE TRUST

 

 

 

 

 

 

 

By:

/s/ Rodman W. Moorhead, III

 

 

Name: Rodman W. Moorhead, III

 

 

Title: Trustee

 

[Signature Page to Subordination Agreement]

 



 

 

ROBERT BOWEN

 

 

 

 

 

/s/ Robert Bowen

 

[Signature Page to Subordination Agreement]

 



 

 

NOEL MOORE

 

 

 

 

 

/s/ Noel S. Moore

 

[Signature Page to Subordination Agreement]

 



 

The undersigned approves of the terms of this Agreement.

 

 

 

“Borrower”

 

 

 

SCIENTIFIC LEARNING CORPORATION

 

 

 

 

 

/s/ Jane A. Freeman

 

By: Jane A. Freeman

 

Title: CFO

 

[Signature Page to Subordination Agreement]

 


EX-99.6 7 a13-10011_1ex99d6.htm EX-99.6

EXHIBIT 99.6

 

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.  THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144.  NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES IN ACCORDANCE WITH U.S. FEDERAL AND STATE SECURITIES LAWS.

 

SCIENTIFIC LEARNING CORPORATION

 

WARRANT TO PURCHASE COMMON STOCK

 

Warrant No.: 4

Number of Shares of Common Stock: 253,753

Date of Issuance: April 5, 2013 (“Issuance Date”)

 

Scientific Learning Corporation, a corporation organized under the laws of Delaware (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Trigran Investments, L.P., the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon surrender of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after the date hereof, but not after 5:30 p.m., New York time, on the Expiration Date (as defined below), up to Two Hundred Fifty-Three Thousand Seven Hundred Fifty-Three (253,753) fully paid nonassessable shares of Common Stock (as defined below) (the “Warrant Shares”).  Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set forth in Section 16; provided, however, to the extent any capitalized terms are used but not defined herein, such capitalized terms shall have the respective meanings ascribed thereto in the Purchase Agreement (as defined below).  This Warrant is one of the Warrants to purchase Common Stock (the “Warrants”) issued pursuant to Section 2.9 of that certain Subordinated Note and Warrant Purchase Agreement, dated as of April 5, 2013 (the “Purchase Date”), by and among the Company and the purchasers (the “Purchasers”) referred to therein (the “Purchase Agreement”).

 



 

1.        EXERCISE OF WARRANT.

 

(a)         Mechanics of Exercise.  Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(e)), this Warrant may be exercised by the Holder on any day on or after the date hereof to and including the Expiration Date, in whole or in part, by (i) delivery of a properly completed and executed written notice, in the form attached hereto as Exhibit A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant and (ii) (A) payment to the Company of an amount equal to the applicable Exercise Price multiplied by the number of Warrant Shares as to which this Warrant is being exercised (the “Aggregate Exercise Price”) in cash or by wire transfer of immediately available funds or (B) by notifying the Company that this Warrant is being exercised pursuant to a Cashless Exercise (as defined in Section 1(d)).  At 5:30 P.M., New York City time, on the Expiration Date, the portion of this Warrant not exercised prior thereto shall be and become void and of no value.  The Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder.  Execution and delivery of the Exercise Notice with respect to less than all of the Warrant Shares shall have the same effect as cancellation of the original Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number of Warrant Shares.  On or before the second (2nd) Business Day following the date on which the Company has received each of the Exercise Notice and the Aggregate Exercise Price (or notice of a Cashless Exercise) (the “Exercise Delivery Documents”), the Company shall transmit by facsimile an acknowledgment of confirmation of receipt of the Exercise Delivery Documents to the Holder and the Company’s transfer agent (the “Transfer Agent”).  On or before the second (2nd) Business Day following the date on which the Company has received all of the Exercise Delivery Documents, the Company shall (X) provided that the Transfer Agent is participating in The Depository Trust Company (“DTC”) Fast Automated Securities Transfer Program and the Warrant Shares may be issued without any restrictive legends, upon the request of the Holder, credit such aggregate number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the Holder’s or its designee’s balance account with DTC through its Deposit Withdrawal Agent Commission system, or (Y) if the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program or the Warrant Shares are required to bear a restrictive legend, issue and dispatch by overnight courier to the address as specified in the Exercise Notice a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of shares of Common Stock to which the Holder is entitled pursuant to such exercise, which certificate shall (if required) bear the legend set forth in Exhibit B hereto.  Upon delivery of the Exercise Delivery Documents, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date such Warrant Shares are credited to the Holder’s DTC account or the date of delivery of the certificates evidencing such Warrant Shares, as the case may be.  If this Warrant is submitted in connection with any exercise pursuant to this Section 1(a) and the aggregate number of Warrant Shares represented by this Warrant at the time this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired upon such exercise, then the Company shall as soon as practicable, and in no event later than five (5) Business Days after any exercise and at its own expense, issue a new Warrant (in accordance with Section 6(d)) representing the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant is then exercised.  No fractional shares of Common Stock are to be issued upon the exercise of this

 

2



 

Warrant, but rather the number of shares of Common Stock to be issued shall be rounded up to the nearest whole number.  The Company shall pay any and all taxes (other than taxes based upon the income of the Holder) which may be payable with respect to the issuance and delivery of the Warrant Shares upon exercise of this Warrant.

 

(b)         Exercise Price.  For purposes of this Warrant, “Exercise Price” means $1.03 per Warrant Share, subject to adjustment as provided herein.

 

(c)          Company’s Failure to Timely Deliver Securities.  If within three (3) Trading Days after the Company’s receipt of the Exercise Delivery Documents the Company shall fail to issue and deliver a certificate to the Holder and register such shares of Common Stock on the Company’s share register or credit the Holder’s balance account with DTC for the number of unrestricted shares of Common Stock to which the Holder is entitled upon the Holder’s exercise hereunder, and if on or after such Trading Day the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of shares of Common Stock issuable upon such exercise that the Holder anticipated receiving from the Company, then the Company shall, within three (3) Business Days after the Holder’s request and in the Holder’s discretion, either (i) pay cash to the Holder in an amount equal to the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased (the “Buy-In Price”), at which point the Company’s obligation to deliver such certificate (and to issue such Warrant Shares) shall terminate, or (ii) promptly honor its obligation to deliver to the Holder a certificate or certificates representing such Warrant Shares and pay cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (A) such number of shares of Common Stock so purchased at the Buy-In Price, times (B) the Weighted Average Price on the date of exercise.

 

(d)         Cashless Exercise.  Notwithstanding anything contained herein to the contrary, if a Registration Statement (as defined in the Registration Rights Agreement) covering the Warrant Shares is not available for the resale of such Warrant Shares, the Holder may, in its sole discretion, exercise this Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the Aggregate Exercise Price, elect instead to receive upon such exercise the “Net Number” of shares of Common Stock determined according to the following formula (a “Cashless Exercise”):

 

Net Number = (A x B) - (A x C)

 

B

 

For purposes of the foregoing formula:

 

A= the total number of shares with respect to which this Warrant is then being exercised.

 

B= the Weighted Average Price of the shares of Common Stock (as reported by Bloomberg) on the date immediately preceding the date of the Exercise Notice.

 

3



 

C= the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.

 

(e)          Limitations on Exercises; Beneficial Ownership.  Notwithstanding anything to the contrary contained herein, the number of Warrant Shares that may be acquired by the Holder upon any exercise of this Warrant (or otherwise in respect hereof) shall be limited to the extent necessary to ensure that, following such exercise (or other issuance), the total number of shares of Common Stock then beneficially owned by the Holder and its Affiliates, and any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act, does not exceed 4.99% of the total number of then issued and outstanding shares of Common Stock (including for such purpose the shares of Common Stock issuable upon such exercise), provided that the foregoing shall not apply if the Holder and its Affiliates as of the date of this Warrant beneficially own more than 4.99% of the total number of issued and outstanding shares of Common Stock. By written notice to the Company, the Holder may waive the provisions of this Section 1(e), but any such waiver will not be effective until the 61st day after delivery of such notice, nor will any such waiver affect any other Holder.  For such purposes, beneficial ownership shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.  To the extent that the limitation contained in this Section 1(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by such Holder) and of which a portion of this Warrant is exercisable shall be in the sole discretion of a Holder, and the submission of a Exercise Notice shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by such Holder) and of which portion of this Warrant is exercisable, in each case subject to such aggregate percentage limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. For purposes of this Warrant, in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company’s most recent Form 10-K, Form 10-Q, Current Report on Form 8-K or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.  For any reason at any time, upon the written request of the Holder, the Company shall within two (2) Business Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.  This provision shall not restrict the number of shares of Common Stock which a Holder may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive in the event of a Merger Event as contemplated in Section 3(b) of this Warrant.

 

(f)           Insufficient Authorized Shares.  The Company covenants that during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.  Notwithstanding the foregoing, if at any time while any of the Warrants remain outstanding the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve for issuance upon exercise of the Warrants at least a number of shares of Common Stock equal to 100% (the “Required Reserve Amount”) of the number of shares of Common Stock as shall from time to time be necessary to effect the exercise of all of the Warrants then outstanding, then

 

4



 

the Company shall use its best efforts to increase the Company’s authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount for the Warrants then outstanding.

 

(g)          Disputes.  In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed and resolve such dispute in accordance with Section 12.

 

2.              ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES.  The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:

 

(a)         Adjustment upon Subdivision or Combination of Common Stock.  If the Company at any time on or after the Purchase Date subdivides (by any stock split, stock dividend, recapitalization or otherwise) its outstanding shares of Common Stock into a larger number of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the number of Warrant Shares will be proportionately increased.  If the Company at any time on or after the Purchase Date combines (by combination, reverse stock split or otherwise) its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately decreased.  Any adjustment under this Section 2(a) shall become effective at the close of business on the date the subdivision or combination becomes effective.

 

(b)         Pro Rata Distributions.  If the Company, at any time while this Warrant is outstanding, distributes to all holders of Common Stock for no consideration (i) evidences of its indebtedness, (ii) any security (other than a distribution of Common Stock covered by the preceding paragraph) or (iii) rights or warrants to subscribe for or purchase any security, or (iv) any other asset, including cash (in each case, “Distributed Property”), then, upon any exercise of this Warrant that occurs after the record date fixed for determination of stockholders entitled to receive such distribution, the Holder shall be entitled to receive, in addition to the Warrant Shares otherwise issuable upon such exercise (if applicable), the Distributed Property that such Holder would have been entitled to receive in respect of such number of Warrant Shares had the Holder been the record holder of such Warrant Shares immediately prior to such record date.

 

(c)          De Minimis Adjustments.  No adjustment in the Exercise Price shall be required unless such adjustment would require an increase or decrease of at least $0.01 in such price, provided, however, that any adjustment which by reason of this Section 2(c) is not required to be made shall be carried forward and taken into account in any subsequent adjustments under this Section 2.  All calculations under this Section 2 shall be made by the Company in good faith and shall be made to the nearest cent or to the nearest one hundredth of a share, as applicable.  No adjustment need be made for a change in the par value or no par value of the Company’s Common Stock.

 

5



 

(d)         Voluntary Adjustment By Company.  The Company may at any time during the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors of the Company.

 

3.        PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS.

 

(a)         Purchase Rights.  In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.

 

(b)         Effect of Reclassification, Consolidation, Merger or Sale.

 

(1)         Upon the occurrence of a Merger Event (as defined below) as a result of which the holders of Common Stock shall be entitled to receive cash, securities or other property or assets with respect to or in exchange for such Common Stock, then at the effective time of the Merger Event, the right to exercise this Warrant will be changed into a right to exercise this Warrant into the type and amount of shares of stock, other securities or other property or assets (including cash or any combination thereof) that a holder of a number of shares of Common Stock issuable upon exercise of this Warrant immediately prior to such Merger Event would have owned or been entitled to receive (the “Reference Property”) upon such Merger Event. If the Merger Event causes the Common Stock to be converted into, or exchanged for, the right to receive more than a single type of consideration (determined based in part upon any form of stockholder election), the Reference Property to be received upon exercise will be deemed to be the weighted average of the types and amounts of Reference Property to be received by the holders of Common Stock that affirmatively make such election.  The terms of any agreement pursuant to which a Merger Event is effected shall include terms requiring the Successor Entity (and, if an entity different from the successor or surviving entity, the entity whose capital stock or assets the holders of Common Stock are entitled to receive as a result of such Merger Event) to comply with the provisions of this Section 3(b)(1) and ensuring that the Warrant (or any such replacement security) will be similarly adjusted in accordance with Sections 2 and 3 hereof upon any subsequent transaction analogous to a Merger Event.  If the Company consummates a Merger Event, the Company shall promptly provide notice to the Holder briefly describing the Merger Event and stating the type or amount of cash, securities, property or other assets that will comprise the Reference Property after any such Merger Event and any adjustment to be made with respect thereto.

 

(2)         Notwithstanding the provisions of Section 3(b)(1) of this Warrant, in the event of the consummation of a Merger Event that is (A) an all-cash transaction, (B) a “Rule 13e-3 transaction” as defined in Rule 13e-3 under the Exchange Act or (C) a Merger

 

6



 

Event involving a person or entity whose securities are not traded on an Eligible Market, at the request of the Holder delivered at any time commencing on the earliest to occur of (x) the public disclosure of the Merger Event or (y) the consummation of the Merger Event, through the date that is ninety (90) days after the public disclosure of the consummation of such Merger Event by the Company pursuant to a Current Report on Form 8-K filed with the SEC, the Company or the Successor Entity (as the case may be) shall purchase this Warrant from the Holder on the later of (i) the date of consummation of the Merger Event and (ii) the fifth Trading Day following the date of such request, in each case by paying to the Holder cash in an amount equal to the Black Scholes Value.

 

(3)         The above provisions of this Section 3(b) shall similarly apply to successive Merger Events and shall be applied without regard to any limitations on the exercise of this Warrant.

 

(4)         In addition to the definitions set forth in this Warrant, for purposes of this Section 3(b),

 

(A)       Black Scholes Value” means the value of the unexercised portion of this Warrant remaining on the date of the Holder’s request pursuant to Section 3(b)(2) of this Warrant, which value is calculated using the Black Scholes Option Pricing Model obtained from the “OV” function on Bloomberg utilizing (i) an underlying price per share equal to the greater of (1) the highest Closing Sale Price of the Common Stock during the period beginning on the Trading Day immediately preceding the earlier to occur of (x) the public disclosure of the applicable Merger Event or (y) the consummation of the applicable Merger Event and ending on the Trading Day of the consummation of the Merger Event and (2) the sum of the price per share being offered in cash in the applicable Merger Event (if any) plus the value of the non-cash consideration being offered in the applicable Merger Event (if any), (ii) a strike price equal to the Exercise Price in effect on the date of the Holder’s request pursuant to Section 3(b)(2) of this Warrant, (iii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the greater of (1) the remaining term of this Warrant as of the date of the Holder’s request pursuant to Section 3(b)(2) of this Warrant and (2) the remaining term of this Warrant as of the date of consummation of the applicable Merger Event and (iv) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public disclosure of the applicable Merger Event.

 

(B)       Merger Event” means the occurrence of any of the following: (i) any reorganization, recapitalization or reclassification of the outstanding shares of Common Stock (other than a change in par value, or from par value to no par value, or from no par value to par value, or as a result of a split, subdivision or combination covered by Section 2(a) of this Warrant), (ii) any consolidation or merger with another Person (whether or not the Company is the surviving corporation), (iii) sale of all or substantially all of the Company’s assets, (iv) a binding share exchange which reclassifies or changes the outstanding shares of Common Stock, (v) the Company, directly or indirectly, consummates a stock purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any

 

7



 

shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock purchase agreement or other business combination) or (vi) any transaction which results in any “person” or “group” (as these terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act) becoming the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock.

 

(C)       Parent Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Merger Event.

 

(D)       Successor Entity” means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Merger Event or the Person (or, if so elected by the Holder, the Parent Entity) with which such Merger Event shall have been entered into.

 

4.        PROVISIONS AS TO SHARES.  The Company (i) shall not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect and (ii) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant.

 

5.        WARRANT HOLDER NOT DEEMED A STOCKHOLDER.  Except as otherwise specifically provided herein, the Holder, solely in such Person’s capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person’s capacity as the Holder of this Warrant, any of the rights of a shareholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant.  In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a shareholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.  Notwithstanding this Section 5, the Company shall provide the Holder with copies of the same notices and other information given to the shareholders of the Company generally, contemporaneously with the giving thereof to the shareholders.

 

6.        REISSUANCE OF WARRANTS.

 

(a)         Transfer of Warrant.  If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, together with a written assignment of this Warrant duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes

 

8



 

payable upon the making of such transfer, if any, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 6(d)), registered as the Holder may request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 6(d)) to the Holder representing the right to purchase the balance of the number of Warrant Shares not being transferred.

 

(b)         Lost, Stolen or Mutilated Warrant.  Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company reasonably satisfactory to the Company and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder a new Warrant (in accordance with Section 6(d)) representing the right to purchase the Warrant Shares then underlying this Warrant.

 

(c)          Exchangeable for Multiple Warrants.  This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company, for a new Warrant or Warrants (in accordance with Section 6(d)) representing in the aggregate the right to purchase the number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares as is designated in writing by the Holder at the time of such surrender; provided, however, that no Warrants for fractional shares of Common Stock shall be given.

 

(d)         Issuance of New Warrants.  Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 6(a) or Section 6(c), the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the other new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date, and (iv) shall have the same rights and conditions as this Warrant.

 

7.        NOTICES.  Whenever notice is required or permitted to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance with Section 6.1 of the Purchase Agreement.  The Company shall provide the Holder with prompt written notice of all actions taken pursuant to this Warrant, including in reasonable detail a description of such action and the reason therefor.  Without limiting the generality of the foregoing, the Company will give written notice to the Holder (i) promptly upon any adjustment of the Exercise Price, setting forth in reasonable detail the calculation of such adjustment, and (ii) at least fifteen days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the shares of Common Stock, or (B) for determining rights to vote with respect to any Merger Event, dissolution or liquidation, provided in each case that such information shall be made known to the public prior to or in conjunction with such notice being provided to the Holder.

 

9



 

8.   AMENDMENT AND WAIVER.  Except as otherwise provided herein, the provisions of this Warrant may be amended only in the manner provided in Section 6.6 of the Purchase Agreement and the Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent of the Holders representing a “Majority in Interest” within the meaning of the Purchase Agreement.  The Company shall give prompt written notice to the Holder of any amendment hereof or waiver hereunder that was effected without the Holder’s written consent.

 

9.   GOVERNING LAW.  This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York.

 

10. SEVERABILITY.  If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties.  The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).

 

11. CONSTRUCTION; HEADINGS.  This Warrant shall be deemed to be jointly drafted by the Company and all the Lenders and shall not be construed against any person as the drafter hereof.  The headings of this Warrant are for convenience of reference and shall not form part of, or affect the interpretation of, this Warrant.

 

12. DISPUTE RESOLUTION.  In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall submit the disputed determinations or arithmetic calculations via facsimile within five (5) Business Days of receipt of the Exercise Notice giving rise to such dispute, as the case may be, to the Holder.  If the Holder and the Company are unable to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three Business Days of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two Business Days submit via facsimile (a) the disputed determination of the Exercise Price to an independent, reputable investment bank selected by the Company and approved by the Holder (or, if the dispute affects multiple Holders, to a majority in interest of such Holders) or (b) the disputed arithmetic calculation of the Warrant Shares to the Company’s independent, outside accountant.  The Company shall cause at its expense the investment bank or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the

 

10



 

Holder of the results no later than ten Business Days from the time it receives the disputed determinations or calculations.  Such investment bank’s or accountant’s determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error.

 

13. REMEDIES, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF.  The remedies provided in this Warrant shall be cumulative and in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply with the terms of this Warrant.  The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate.  The Company therefore agrees that, in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security being required.

 

14. TRANSFER.  Subject to applicable law, this Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company, except as may otherwise be required by Section 3.3 of the Purchase Agreement.

 

15. PRINCIPAL MARKET.    In no event shall the Company be required to adjust the Exercise Price or the number of shares issuable upon exercise of the Warrant if such adjustment would violate the listing requirements of the Company’s Principal Market.  In addition, the Company will not take any voluntary action that would result in an adjustment to the Exercise Price pursuant to this Warrant (other than pursuant to Section 2(a)) without complying, if applicable, with the stockholder approval rules of the Principal Market and any similar rule of any stock exchange on which the Company’s common stock is listed at the relevant time.  In accordance with such listing standard, this restriction will apply at any time when the Warrants are outstanding, regardless of whether the Company then has a class of securities listed on the Principal Market.

 

16. CERTAIN DEFINITIONS.  For purposes of this Warrant, the following terms shall have the following meanings:

 

(a)   “Bloomberg” means Bloomberg Financial Markets.

 

(b)   “Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York or Oakland, California are authorized or required by law to remain closed.

 

(c)   “Closing Bid Price” and “Closing Sale Price” means, for any security as of any date, the last closing bid price and last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade price, as the case may be, then the last bid price or last trade price, respectively, of such security prior to 4:00 p.m., New York time, as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security, the last closing bid

 

11



 

price or last trade price, respectively, of such security on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade price, respectively, of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or, if no closing bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of the bid prices, or the ask prices, respectively, of any market makers for such security as reported in the “pink sheets” by Pink Sheets LLC (or any such similar service).  If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price or the Closing Sale Price, as the case may be, of such security on such date shall be the fair market value as mutually determined by the Company and the Holder.  If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved pursuant to Section 12.  All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period.

 

(d)   “Common Stock” means (i) the Company’s shares of Common Stock, par value $0.01 per share, and (ii) any share capital into which such Common Stock shall have been changed or any share capital resulting from a reclassification of such Common Stock.

 

(e)   “Convertible Securities” means any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable for shares of Common Stock.

 

(f)    “Dollar”, “US Dollar” and “$” each mean the lawful money of the United States.

 

(g)   “Eligible Market” means the Principal Market, The New York Stock Exchange, Inc., the American Stock Exchange, The NASDAQ Global Select Market, The NASDAQ Global Market, The NASDAQ Capital Market or the OTC Markets Group Inc.

 

(h)   “Expiration Date” means the date that is 36 months after the Closing Date or, if such date falls on a day other than a Business Day or on which trading does not take place on the Principal Market (a “Holiday”), the next date that is not a Holiday.

 

(i)    “Options” means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.

 

(j)    “Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity and a government or any department or agency thereof.

 

(k)   “Principal Market” means OTC Markets Group Inc.

 

(l)    “Reference Property” shall have the meaning set forth in Section 3(b).

 

(m)  “Trading Day” means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market for the

 

12



 

Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded; provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00 p.m., New York time).

 

(n)   “Weighted Average Price” means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg through its “Volume at Price” function or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in the “pink sheets” by Pink Sheets LLC (formerly the National Quotation Bureau, Inc.).  If the Weighted Average Price cannot be calculated for such security on such date on any of the foregoing bases, the Weighted Average Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder.  If the Company and the Holder are unable to agree upon the fair market value of the such security, then such dispute shall be resolved pursuant to Section 12 with the term “Weighted Average Price” being substituted for the term “Exercise Price.” All such determinations shall be appropriately adjusted for any share dividend, share split or other similar transaction during such period.

 

[Signature Page Follows]

 

13



 

IN WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date set out above.

 

 

 

SCIENTIFIC LEARNING CORPORATION

 

 

 

 

 

 

 

By:

/s/ Jane A. Freeman

 

Name:

Jane A. Freeman

 

Title:

CFO

 

[Signature Page to Warrant]

 



 

EXHIBIT A

 

EXERCISE NOTICE

 

TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

WARRANT TO PURCHASE COMMON STOCK

 

SCIENTIFIC LEARNING CORPORATION

 

The undersigned holder hereby exercises the right to purchase                                    of the shares of Common Stock (“Warrant Shares”) of Scientific Learning Corporation, a corporation organized under the laws of Delaware (the “Company”), evidenced by the attached Warrant to Purchase Common Stock (the “Warrant”).  Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

 

1.  Form of Exercise Price.  The Holder intends that payment of the Exercise Price shall be made as:

 

o                                    a “Cash Exercise” with respect to                                    Warrant Shares and in connection therewith by checking such box hereby certifies that such Holder is an “accredited investor” within the meaning of Rule 501 of the Securities Act; and/or

 

o                                    a “Cashless Exercise” with respect to                                Warrant Shares.

 

2.  Payment of Exercise Price.  In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be issued pursuant hereto, the holder shall pay the Aggregate Exercise Price in the sum of $                                       to the Company in accordance with the terms of the Warrant.

 

3.  Delivery of Warrant Shares.  The Company shall deliver to the holder                      Warrant Shares in accordance with the terms of the Warrant.

 

Date:                                    ,

 

 

 

Name of Registered Holder

 

 

 

 

 

By:

 

 

 

Name:

 

 

Title:

 

 



 

ACKNOWLEDGMENT

 

The Company hereby acknowledges this Exercise Notice and hereby directs                                        to issue the above indicated number of shares of Common Stock in accordance with the Transfer Agent Instructions dated                   , 2013 from the Company and acknowledged and agreed to by                                       .

 

 

SCIENTIFIC LEARNING CORPORATION

 

 

 

 

 

By:

 

 

Name:

 

 

Title:

 

 



 

Exhibit B

 

THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS.

 


EX-99.7 8 a13-10011_1ex99d7.htm EX-99.7

EXHIBIT 99.7

 

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.  THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144.  NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES IN ACCORDANCE WITH U.S. FEDERAL AND STATE SECURITIES LAWS.

 

SCIENTIFIC LEARNING CORPORATION

 

WARRANT TO PURCHASE COMMON STOCK

 

Warrant No.: 4

Number of Shares of Common Stock: 147,755

Date of Issuance: April 5, 2013 (“Issuance Date”)

 

Scientific Learning Corporation, a corporation organized under the laws of Delaware (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Trigran Investments, L.P. II, the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon surrender of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after the date hereof, but not after 5:30 p.m., New York time, on the Expiration Date (as defined below), up to One Hundred Forty-Seven Thousand Seven Hundred Fifty-Five (147,755) fully paid nonassessable shares of Common Stock (as defined below) (the “Warrant Shares”).  Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set forth in Section 16; provided, however, to the extent any capitalized terms are used but not defined herein, such capitalized terms shall have the respective meanings ascribed thereto in the Purchase Agreement (as defined below).  This Warrant is one of the Warrants to purchase Common Stock (the “Warrants”) issued pursuant to Section 2.9 of that certain Subordinated Note and Warrant Purchase Agreement, dated as of April 5, 2013 (the “Purchase Date”), by and among the Company and the purchasers (the “Purchasers”) referred to therein (the “Purchase Agreement”).

 



 

1.   EXERCISE OF WARRANT.

 

(a)   Mechanics of Exercise.  Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(e)), this Warrant may be exercised by the Holder on any day on or after the date hereof to and including the Expiration Date, in whole or in part, by (i) delivery of a properly completed and executed written notice, in the form attached hereto as Exhibit A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant and (ii) (A) payment to the Company of an amount equal to the applicable Exercise Price multiplied by the number of Warrant Shares as to which this Warrant is being exercised (the “Aggregate Exercise Price”) in cash or by wire transfer of immediately available funds or (B) by notifying the Company that this Warrant is being exercised pursuant to a Cashless Exercise (as defined in Section 1(d)).  At 5:30 P.M., New York City time, on the Expiration Date, the portion of this Warrant not exercised prior thereto shall be and become void and of no value.  The Holder shall not be required to deliver the original Warrant in order to effect an exercise hereunder.  Execution and delivery of the Exercise Notice with respect to less than all of the Warrant Shares shall have the same effect as cancellation of the original Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number of Warrant Shares.  On or before the second (2nd) Business Day following the date on which the Company has received each of the Exercise Notice and the Aggregate Exercise Price (or notice of a Cashless Exercise) (the “Exercise Delivery Documents”), the Company shall transmit by facsimile an acknowledgment of confirmation of receipt of the Exercise Delivery Documents to the Holder and the Company’s transfer agent (the “Transfer Agent”).  On or before the second (2nd) Business Day following the date on which the Company has received all of the Exercise Delivery Documents, the Company shall (X) provided that the Transfer Agent is participating in The Depository Trust Company (“DTC”) Fast Automated Securities Transfer Program and the Warrant Shares may be issued without any restrictive legends, upon the request of the Holder, credit such aggregate number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the Holder’s or its designee’s balance account with DTC through its Deposit Withdrawal Agent Commission system, or (Y) if the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program or the Warrant Shares are required to bear a restrictive legend, issue and dispatch by overnight courier to the address as specified in the Exercise Notice a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of shares of Common Stock to which the Holder is entitled pursuant to such exercise, which certificate shall (if required) bear the legend set forth in Exhibit B hereto.  Upon delivery of the Exercise Delivery Documents, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date such Warrant Shares are credited to the Holder’s DTC account or the date of delivery of the certificates evidencing such Warrant Shares, as the case may be.  If this Warrant is submitted in connection with any exercise pursuant to this Section 1(a) and the aggregate number of Warrant Shares represented by this Warrant at the time this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired upon such exercise, then the Company shall as soon as practicable, and in no event later than five (5) Business Days after any exercise and at its own expense, issue a new Warrant (in accordance with Section 6(d)) representing the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant is then exercised.  No fractional shares of Common Stock are to be issued upon the exercise of this

 

2



 

Warrant, but rather the number of shares of Common Stock to be issued shall be rounded up to the nearest whole number.  The Company shall pay any and all taxes (other than taxes based upon the income of the Holder) which may be payable with respect to the issuance and delivery of the Warrant Shares upon exercise of this Warrant.

 

(b)   Exercise Price.  For purposes of this Warrant, “Exercise Price” means $1.03 per Warrant Share, subject to adjustment as provided herein.

 

(c)   Company’s Failure to Timely Deliver Securities.  If within three (3) Trading Days after the Company’s receipt of the Exercise Delivery Documents the Company shall fail to issue and deliver a certificate to the Holder and register such shares of Common Stock on the Company’s share register or credit the Holder’s balance account with DTC for the number of unrestricted shares of Common Stock to which the Holder is entitled upon the Holder’s exercise hereunder, and if on or after such Trading Day the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of shares of Common Stock issuable upon such exercise that the Holder anticipated receiving from the Company, then the Company shall, within three (3) Business Days after the Holder’s request and in the Holder’s discretion, either (i) pay cash to the Holder in an amount equal to the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased (the “Buy-In Price”), at which point the Company’s obligation to deliver such certificate (and to issue such Warrant Shares) shall terminate, or (ii) promptly honor its obligation to deliver to the Holder a certificate or certificates representing such Warrant Shares and pay cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (A) such number of shares of Common Stock so purchased at the Buy-In Price, times (B) the Weighted Average Price on the date of exercise.

 

(d)   Cashless Exercise.  Notwithstanding anything contained herein to the contrary, if a Registration Statement (as defined in the Registration Rights Agreement) covering the Warrant Shares is not available for the resale of such Warrant Shares, the Holder may, in its sole discretion, exercise this Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the Aggregate Exercise Price, elect instead to receive upon such exercise the “Net Number” of shares of Common Stock determined according to the following formula (a “Cashless Exercise”):

 

Net Number = (A x B) - (A x C)

 

B

 

For purposes of the foregoing formula:

 

A= the total number of shares with respect to which this Warrant is then being exercised.

 

B= the Weighted Average Price of the shares of Common Stock (as reported by Bloomberg) on the date immediately preceding the date of the Exercise Notice.

 

3



 

C= the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.

 

(e)   Limitations on Exercises; Beneficial Ownership.  Notwithstanding anything to the contrary contained herein, the number of Warrant Shares that may be acquired by the Holder upon any exercise of this Warrant (or otherwise in respect hereof) shall be limited to the extent necessary to ensure that, following such exercise (or other issuance), the total number of shares of Common Stock then beneficially owned by the Holder and its Affiliates, and any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act, does not exceed 4.99% of the total number of then issued and outstanding shares of Common Stock (including for such purpose the shares of Common Stock issuable upon such exercise), provided that the foregoing shall not apply if the Holder and its Affiliates as of the date of this Warrant beneficially own more than 4.99% of the total number of issued and outstanding shares of Common Stock. By written notice to the Company, the Holder may waive the provisions of this Section 1(e), but any such waiver will not be effective until the 61st day after delivery of such notice, nor will any such waiver affect any other Holder.  For such purposes, beneficial ownership shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.  To the extent that the limitation contained in this Section 1(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by such Holder) and of which a portion of this Warrant is exercisable shall be in the sole discretion of a Holder, and the submission of a Exercise Notice shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by such Holder) and of which portion of this Warrant is exercisable, in each case subject to such aggregate percentage limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. For purposes of this Warrant, in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company’s most recent Form 10-K, Form 10-Q, Current Report on Form 8-K or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.  For any reason at any time, upon the written request of the Holder, the Company shall within two (2) Business Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.  This provision shall not restrict the number of shares of Common Stock which a Holder may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive in the event of a Merger Event as contemplated in Section 3(b) of this Warrant.

 

(f)    Insufficient Authorized Shares.  The Company covenants that during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.  Notwithstanding the foregoing, if at any time while any of the Warrants remain outstanding the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation to reserve for issuance upon exercise of the Warrants at least a number of shares of Common Stock equal to 100% (the “Required Reserve Amount”) of the number of shares of Common Stock as shall from time to time be necessary to effect the exercise of all of the Warrants then outstanding, then

 

4



 

the Company shall use its best efforts to increase the Company’s authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the Required Reserve Amount for the Warrants then outstanding.

 

(g)   Disputes.  In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed and resolve such dispute in accordance with Section 12.

 

2.     ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES.  The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:

 

(a)   Adjustment upon Subdivision or Combination of Common Stock.  If the Company at any time on or after the Purchase Date subdivides (by any stock split, stock dividend, recapitalization or otherwise) its outstanding shares of Common Stock into a larger number of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the number of Warrant Shares will be proportionately increased.  If the Company at any time on or after the Purchase Date combines (by combination, reverse stock split or otherwise) its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately decreased.  Any adjustment under this Section 2(a) shall become effective at the close of business on the date the subdivision or combination becomes effective.

 

(b)   Pro Rata Distributions.  If the Company, at any time while this Warrant is outstanding, distributes to all holders of Common Stock for no consideration (i) evidences of its indebtedness, (ii) any security (other than a distribution of Common Stock covered by the preceding paragraph) or (iii) rights or warrants to subscribe for or purchase any security, or (iv) any other asset, including cash (in each case, “Distributed Property”), then, upon any exercise of this Warrant that occurs after the record date fixed for determination of stockholders entitled to receive such distribution, the Holder shall be entitled to receive, in addition to the Warrant Shares otherwise issuable upon such exercise (if applicable), the Distributed Property that such Holder would have been entitled to receive in respect of such number of Warrant Shares had the Holder been the record holder of such Warrant Shares immediately prior to such record date.

 

(c)   De Minimis Adjustments.  No adjustment in the Exercise Price shall be required unless such adjustment would require an increase or decrease of at least $0.01 in such price, provided, however, that any adjustment which by reason of this Section 2(c) is not required to be made shall be carried forward and taken into account in any subsequent adjustments under this Section 2.  All calculations under this Section 2 shall be made by the Company in good faith and shall be made to the nearest cent or to the nearest one hundredth of a share, as applicable.  No adjustment need be made for a change in the par value or no par value of the Company’s Common Stock.

 

5



 

(d)   Voluntary Adjustment By Company.  The Company may at any time during the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors of the Company.

 

3.   PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS.

 

(a)   Purchase Rights.  In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.

 

(b)   Effect of Reclassification, Consolidation, Merger or Sale.

 

(1)   Upon the occurrence of a Merger Event (as defined below) as a result of which the holders of Common Stock shall be entitled to receive cash, securities or other property or assets with respect to or in exchange for such Common Stock, then at the effective time of the Merger Event, the right to exercise this Warrant will be changed into a right to exercise this Warrant into the type and amount of shares of stock, other securities or other property or assets (including cash or any combination thereof) that a holder of a number of shares of Common Stock issuable upon exercise of this Warrant immediately prior to such Merger Event would have owned or been entitled to receive (the “Reference Property”) upon such Merger Event. If the Merger Event causes the Common Stock to be converted into, or exchanged for, the right to receive more than a single type of consideration (determined based in part upon any form of stockholder election), the Reference Property to be received upon exercise will be deemed to be the weighted average of the types and amounts of Reference Property to be received by the holders of Common Stock that affirmatively make such election.  The terms of any agreement pursuant to which a Merger Event is effected shall include terms requiring the Successor Entity (and, if an entity different from the successor or surviving entity, the entity whose capital stock or assets the holders of Common Stock are entitled to receive as a result of such Merger Event) to comply with the provisions of this Section 3(b)(1) and ensuring that the Warrant (or any such replacement security) will be similarly adjusted in accordance with Sections 2 and 3 hereof upon any subsequent transaction analogous to a Merger Event.  If the Company consummates a Merger Event, the Company shall promptly provide notice to the Holder briefly describing the Merger Event and stating the type or amount of cash, securities, property or other assets that will comprise the Reference Property after any such Merger Event and any adjustment to be made with respect thereto.

 

(2)   Notwithstanding the provisions of Section 3(b)(1) of this Warrant, in the event of the consummation of a Merger Event that is (A) an all-cash transaction, (B) a “Rule 13e-3 transaction” as defined in Rule 13e-3 under the Exchange Act or (C) a Merger

 

6



 

Event involving a person or entity whose securities are not traded on an Eligible Market, at the request of the Holder delivered at any time commencing on the earliest to occur of (x) the public disclosure of the Merger Event or (y) the consummation of the Merger Event, through the date that is ninety (90) days after the public disclosure of the consummation of such Merger Event by the Company pursuant to a Current Report on Form 8-K filed with the SEC, the Company or the Successor Entity (as the case may be) shall purchase this Warrant from the Holder on the later of (i) the date of consummation of the Merger Event and (ii) the fifth Trading Day following the date of such request, in each case by paying to the Holder cash in an amount equal to the Black Scholes Value.

 

(3)   The above provisions of this Section 3(b) shall similarly apply to successive Merger Events and shall be applied without regard to any limitations on the exercise of this Warrant.

 

(4)   In addition to the definitions set forth in this Warrant, for purposes of this Section 3(b),

 

(A)  Black Scholes Value” means the value of the unexercised portion of this Warrant remaining on the date of the Holder’s request pursuant to Section 3(b)(2) of this Warrant, which value is calculated using the Black Scholes Option Pricing Model obtained from the “OV” function on Bloomberg utilizing (i) an underlying price per share equal to the greater of (1) the highest Closing Sale Price of the Common Stock during the period beginning on the Trading Day immediately preceding the earlier to occur of (x) the public disclosure of the applicable Merger Event or (y) the consummation of the applicable Merger Event and ending on the Trading Day of the consummation of the Merger Event and (2) the sum of the price per share being offered in cash in the applicable Merger Event (if any) plus the value of the non-cash consideration being offered in the applicable Merger Event (if any), (ii) a strike price equal to the Exercise Price in effect on the date of the Holder’s request pursuant to Section 3(b)(2) of this Warrant, (iii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the greater of (1) the remaining term of this Warrant as of the date of the Holder’s request pursuant to Section 3(b)(2) of this Warrant and (2) the remaining term of this Warrant as of the date of consummation of the applicable Merger Event and (iv) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public disclosure of the applicable Merger Event.

 

(B)  “Merger Event” means the occurrence of any of the following: (i) any reorganization, recapitalization or reclassification of the outstanding shares of Common Stock (other than a change in par value, or from par value to no par value, or from no par value to par value, or as a result of a split, subdivision or combination covered by Section 2(a) of this Warrant), (ii) any consolidation or merger with another Person (whether or not the Company is the surviving corporation), (iii) sale of all or substantially all of the Company’s assets, (iv) a binding share exchange which reclassifies or changes the outstanding shares of Common Stock, (v) the Company, directly or indirectly, consummates a stock purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any

 

7



 

shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock purchase agreement or other business combination) or (vi) any transaction which results in any “person” or “group” (as these terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act) becoming the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock.

 

(C)  “Parent Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent equity security is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Merger Event.

 

(D)  “Successor Entity” means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Merger Event or the Person (or, if so elected by the Holder, the Parent Entity) with which such Merger Event shall have been entered into.

 

4.   PROVISIONS AS TO SHARES.  The Company (i) shall not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect and (ii) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant.

 

5.   WARRANT HOLDER NOT DEEMED A STOCKHOLDER.  Except as otherwise specifically provided herein, the Holder, solely in such Person’s capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person’s capacity as the Holder of this Warrant, any of the rights of a shareholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant.  In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a shareholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.  Notwithstanding this Section 5, the Company shall provide the Holder with copies of the same notices and other information given to the shareholders of the Company generally, contemporaneously with the giving thereof to the shareholders.

 

6.   REISSUANCE OF WARRANTS.

 

(a)   Transfer of Warrant.  If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, together with a written assignment of this Warrant duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes

 

8



 

payable upon the making of such transfer, if any, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 6(d)), registered as the Holder may request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 6(d)) to the Holder representing the right to purchase the balance of the number of Warrant Shares not being transferred.

 

(b)   Lost, Stolen or Mutilated Warrant.  Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company reasonably satisfactory to the Company and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder a new Warrant (in accordance with Section 6(d)) representing the right to purchase the Warrant Shares then underlying this Warrant.

 

(c)   Exchangeable for Multiple Warrants.  This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company, for a new Warrant or Warrants (in accordance with Section 6(d)) representing in the aggregate the right to purchase the number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares as is designated in writing by the Holder at the time of such surrender; provided, however, that no Warrants for fractional shares of Common Stock shall be given.

 

(d)   Issuance of New Warrants.  Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 6(a) or Section 6(c), the Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the other new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date, and (iv) shall have the same rights and conditions as this Warrant.

 

7.   NOTICES.  Whenever notice is required or permitted to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance with Section 6.1 of the Purchase Agreement.  The Company shall provide the Holder with prompt written notice of all actions taken pursuant to this Warrant, including in reasonable detail a description of such action and the reason therefor.  Without limiting the generality of the foregoing, the Company will give written notice to the Holder (i) promptly upon any adjustment of the Exercise Price, setting forth in reasonable detail the calculation of such adjustment, and (ii) at least fifteen days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the shares of Common Stock, or (B) for determining rights to vote with respect to any Merger Event, dissolution or liquidation, provided in each case that such information shall be made known to the public prior to or in conjunction with such notice being provided to the Holder.

 

9



 

8.        AMENDMENT AND WAIVER.  Except as otherwise provided herein, the provisions of this Warrant may be amended only in the manner provided in Section 6.6 of the Purchase Agreement and the Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent of the Holders representing a “Majority in Interest” within the meaning of the Purchase Agreement.  The Company shall give prompt written notice to the Holder of any amendment hereof or waiver hereunder that was effected without the Holder’s written consent.

 

9.        GOVERNING LAW.  This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York.

 

10. SEVERABILITY.  If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties.  The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).

 

11. CONSTRUCTION; HEADINGS.  This Warrant shall be deemed to be jointly drafted by the Company and all the Lenders and shall not be construed against any person as the drafter hereof.  The headings of this Warrant are for convenience of reference and shall not form part of, or affect the interpretation of, this Warrant.

 

12. DISPUTE RESOLUTION.  In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall submit the disputed determinations or arithmetic calculations via facsimile within five (5) Business Days of receipt of the Exercise Notice giving rise to such dispute, as the case may be, to the Holder.  If the Holder and the Company are unable to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three Business Days of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two Business Days submit via facsimile (a) the disputed determination of the Exercise Price to an independent, reputable investment bank selected by the Company and approved by the Holder (or, if the dispute affects multiple Holders, to a majority in interest of such Holders) or (b) the disputed arithmetic calculation of the Warrant Shares to the Company’s independent, outside accountant.  The Company shall cause at its expense the investment bank or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the

 

10



 

Holder of the results no later than ten Business Days from the time it receives the disputed determinations or calculations.  Such investment bank’s or accountant’s determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error.

 

13. REMEDIES, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF.  The remedies provided in this Warrant shall be cumulative and in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply with the terms of this Warrant.  The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate.  The Company therefore agrees that, in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security being required.

 

14. TRANSFER.       Subject to applicable law, this Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company, except as may otherwise be required by Section 3.3 of the Purchase Agreement.

 

15. PRINCIPAL MARKET.    In no event shall the Company be required to adjust the Exercise Price or the number of shares issuable upon exercise of the Warrant if such adjustment would violate the listing requirements of the Company’s Principal Market.  In addition, the Company will not take any voluntary action that would result in an adjustment to the Exercise Price pursuant to this Warrant (other than pursuant to Section 2(a)) without complying, if applicable, with the stockholder approval rules of the Principal Market and any similar rule of any stock exchange on which the Company’s common stock is listed at the relevant time.  In accordance with such listing standard, this restriction will apply at any time when the Warrants are outstanding, regardless of whether the Company then has a class of securities listed on the Principal Market.

 

16. CERTAIN DEFINITIONS.  For purposes of this Warrant, the following terms shall have the following meanings:

 

(a)         Bloomberg” means Bloomberg Financial Markets.

 

(b)         Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York or Oakland, California are authorized or required by law to remain closed.

 

(c)          Closing Bid Price” and “Closing Sale Price” means, for any security as of any date, the last closing bid price and last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade price, as the case may be, then the last bid price or last trade price, respectively, of such security prior to 4:00 p.m., New York time, as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security, the last closing bid

 

11



 

price or last trade price, respectively, of such security on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade price, respectively, of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or, if no closing bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of the bid prices, or the ask prices, respectively, of any market makers for such security as reported in the “pink sheets” by Pink Sheets LLC (or any such similar service).  If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price or the Closing Sale Price, as the case may be, of such security on such date shall be the fair market value as mutually determined by the Company and the Holder.  If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved pursuant to Section 12.  All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period.

 

(d)         Common Stock” means (i) the Company’s shares of Common Stock, par value $0.01 per share, and (ii) any share capital into which such Common Stock shall have been changed or any share capital resulting from a reclassification of such Common Stock.

 

(e)          Convertible Securities” means any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable for shares of Common Stock.

 

(f)           Dollar”, “US Dollar” and “$” each mean the lawful money of the United States.

 

(g)          Eligible Market” means the Principal Market, The New York Stock Exchange, Inc., the American Stock Exchange, The NASDAQ Global Select Market, The NASDAQ Global Market, The NASDAQ Capital Market or the OTC Markets Group Inc.

 

(h)         Expiration Date” means the date that is 36 months after the Closing Date or, if such date falls on a day other than a Business Day or on which trading does not take place on the Principal Market (a “Holiday”), the next date that is not a Holiday.

 

(i)             Options” means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.

 

(j)            Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity and a government or any department or agency thereof.

 

(k)         Principal Market” means OTC Markets Group Inc.

 

(l)             Reference Property” shall have the meaning set forth in Section 3(b).

 

(m)     Trading Day” means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market for the

 

12



 

Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded; provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00 p.m., New York time).

 

(n)         Weighted Average Price” means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg through its “Volume at Price” function or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York City time, and ending at 4:00:00 p.m., New York City time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in the “pink sheets” by Pink Sheets LLC (formerly the National Quotation Bureau, Inc.).  If the Weighted Average Price cannot be calculated for such security on such date on any of the foregoing bases, the Weighted Average Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder.  If the Company and the Holder are unable to agree upon the fair market value of the such security, then such dispute shall be resolved pursuant to Section 12 with the term “Weighted Average Price” being substituted for the term “Exercise Price.” All such determinations shall be appropriately adjusted for any share dividend, share split or other similar transaction during such period.

 

[Signature Page Follows]

 

13



 

IN WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date set out above.

 

 

 

SCIENTIFIC LEARNING CORPORATION

 

 

 

 

 

 

 

By:

/s/ Jane A. Freeman

 

Name:

Jane A. Freeman

 

Title:

CFO

 

[Signature Page to Warrant]

 



 

EXHIBIT A

 

EXERCISE NOTICE

 

TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

WARRANT TO PURCHASE COMMON STOCK

 

SCIENTIFIC LEARNING CORPORATION

 

The undersigned holder hereby exercises the right to purchase                                    of the shares of Common Stock (“Warrant Shares”) of Scientific Learning Corporation, a corporation organized under the laws of Delaware (the “Company”), evidenced by the attached Warrant to Purchase Common Stock (the “Warrant”).  Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

 

1.  Form of Exercise Price.  The Holder intends that payment of the Exercise Price shall be made as:

 

o                                    a “Cash Exercise” with respect to                                    Warrant Shares and in connection therewith by checking such box hereby certifies that such Holder is an “accredited investor” within the meaning of Rule 501 of the Securities Act; and/or

 

o                                    a “Cashless Exercise” with respect to                                Warrant Shares.

 

2.  Payment of Exercise Price.  In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be issued pursuant hereto, the holder shall pay the Aggregate Exercise Price in the sum of $                                       to the Company in accordance with the terms of the Warrant.

 

3.  Delivery of Warrant Shares.  The Company shall deliver to the holder                      Warrant Shares in accordance with the terms of the Warrant.

 

Date:                                    ,

 

 

 

Name of Registered Holder

 

 

 

By:

 

 

 

Name:

 

 

Title:

 

 



 

ACKNOWLEDGMENT

 

The Company hereby acknowledges this Exercise Notice and hereby directs                                        to issue the above indicated number of shares of Common Stock in accordance with the Transfer Agent Instructions dated                   , 2013 from the Company and acknowledged and agreed to by                                       .

 

 

SCIENTIFIC LEARNING CORPORATION

 

 

 

 

 

By:

 

 

Name:

 

 

Title:

 

 



 

Exhibit B

 

THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS.